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ABSTRACT
Synthesis, Characterization and Capillary Electrophoretic Use of New, Single-isomer
Hexasulfated a-Cyclodextrins. (May 2004)
Shulan Li, B.S., Shandong University of Building Material;
M.S., Shandong University
Chair of Advisory Committee: Dr. Gyula Vigh
The first three, pure, single-isomer, 6-O-sulfo a-cyclodextrins, the sodium salts of
hexakis(6-O-sulfo)-a-CD (HxS), hexakis(2,3-di-O-methyl-6-O-sulfo)-a-cyclodextrin
(HxDMS) and hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-cyclodextrin (HxDAS) have been
synthesized, analytically characterized and utilized as chiral resolving agents in capillary
electrophoresis. The purity of each synthetic intermediate and of the final product was
determined by HPLC-ELSD and  indirect UV-detection capillary electrophoresis. The
structural identity of each intermediate and final product was verified by 1D and 2D NMR, and
mass spectrometry.
HxS, HxDMS and HxDAS have been used to separate a series of neutral, basic,
ampholytic and acidic enantiomers in pH 2.5 and pH 9.5 aqueous and acidic methanol
background electrolytes using capillary electrophoresis. Rapid separations with satisfactory
peak resolution values were obtained for most of the analytes,  indicating that HxS, HxDAS and
HxDMS can serve as chiral resolving agent for a wide range of analytes. The observed
separation patterns follow the predictions of the CHArged Resolving agent Migration
(CHARM) model. The separation patterns observed with HxS, HxDAS and HxDMS as chiral
resolving agent were compared with those of (1) b-cyclodextrin analogues, such as, heptakis(6-
iv
O-sulfo)-b-cyclodextrin (HS), heptakis(2,3-di-O-acetyl-6-O-sulfo)-b-cyclodextrin (HDAS)
and heptakis(2,3-di-O-methyl-6-O-sulfo)-b-cyclodextrin (HDMS); (2) g-cyclodextrin
analogues, such as, octakis(6-O-sulfo)-g-cyclodextrin (OS), octakis(2,3-di-O-acetyl-6-O-
sulfo)-g-cyclodextrin (ODAS) and octakis(2,3-di-O-methyl-6-O-sulfo)-g-cyclodextrin
(ODMS). The effects of the structure of the analytes, and those of the pH and the solvent of the
background electrolyte were also studied.
vTo my husband, Xiaodong, my daughter, Tong, my parents, Peiqiao and Qinying, and
parents-in-law, Chuntian and Baorong for their unconditional support.
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1CHAPTER I
INTRODUCTION
1.1 Enantiomers Separation and Capillary Electrophoresis
 For many synthetic, biological organic compounds and widely prescribed drugs,
chirality is one of their important properties [1]. When a chiral environment is absent, the
enantiomers cannot be differentiated because they have the same physical and chemical
properties. However, enantiomers can be distinguished in a chiral environment, such as in
biological systems, including human bodies [2], which can lead to different pharmacokinetic,
pharmacologic and toxicologic  properties for the enantiomers. For some of the chiral drugs,
one of the enantiomers exhibits the desired biological or pharmaceutical activity, which the
other enantiomer can be inactive, or have side effects, even toxic effects. Therefore, the
pharmacological effects and metabolic pathways for each enantiomer of a new chiral drug must
be studied before it is approved for use in humans [3,4]. Since enantiomeric separation on an
analytical scale is required both for monitoring the enantiomeric purity of the chiral drug, and
for performing drug metabolism, pharmacokinetic and clinical studies, separation techniques
play an important and essential role [5].
Different techniques can be used for enantiomer separations, such as gas
chromatography (GC) [6],  high performance liquid chromatography (HPLC), including both
reversed phase and normal phase HPLC [7-21], supercritical fluid chromatography (SFC)
_________
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2[22,23], capillary electrochromatography (CEC) [22-26], and capillary electrophoresis
(CE)[27-35]. Though the separation efficiency of capillary GC is high, it is limited to the
analysis of volatile analytes or their derivatives. Compared to CE, HPLC has lower separation
efficiency and requires larger amounts of chiral resolving agents. SFC with a chiral stationary
phase has the same disadvantages as HPLC. The use of CE for enantiomer separation has
attracted considerable attention as a result of its distinct separation mechanism, high separation
efficiency, versatility, low running costs, rapid method development, speed of analysis, small
sample volumes, and low consumption of chiral resolving agents and solvents [33, 36-46].
There are indirect and direct CE enantiomer separation methods. Compared to the indirect CE
method, which needs to introduce another chiral center into the target analyte to form two
diastereomers, the direct CE method simply requires the addition of a chiral selector to the
BGEs [26, 33, 46].
1.1.1 Generation of EOF and Its Roles
The electroosmotic flow (EOF), which acts as the pump in HPLC but without the
mechanical complexity of HPLC pump, is one of the advantages of CE [47]. The EOF is
generated due to the partial dissociation of silanol groups on the inner surface of the fused
silica capillary which creates immobile negative surface charges. In order to maintain electric
neutrality, the immobile SiO- groups attract mobile cations from the background electrolytes
(BGEs). Some of the cations from the BGEs are attracted strongly and form the compact (Stern)
layer. The less-tightly held cations in the diffuse (Gouy-Chapman) layer are farther out into the
solution. Thus, a double layer is formed, and the potential at the shear plane  between these two
layers is known as the zeta (z) potential [48]. During a CE run, when potential is applied
3across the capillary, charged particles outside the shear plane move with a constant velocity.
The solvated mobile cations in the diffuse layer migrate toward the cathode dragging along
their hydrate layer (bulk solvent). Since the SiO- groups can not move, an unbalanced bulk
flow, the electroosmotic flow (EOF) arises. The radial velocity profile of electroosmotic flow
is plug-like, not parabolic as with pressure driven flow [49]. This eliminates the most
significant band broadening mechanisms (parabolic flow profile, multiple flow paths) that limit
column efficiency in HPLC and provides CE with an order of magnitude higher separation
efficiency than HPLC. When the reciprocal of the Debye-Huckel parameter, 1/k, called the
thickness of the double layer, is much smaller than the radius of a capillary r, the
electroosmotic flow velocity n eo depends on the permittivity of the medium (e), the dielectric
constant (e0), the zeta potential of the capillary wall (z), the dynamic viscosity of the medium
(h) and the applied electric field strength (E). The relationship
between these parameters  can be described by the following formula [47]:
    n eo= -ze0eE/h                                         (1)
Here, the negative sign means that when z is negative, the bulk flow is toward the negative
electrode. The z potential, whose value depends on the surface charge density (s), ionic
strength (I), the permittivity of the medium (e) and the dielectric constant (e0), can be written
as [47]:
                  z=-s(RT/e0eIF2)½/h                                      (2)
Thus,
4meo=neo/E=-ze0e/h=s(e0eRT/IF2)1/2/h                             (3)
i.e. EOF mobility depends on the ionic strength (I) and the viscosity of the solution. Since
viscosity changes around 2 % /oC, it is mandatory to control the temperature in capillary
electrophoresis. 
In CE, separation of the charged analytes depends on their mobility (m) difference in
the applied electric field, which is proportional to their charge to hydrodynamic size ratios:
m=z/(6hpr)                                           (4)
where z is the charge number of the analyte, r is the hydrodynamic radius of the analyte ion, and
h is the viscosity of the solution. Charged molecules migrate with the observed mobility (m obs)
which is a combination of their electrophoretic mobility (m eff ) and the non-selective 
electroosmotic mobility (m eo):
mobs=me f f+meo                                   (5)
Since non-charged molecules have zero effective mobilities, they will arrive the detector at the
same time by migrating with the electroosmotic flow (EOF), a charged agent need to be used
to separate neutral components from each other in CE.
1.1.2 Role of Background Electrolytes
The major purposes of BGEs are to conduct the electric current for the separation of
analytes and to regulate the pH. Suitable BGEs must contain enough ions (including cations or
5anions) to transport the electric current, and also must have significant buffering capacity at the
selected pH [50]. When a voltage is applied across the capillary and generates an electric
current, the temperature of the solution increases due to generation of Joule heat. The increased
temperature of the solution will change the properties of the BGEs (such as viscosity, EOF,
etc.). Joule heat will also cause temperature differences (DT) between the walls and the center
of the capillary [51]. DT depends on the electric field strength (E), the
 conductivity of the solution (k)and the capillary radius (r) [51]:
D T ~ E 2 k r 2                ( 6 )
The temperature difference leads to extra peak broadening which in turn decreases separation
efficiency and peak resolution. According to Equation 6,  low-conductive BGEs, which can
bring low currents, are preferred. 
The mobility of EOF mainly depends on the pH and ionic strength of the BGEs. Analyte
mobility (m) also strongly depends on the ionic strength (I) and the charge of the 
analyte (z) [52-54].
    m=exp(-0.77(zI)1/2)               (7)
where,      I=0.5Scizi2                         (8)
and ci is the concentration of the component i of the BGE, and zi is the charge of the component.
Higher BGEs ionic strength will lower both the analyte and EOF mobilities.
61.2 Chiral Resolving Agents and Charged Cyclodextrins
By adding a chiral resolving agent to the BGEs to provide enantioselective
intermolecular interactions, the enantiomers may form diastereomeric complexes with the chiral
resolving agent in a dynamic equilibrium process. If the complexation constants of the
enantiomers with the chiral resolving agent are different, enantiomer separations in CE can be
achieved. The chiral resolving agents can be crown ethers [55-57], macrocyclic antibiotics
[58-62], cyclopeptides [63, 64], proteins [65, 66], chiral surfactants (including amino acid
based surfactants, bile salts and glycosidic surfactants) [67, 68], chiral calixarenes [69],
polysaccharides and  cyclic carbohydrates [70, 71], cyclodextrins (CD) [33, 36, 72-74], etc.
Among all the resolving agents that were used, CDs proved to be the most useful [33, 36, 72-
74]. Native CDs are relatively cheap, stable, have low toxicity, are relatively soluble in
aqueous BGEs, and are transparent above 210 nm which makes UV detection possible [33, 36,
72-74]. Native CDs are neutral, cyclic, nonreducing oligosaccharides obtained from enzymatic
degradation of starch, and consist of six (a-), seven (b-), and eight (g-) D(+)-glucopyranose
units bonded through a-(1,4) linkages to form truncated cones with relatively hydrophobic
cavities and hydrophilic exteriors. The crystallographic diameter of the hydrophobic cavity is
0.57, 0.78, and 0.95 nm for a-, b-, and g- CD, respectively [75]. The secondary hydroxyl
groups are located on the wider side of the cone, while the primary hydroxyl group are located
on the narrow side of the cone. CDs can form inclusion complexes with a wide range of small
molecules. Chiral recognition in CDs comes from the five asymmetric chiral carbons on each
glucose units [72]. Depending on the inner diameter of the cavity of the CDs and the size of the
analytes, analytes can form host-guest complexes in dynamic equilibrium with CDs through full
or partial inclusion into cavities of the CDs. Formation and stabilization of the host-guest
7inclusion complexes is influenced by the steric parameters of the analytes, and by the
possibility of creating intermolecular interactions, such as hydrogen bonding, Van der Waals
interactions, metal coordination, Coulombic interactions, and hydrophobic interactions between
substituents of the analyte and the CDs [76]. The interaction strength of the two enantiomers
with the host-cyclodextrin molecule will be different from each other, which leads to different
complex  formation constants. This, in turn, leads to different electrophoretic mobilities and
possibly CE separation. 
The hydroxyl groups of CDs can be chemically modified to enhance the hydrophobicity
of the CD by alkylation or to improve their solubility by adding polar or nonpolar groups to the
CDs. Derivatization of a-, b-, and g-CDs can change their chiral recognition ability and their
physicochemical properties (such as, their solubilities in selected solvents).  
Native CDs and their neutral derivatives, such as, 2,6-dimethyl-, 3,6-dimethyl-, 2,3,6-
trimethyl- [77, 78],  2,3-diacetyl-, 2,3- hydroxyethyl, 2,3-hydroxypropyl- [26, 79],  cyanoethyl
[80], mono-3-phenylcarbamoyl [81], have been used extensively as chiral resolving agents in
CE. They can not be used to separate neutral analytes since neutral analytes have zero effective
mobility. Charged cyclodextrin derivatives provide at least two important advantages over
neutral CDs. First, both neutral analytes and charged analytes can be enantioresolved with
charged CDs. Second, the introduction of ionic groups onto the CD rim or connected to it via
a short alkyl chain enhances the solubility of charged CDs in aqueous media  [74, 82]. Charged
cyclodextrin derivatives, including weak and strong electrolyte cationic and anionic derivatives
have been used as chiral resolving agents to separate neutral analytes. Though weak electrolyte
CDs, including anionic carboxymethyl-, carboxyethyl-, succinyl-, phosphate- [83, 84] and
cationic methylamino-, ethylamino-,  mono-6-amino-6-deoxy, mono-6-b-aminoethylamino-6-
8deoxy- [76, 85-87] derivatives, can provide special selectivity for certain analytes, their
charge number depends on the pH and can only be used in a limited pH range. The zwitterionic
CDs derivatives [88-89], for example mono-6-d-glutamylamino-6-deoxy-b-CD [88], also
behave as weak electrolytes CDs derivatives and their charge depends on  the pH of the buffer.
Strong electrolyte CDs, including cationic and anionic derivatives can be used over the
entire working pH range of CE and make optimization of enantiomer separations possible.
However, cationic CDs, such as quaternary ammonium-b-CD, 2-hydroxy-3-
trimethylammoniumpropyl-b-CD, 6-tris(hydroxyethylamino)-b-CD, 2-hydroxypropyltrimethyl
ammonium b-CD  [90-92] adsorb on the negatively-charged wall of the fused silica capillary
and act as a stationary phase, which reduces the separation efficiency. Therefore permanently-
charged, anionic CDs, including sulfoethyl ether-, sulfopropyl ether-, sulfobutyl ether- [93-96],
and sulfated-CDs [97, 98], which cannot adsorb on the negatively charged wall, have attracted
attention.
Most commercially available charged CDs are randomly substituted,  which means that
they are complex mixtures of different isomers with different substitution positions and different
degrees of substitution. The effective mobilities of the CD isomers differ when their degree of
substitution is different. The complexation rates of the different CD isomers are also slightly
different, consequently kinetic band broadening can occur, and lead to decrease of separation
efficiency. Each CD isomer may have their own selectivity for a given pair of enantiomers.
Mixtures of CD isomers may reduce, cancel or enhance the overall separation selectivity of a
CE system. With resolving agent mixtures, fundamental molecular-level studies, such as NMR,
crystallographic, and molecular modeling studies, which can help the understanding of the
chiral recognition process are not possible. Compositional variation in the randomly substituted
9CDs in different batches can cause unpredictable separations [99-101]. All these problems
make rational experimental design difficult. Therefore, it is very important to synthesize single
isomer charged CDs with control over both the degree and the site of substitution. Since 1997,
Vigh and coworkers synthesized, purified and characterized a family of single-isomer CDs and
used them for CE enantiomer separations, including heptakis(6-sulfo)-b-CD [102],
heptakis(2,3-diacetyl-6-sulfo)-b-CD [103], heptakis(2,3-dimethyl-6-sulfo)-b-CD [104],
octakis(6-sulfo)-g-CD [105, 106], octakis(2,3-diacetyl-6-sulfo)-g-CD [107-109], octakis(2,3-
dimethyl-6-sulfo)-g-CD [110-112] and heptakis(2-methyl-3,6-di-sulfo)-b-CD [113].
1.3 Theoretical Background and CHARM Model
Several research groups have developed theoretical models to describe CE enantiomer
separations [114-118]. Wren and Rowe’s model [117] related the mobility to the
concentration of CD selectors:
Dmep=mA-mB=[C](mf-mc)(KB-KA)/{1+[C](KA+KB)+KAKB[C]2}     (9)
where, Dmep is the difference in the apparent electrophoretic mobility of the enantiomer pair,
mA and mB, mf is the electrophoretic mobility of the analyte in free solution, mc is the
electrophoretic mobility of the analyte-chiral resolving agent complex, KA and KB are
equilibrium constants, and [C] is the concentration of the chiral resolving agent. Selectivity,
which was expressed as the mobility difference, depends not only on the chiral discrimination
ability of the chiral resolving agent (expressed by the two binding constants KA, KB), but also
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on the mobility difference between the free and complexed forms of the enantiomers. In 1994,
Goodall [118] proposed another theoretical model to consider both mobility differences and
resolution. However, these models were only suitable for neutral analytes and charged chiral
resolving agents. 
In 1994, Vigh’s group introduced a multiple-equilibria-based model, called the
CHArged Resolving agents Migration model (CHARM model) [119], for  rational, predictable
design of separation with charged chiral resolving agents for the enantiomers of chiral weak
electrolytes (including weak acids and weak bases) and neutral analytes as a function of both
pH and the concentration of the single-isomer, permanently-charged cyclodextrins. According
to this paper, peak resolution and separation selectivity depend on the pH of the BGEs, the EOF
rate, the charge number of the resolving agent, the effective charge number of the analytes and
the CD concentration. Resolution of the two enantiomer 
peaks was expressed as [115, 119]:
  Rs~[(a-1)[(a+b)(1+b)(Z1)(Z2)]½ / {[(a+b)3(Z1)]½+[a(1+b)3Z2]½}                 (10)
Here, k is the Boltzman constant, eo is the electric charge, T is the absolute
temperature, l is the capillary length from injector to the detector, E is the electric field
strength, a is separation selectivity which can be defined as the mobility ratio of two 
enantiomers:
a=m1 e f f /m2 e f f                        (11)
and b is the normalized electroosmotic flow mobility, defined as:
11
 b=meo/m2 e f f                        (12)
Thus, peak  resolution depends on a, b and Zeff. If all the other parameters are kept constant,
the higher the Zeff , the higher the resolution. It also shows that initially, peak resolution
increases linearly with a. The a value depends on the ionic mobilities of the free and
complexed analytes, the binding constants, the pH of the BGEs, and the concentration of the
chiral resolving agent. Another key to the development of enantiomer separations is to optimize
the b term by using a coated capillary and / or appropriate background electrolyte constituents.
Under identical a and Zeff, peak resolution increases towards infinitely high values as b
approaches -1. As long as the CD shows any selectivity for the enantiomers, peak resolution
can be improved by optimizing b at the expense of increased analysis time.
Because a-, b-, and g- cyclodextrins and their corresponding derivatives have different
cavity sizes, their complexation strength with analytes will be different. Since single isomer,
sulfated a-CDs have not been made yet, this dissertation will discuss the synthesis, analytical
characterization and applications of a new class of single-isomer sulfated cyclodextrins,
hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-CD (HxDAS), hexakis(2,3-di-O-methyl-6-O-sulfo)-a-
CD (HxDMS) and hexakis(6-O-sulfo)-a-CD (HxS).
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CHARTER II
SYNTHESIS AND CHARACTERIZATION*
Single isomer CDs, sulfated b- and g-CD derivatives, are now commercially available.
In this work, the first three single-isomer, 6-sulfated a-CDs, the sodium salts of hexakis(2,3-di-
O-acetyl-6-O-sulfo)-a-CD (HxDAS), the sodium salts of hexakis(6-O-sulfo)-a-CD (HxS), and
the sodium salts of hexakis(2,3-di-O-methyl-6-O-sulfo)-a-CD (HxDMS) have been synthesized
on a large scale and analytically characterized.
2.1 Materials and General Methods
Except for native a-CD, which was purchased from Cargill (Hammond, IN, USA), all
chemicals used in this work were obtained from Aldrich Chemical Company (Milwaukee, WI,
USA). For the a-CD intermediates, progress of the reaction was monitored by thin layer
chromatography (TLC), using Silica-60 plates (E. M. Science, Gibbstown, NJ). The developed
plates were visualized by dipping them into an a-naphthol staining solution (mix 
26.25 g of a-naphthol, 315 ml of 100% ethanol, 105 ml of concentrated sulfuric acid, and 66
ml of distilled water) and heating for 10 min at 100oC. 
The purity of the intermediates was determined by analytical isocratic HPLC using a
Programmable Solvent Module 126 (Beckman-Coulter, Fullerton, CA), a Sedex Model 55
____________
* Part of this chapter is reprinted with permission from: S. L. Li and Gy. Vigh, Electrophoresis,
24 (2003) 2487-2498; Copyright 2003 - Wiley -VCH.
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evaporative light scattering detector (S.E.D.E.R.E., Alfortville, France), and an AD 406 data
acquisition system operated under Gold 8.1 software control (Beckman-Coulter) running on a
486DX4 personal computer (Computer Associates, College Station, TX). The separations were
obtained on a 4.6mm I. D. × 250mm column packed with a 5mm Zorbax ODS stationary phase
(Agilent, Newport, DE). The purity values reported in this dissertation were calculated on the
assumption that the response factors of the evaporative light scattering detector were the same
for all CD isomers. The progress of the sulfation reaction and the purity of the sulfated a-CD
products were monitored by indirect UV detection CE using a P/ACE 2000 system (Beckman-
Coulter), at 214 nm and 10 kV applied potential, on a 26.4 / 19.6 cm long, 26mm I. D. bare
fused silica capillary column (Polymicro Technologies, Phoenix, AZ). The cartridge coolant
of the P/ACE 2000 was thermostated at 20oC.
The molecular weight of the intermediates was obtained by high resolution MALDI-
TOF-MS. A Voyager Elite XL TOF mass spectrometer equipped with delayed extraction
capability (PerSeptive Biosystems, Framingham, MA) in reflectron mode, with an acceleration
voltage of 25 kV, 70% grid voltage, 0.035% guide wire voltage, and a delay of 180 ms, was
used to collect high-resolution mass spectra. The analytes were spotted onto a Teflon target
using the dried droplet method [120]. The matrix was prepared by dissolving 10 mg 2,4,6-
trihydroxyacetophenone in 1mL acetonitrile [121]. 
The molecular weight of  products HxDAS, HxS, and HxDMS were obtained by ESI-
TOF-MS with a Vestec Model 201-A single quadrupole mass spectrometer equipped with a
Vestec electrospray ion source (PerSeptive Biosystems). The sample was prepared at a
concentration of 4 mg/mL in an ACN : water 1:1 (v/v) solvent mixture.
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1H and 13C NMR spectra were measured on UnityPlus 300 and 500 spectrometers with
a quad nucleus (1H / 19F / 31P / 13C) probes, which employed Solaries 2.4 and Vnmrx 5.3 b
softwares. The proton (H) and carbon (C) assignments were based on the 1H-1H 2D COSY
(Correlation Spectroscopy) and 1H-13C HETCOR ( Heteronuclear Chemical Shift Correlation)
spectra.
The single crystal structure was obtained with a Bruker SMART 1000 X-ray
Diffractometer (Bruker AXS, Madison WI) to collect diffraction data, and the structure was
solved by the SHELXTL program suite [122]. Crystal structure figures and solvent-accessible
surfaces were obtained with the Insight II program, and the Connolly algorithm as implemented
in Insight II [123].
2.2 Synthesis and Characterization of HxDAS, HxS and HxDMS
Regioselective protection methods for the 2,3,6-hydroxyl groups of native a-CD were
used to synthesize, hexakis (2,3-di-O-acetyl-6-O-sulfo)-a-cyclodextrin (HxDAS), hexakis (6-
O-sulfo)-a-cyclodextrin (HxS), and hexakis (2,3-di-O-methyl-6-O-sulfo)-a-cyclodextrin
(HxDMS)according to the scheme shown in Figure 1. The details of the synthetic procedures
are outlined in Appendix.
2.2.1 Hexakis(6-O-tert-butyldimethylsilyl)-a-Cyclodextrin
According to a modified procedure of Takeo [102, 124], the primary hydroxyl groups
at the sixth position of the glucopyranose units of native a-CD (1) were protected by reacting
them with tert-butyldimethylchlorosilane in DMF and CH2Cl2 to produce hexakis (6-O-tert-
butyldimethylsilyl)-a-CD (intermediate (2)). The progress of the reaction was monitored by
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TLC, using aluminum-backed Silica 60 plates and 50:10:1 CHCl3 : CH3OH : H2O as running
solvent, giving an Rf=0.42 for intermediate (2). The purity of (2) was analyzed by isocratic
non-aqueous reverse phase HPLC, using a 4.6mm × 250mm Zorbax C18 column and a 20: 80
EtOAc : CH3OH mobile phase at 2mL / min at ambient temperature. Intermediate (2) with
purity > 99 % was obtained using methylethylketone (MEKT) as the recrystallizing solvent.
Figure 2 shows a non-aqueous, reversed-phase HPLC separation of (2) after recrystallization
and its corresponding MEKT mother liquor. The HPLC method can detect as little as  0.1%
impurity.
The structure of intermediate (2) was characterized by high resolution 1H and 13C NMR
spectroscopy. The peak assignments for 1H and 13C NMR were determined from the 1-
dimensional 1H and 13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-13C
HETCOR NMR spectroscopy (1H NMR data in CDCl3: d 4.90 (doublet, 6 H-1, J1-2 = 2.5 Hz);
d 4.03 (triplet, 6 H-3, J3-2 = 8.7 Hz, J3-4 = 8.7 Hz); d 3.94 (doublet, 6 H-6,  J6-6' = 11.6 Hz); d
3.84 (doublet, 6 H-5, J5-4  = 8.7 Hz); d 3.76 (doublet, 6 H-6', J6'-6 = 11.6 Hz); d 3.63,  3.59 ( 12
H-2, 4); d 0.89 ( singlet, 6 (CH3)3C); d 0.06, 0.05 (two sets of singlet, 6 (CH3)2Si); 13C NMR
data in CDCl3: d 101.78 (C-1); d 81.53 (C-4); d 74.60 (C-2); d 73.25 (C-3); d 72.46 (C-5); d
62.20 (C-6); d 26.21 ( (CH3)3C); d 18.65 ( (CH3)3C); d -4.93, -4.97 ( (CH3)2Si)).  1H - 1H
COSY and 1H - 13C HETCOR NMR spectra in Figures 3 and 4 show only those proton and
carbon contours that are related to the glucose unit. The tert-butyldimethylsilyl group portions
are omitted, since their chemical shift are far away from those of the glucose unit, and can be
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Figure 1. Synthesis scheme for  hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-CD (HxDAS),
hexakis(6-O-sulfo)-a-CD (HxS), and hexakis(2,3-di-O-methyl-6-O-sulfo)-a-CD (HxDMS).
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Figure 2. Chromatograms of crystalline (2) and its mother liquor. Purity of the product > 99 %.
Conditions: EtOAc : MeOH = 80 : 20, F = 2mL / min, C18 column.
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Figure 3. 2D COSY of (2) in CDCl3 using 300 mHz NMR.
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Figure 4. 2D HETCOR of (2) in CDCl3 using 300 mHz NMR.
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unambiguously assigned. 
High resolution MALDI-TOF-MS was used to determine the molecular weight of
intermediate (2). The MALDI-TOF-MS of the Na+ and K+ ion-adduct portion of intermediate
(2) is shown in Figure 5: the calculated molecular weight values of the Na+ and K+ ion-adducts
of the parent molecule, 1681.43 and 1697.53, agree well with the value obtained using
MALDI-TOF-MS, 1680.89 and 1696.88 for the Na+, K+ ion-adducts, respectively, indicating
the presence of six tert-butyldimethylsilyl groups on intermediate (2). 
To prove structural identity, a single crystal of intermediate (2) was grown by
dissolving intermediate (2) in ethanol to obtain a saturated solution, followed by evaporation
of the solvent at room temperature in air to give white, transparent, single crystals suitable for
x-ray diffraction analysis. The crystal structure of intermediate (2) is shown in Figure 6,
indicating that the tert-butyldimethylsilyl ether groups are located on C6 in each of the six
glucose subunits. The Connolly surface rendering of intermediate (2) demonstrated that this
intermediate has a large hydrophobic surface.
2.2.2 Hexakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)-a-Cyclodextrin
Hexakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)-a-CD (3), was obtained by
complete acetylation of the 2,3-hydroxyl groups of intermediate (2) with acetic anhydride in
ethyl acetate solvent. The progress of the reaction was monitored by TLC, using Silica 60
plates and 4:1 toluene : EtOH as running solvent, giving an Rf = 0.56 for intermediate (3).
Using DMF as the recrystallizing solvent, intermediate (3) with a purity > 99 % was obtained,
21
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Figure 5. MALDI-TOF-MS spectrum of (2).
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Figure 6. X-ray crystal structure of (2) and the Connolly surface rending.
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 as determined by isocratic analytical HPLC, using a 4.6mm × 250mm Zorbax C18 column and
a 20 : 80 EtOAc : CH3OH mobile phase at 2mL / min, at ambient temperature. Figure 7 shows
the chromatogram of intermediate (3) after recrystallization and its DMF mother liquor.
The 1H and 13C NMR chemical shifts and peak assignments for intermediate (3) were
also determined from the 1-dimensional 1H and 13C NMR spectra, coupled with 2-dimensional
1H-1H COSY and 1H-13C HETCOR NMR spectroscopy (1H NMR data in CDCl3: d 5.47
(doublet of doublet, 6 H-3, J3-2 = 10.3 Hz, J3-4 = 8.9 Hz); d 5.10 (doublet, 6 H-1, J1-2 = 3.4 Hz);
d 4.68 (doublet of doublet, 6 H-2,  J2-1 = 3.4 Hz, J2-3 = 10.3 Hz); d 4.12 (doublet of doublet, 6
H-6, J6-5 = 2.0 Hz, J6-6' = 11.9 Hz); d 4.02 (triplet, 6 H-4, J4-3 = 8.9 Hz, J4-5 = 8.9 Hz); d 3.91
(doublet, 6 H-5, J5-4 = 8.9 Hz); d 3.70 (doublet, 6 H-6', J6'-6 = 11.9 Hz); d 2.07, 2.05 ( two sets
of singlet, 6 COCH3 on C2 and 6 COCH3 on C3); d 0.89 ( singlet, 6 (CH3)3C); d 0.06, 0.05
(two sets of singlet, 6 (CH3)2Si); 13C NMR data in CDCl3: d 171.05, 169.91 ( COCH3 on C2
and COCH3 on C3); d 96.78 (C-1); d 75.52 (C-4); d 72.35 (C-5); d 72.09 (C-3); d 71.67 (C-2);
d 62.26 (C-6); d 26.20 ( (CH3)3C); d 21.27, 21.10 (COCH3 on C2 and COCH3 on C3); d 18.60
( (CH3)3C); d -4.67, -4.95 ( (CH3)2Si)). 2D 1H-1H COSY and 1H-13C HETCOR NMR spectra,
which show those proton and carbon contours that are related to the glucose units, are shown
in Figures 8 and 9, respectively. 
Figure 10 shows the MALDI-TOF-MS of the  Na+ and K+ ion-adduct portion of
intermediate (3). The calculated molecular weight values of the Na+ and K+ ion-adducts of the
parent molecule, 2183.95 and 2199.93, agree well with the value obtained using high 
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Figure 7. Chromatograms of crystalline (3) and its mother liquor. Purity of the product > 99 %.
Conditions: EtOAc : MeOH = 20 : 80, F = 2mL / min, C18 column.
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Figure 8. 2D COSY of (3) in CDCl3 using 300 mHz NMR.
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Figure 9. 2D HETCOR of (3) in CDCl3 using 300 mHz NMR.
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Figure 10. MALDI-TOF-MS spectrum of (3). The measured m/z values agree well with the m/z
values calculated for the monoisotopic sodium and potassium adducts.
28
resolution MALDI-TOF-MS: 2183.69 and 2199.65, respectively, indicating the presence of
six tert-butyldimethylsilyl groups and twelve acetyl groups on intermediate (3).
2.2.3 Hexakis(2,3-di-O-acetyl)-a-Cyclodextrin
In the third step, the tert-butyldimethylsilyl protecting groups at the sixth position were
removed from intermediate (3) with BF3.EtOEt complex in CH2Cl2 to produce hexakis(2,3-di-
O-acetyl)-a-CD (intermediate (4)). The progress of the reaction was monitored by TLC, using
Silica 60 plates and 50 :10 :1 CHCl3 : CH3OH : H2O as running solvent, giving an Rf=0.33 for
intermediate (4). Intermediate (4) with a purity > 99 % was obtained by recrystallization from
acetone as determined by isocratic analytical HPLC, using a 4.6mm × 250mm Zorbax C18
column and a 48 : 52 H2O : CH3OH mobile phase with 1.5mL / min rate, at temperature 40oC.
Figure 11 shows the chromatogram of intermediate (4) after recrystallization and its
corresponding acetone mother liquor.
The 1H and 13C NMR chemical shifts and peak assignments were determined from the
1D 1H and 13C NMR spectra, coupled with 2D 1H - 1H COSY and 1H - 13C HETCOR NMR
spectroscopy (1H NMR data in CDCl3: d 5.43 (triplet, 6 H-3, J3-2 = 8.8 Hz, J3-4 = 8.8 Hz); d
5.09 (doublet, 6 H-1, J1-2 = 2.7 Hz); d 4.81 (doublet of doublet, 6 H-2,  J2-1 = 2.7 Hz, J2-3 = 8.8
Hz); d 4.02, 3.90 and 3.81 (24 H-4, 5, 6); d 2.06, 2.04 ( two sets of singlet, 6 COCH3 on C2
and 6 COCH3 on C3); 13C NMR data in CDCl3: d 170.97, 170.00 ( COCH3 on C2 and COCH3
on C3); d 96.95 (C-1); d 77.09 (C-4); d 72.66 (C-5); d 71.83 (C-3); d 70.92 (C-2); d 61.55 (C-
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Figure 11. Chromatograms of crystalline (4) and its mother liquor. Purity of the product > 99
%. Conditions: H2O : MeOH = 48 : 52, F = 1.5mL / min, T = 40oC, C18 column.
30
 6); d 21.07, 20.99 (COCH3 on C2 and COCH3 on C3)). Since all the acetyl groups are easily
assigned, Figures 12 and 13 show 2D 1H - 1H COSY and 1H - 13C HETCOR NMR spectra of
those proton and carbon contours that are related to the glucose unit of intermediate (4).
The calculated molecular weight values of the Na+ and K+ ion-adducts of the parent
molecule, 1499.43 and 1515.41, agree well with the values obtained using high resolution
MALDI-TOF-MS, 1498.85 and 1515.65, respectively, as shown in Figure 14, indicating that
the six tert-butyldimethylsilyl groups on intermediate (4) were removed completely, but the 12
acetyl groups still remained on intermediate (4).
2.2.4 Hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-Cyclodextrin
Finally, intermediate (4) was sulfated at the sixth positions of the glucopyranose units
using sulfur trioxide-pyridine complex in the presence of DMF and anhydrous pyridine. Indirect
UV detection CE with a 20 mM para-toluenesulfonic acid (pTSA) / b-alanine (pH 3.5)
background electrolyte with (-) to (+) polarity was used to monitor the progress of the reaction
and to assay the purity of the target material. The reaction was quenched by slowly adding a
hot saturated sodium bicarbonate solution to obtain the sodium salt of hexakis(2,3-di-O-acetyl-
6-O-sulfo)-a-CD (HxDAS). Using isopropanol induced precipitation, HxDAS was obtained
with a calculated purity of 97.8 % (assuming identical response factors). The electropherogram
is shown in Figure 15. 
The 1H and 13C NMR chemical shifts and peak assignments were determined from the
1D 1H and 13C NMR spectra, coupled with 2D 1H - 1H COSY and 1H - 13C HETCOR NMR 
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Figure 12. 2D COSY of (4) in CDCl3 using 300 mHz NMR.
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Figure 13. 2D HETCOR of (4) in CDCl3 using 300 mHz NMR.
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Figure 14. MALDI-TOF-MS spectrum of (4). The measured m/z values agree well with the m/z
values calculated for the monoisotopic sodium and potassium adducts.
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Figure 15. Indirect UV detection CE electropherogram of HxDAS. Purity > 97.8 %. Conditions:
20 mM pTSA / b-alanine, pH = 3.5, (-) to (+) polarity, Lt / Ld =26.4 / 19.6 cm, 10 kV, 214 nm,
T = 20oC.
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spectroscopy (1H NMR data in D2O: d 5.36 (triplet, 6 H-3, J3-2 = 8.5 Hz, J3-4 = 8.5 Hz); d 5.18
(doublet, 6 H-1, J1-2 = 2.9 Hz); d 4.81 (doublet of doublet, 6 H-2,  J2-1 = 2.9 Hz, J2-3 = 8.5 Hz);
d 4.44 (doublet, 6 H-6, J6-6' = 11.5 Hz); d 4.25 (doublet, 6 H-6', J6'-6 = 11.5 Hz); d 4.14
(doublet, 6 H-5, J5-4 = 8.5 Hz); d 4.02 (triplet, 6 H-4, J4-5 = 8.5 Hz, J4-3 = 8.5 Hz); d 2.02, 2.01
(two sets of singlet, 6 COCH3 on C2 and 6 COCH3 on C3); 13C NMR data in CDCl3: d 173.28,
173.03 ( COCH3 on C2 and COCH3 on C3); d 96.78 (C-1); d 75.58 (C-4); d 71.77(C-3); d
71.02 (C-2); d 70.35 (C-5); d 66.97 (C-6); d 20.64, 20.58 (COCH3 on C2 and COCH3 on C3)).
2D 1H - 1H COSY and 1H - 13C HETCOR NMR spectra of HxDAS, in Figures 16 and 17, show
the 1H - 1H and 1H - 13C connectivities, respectively.
The measured m/z value of 1067.05 obtained using high resolution positive ion-mode
ESI-TOF-MS (Figure 18) agrees well with the m/z value calculated for the monoisotopic
disodium adduct, [C60H78O60S6Na8]2+, 1067.03, indicating that the sulfation process was
successful.
2.2.5 Hexakis-6-O-sulfo-a-Cyclodextrin
The second product, the sodium salt of hexakis(6-O-sulfo)-a-CD (HxS), was obtained
by reacting HxDAS with a 500 mM aqueous sodium hydroxide solution. Indirect UV detection
CE with a 20 mM TEMED / phthalic acid (pH 5.5) background electrolyte with (-) to (+)
polarity was used to monitor the progress of the reaction and to assay the purity of the target
material.  Using methanol-induced precipitation, HxS with a calculated purity of 98 %
(assuming identical response factors) was obtained (electropherogram shown in Figure 19).
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Figure 16. 2D COSY of HxDAS in D2O using 300 mHz NMR.
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Figure 17. 2D HETCOR of HxDAS in D2O using 300 mHz NMR.
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Figure 18. High resolution ESI-TOF-MS spectrum of HxDAS. The measured m/z value of
1067.05 agrees well with the m/z value calculated for the monoisotopic disodium adduct,
[C60H78O60S6Na8]2+, 1067.03.
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Figure 19. Indirect UV detection CE electropherogram of HxS. Purity > 99 %. Conditions: 20
mM TEMED / phthalic acid, pH = 5.5, (-) to (+) polarity, Lt / Ld = 26.4 /19.6 cm, 214 nm, 10
kV, T = 20oC.
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The 1H and 13C NMR chemical shifts and peak assignments were determined from the 1D 1H
and 13C NMR spectra, coupled with 2D 1H - 1H COSY and 1H - 13C HETCOR NMR
spectroscopy (shown in Figures 20 and 21, respectively) (1H NMR data in D2O: d 5.22
(doublet, 6 H-1, J1-2 = 3.2 Hz); d 4.54 (doublet, 6 H-6, J6-6' = 9.2 Hz); d 4.38 (doublet 6 H-6',
J6'-6 = 9 .2Hz); d 4.22 (doublet, 6 H-5, J5-4 = 9.9 Hz); d 4.09 (triplet, 6 H-3, J3-2 = 9.9 Hz, J3-4 =
9.9 Hz); d 3.79 (triplet, 6 H-4, J4-3  = 9.9 Hz; J4-5 = 9.9 Hz); d 3.75 (doublet of doublet, 6 H-2,
J2-1 = 3.2 Hz, J2-3 = 9.9 Hz); 13C NMR data in CDCl3: d 101.22 (C-1); d 80.65 (C-4); d 73.22
(C-3); d 71.77 (C-2); d 70.05 (C-5); d 67.38 (C-6)).
 High resolution negative-ion mode ESI-TOF-MS indicated very good agreement
between the calculated and measured m/z values: portions of the mass spectra corresponding
to HxS ions with three to six negative charges (brought about by the dissociation of three to six
Na+ ions), which are shown in Figure 22. The high agreements indicate that the deacetylation
process was successful.
2.2.6 Hexakis(2,3-di-O-methyl-6-O-t-butyldimethylsilyl)-a-Cyclodextrin
The secondary hydroxyl groups of intermediate (2) were methylated in THF at room
temperature using iodomethane and dry NaH for 4 h to obtain hexakis(2,3-di-O-methyl-6-O-t-
butyldimethylsilyl)-a-cyclodextrin (intermediate (5)) with 99 % conversion at the 50 g scale.
Reaction progress was monitored using a 5mm Luna C18 RP-HPLC column with a 65:35
MeOH : EtOAc isocratic mobile phase at 2mL / min, at ambient temperature. Intermediate (5)
with a purity > 99 % was obtained by using ethanol : H2O (1:10 v:v) mixture as the 
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Figure 20. 2D COSY of HxS in D2O using 500 mHz NMR.
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Figure 21. 2D HETCOR of HxS in D2O using 500 mHz NMR.
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Figure 22. Portions of the high resolution ESI-TOF-MS spectrum of HxS.
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recrystallizing solvent to remove trace salt, and pure ethanol was used to remove the over-
methylated under-silylated cyclodextrin impurities. Figure 23 shows a non-aqueous, reversed-
phase HPLC separation of intermediate (5) after recrystalization and its corresponding ethanol
mother liquor. The postulated structure of intermediate (5) was verified by 1D 1H and 13C and
2D 1H - 1H COSY and 2D 1H - 13C HETCOR NMR spectroscopy (1H NMR data in CDCl3: d
5.03 (doublet, 6 H-1, J1-2 = 3.2 Hz); d 4.07 (doublet of doublet, 6 H-6, J6-5 = 2.7 Hz, J6-6 '= 11.5
Hz); d 3.69 (quartet, 12 H-(4+5), J4-3 = 9.7 Hz, J4-5 = 9.7 Hz); d 3.63 (doublet, 6 H-6', J6'-6 =
11.5 Hz); d 3.58 (triplet, 6 H-3, J3-2 = 9.7 Hz, J3-4 = 9.7 Hz); d 3.05 (doublet of doublet, 6 H-2,
J2-1 = 3.2 Hz, J2-3 = 9.7 Hz); d 3.65, 3.49 (two sets of singlet, 6 OCH3 on C2 and 6 OCH3 on
C3); d 0.87 ( singlet, 6 (CH3)3C); d 0.03, 0.02 (two sets of singlet, 6 (CH3)2Si); 13C NMR data
in CDCl3: d 99.64 (C-1); d 82.59 (C-2); d 81.61 (C-3); d 81.30 (C-4); d 72.73 (C-5); d 62.46
(C-6); d 61.94, 58.11 (OCH3 on C2 and OCH3 on C3); d 26.09 ( (CH3)3C); d 18.42 ( (CH3)3C);
d -4.72, -4.95 ( (CH3)2Si)).  Figures 24 and 25, showed the 1H - 1H and 1H - 13C connectivities,
respectively. Once again, the structure omitted the tert-butyldimethylsilyl group portions.
The Na+ ion-adduct portion of the high resolution MALDI-TOF mass spectrum  of the
parent molecule (5) is shown in Figure 26. The measured m/z value of 1848.01 agrees well
with the calculated  monoisotopic value of [C84H168O30Si6Na]+, 1847.55.
2.2.7 Hexakis(2,3-di-O-methyl)-a-Cyclodextrin
Deprotection of intermediate (5) was accomplished using 48 % HFaq in 100 % ethanol
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Figure 23. Chromatograms of crystalline (5) and its mother liquor. Purity of the product > 99
%. Conditions: MeOH : EtOAc = 65 : 35, F = 2mL / min, C18 column.
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Figure 24. 2D COSY of (5) in CDCl3 using 500 mHz NMR.
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Figure 25. 2D HETCOR of (5) in CDCl3 using 500 mHz NMR.
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Figure 26. High resolution MALDI-TOF-MS spectrum of (5). The measured m/z value of
1848.01 agrees well with the m/z value calculated for the monoisotopic sodium adduct,
[C84H168O30Si6Na]+, 1847.55.
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for 24 h at room temperature to obtain hexakis(2,3-di-O-methyl)-a-cyclodextrin (intermediate
(6)) with a 99 % conversion at the 200 g scale. The reaction was monitored by TLC with a
50:10:1 CHCl3: MeOH: H2O mobile phase giving an Rf = 0.42 for the target compound. The
purity of the product was determined by a 5 mm Luna C18 RP-HPLC column with a 75:25
MeOH : H2O isocratic mobile phase at 1.2mL / min, with temperature 50oC. The crude material
was recrystallized three times from DMF : water : acetone to yield a 99.6% isomerically pure
white powder (Figure 27). Assigned 2D 1H - 1H COSY and 2D 1H - 13C HETCOR NMR
spectra of intermediate (6) are included in Figures 28 and 29, respectively.
The Na+ ion-adduct portion of the high resolution MALDI-TOF mass spectrum of the
parent molecule (6) is shown in Figure 30. The measured m/z values of 1163.50, 1179.37
agree well with the calculated monoisotopic value of sodium and potassium adduct portions
of [C48H84O30Na]+, [C48H84O30K]+, 1163.49, 1179.47, respectively.
2.2.8 Hexakis(2,3-di-O-methyl-6-O-sulfo)-a-Cyclodextrin
Intermediate (6) was sulfated in DMF at room temperature for 48 h using pyridine sulfur
trioxide complex to obtain Hexakis(2,3-di-O-methyl-6-O-sulfo)-a-cyclodextrin (HxDMS) with
a 97% conversion at the 100 g scale. The reaction was monitored by indirect UV detection CE
analysis using a 20 mM para-toluene sulfonic acid : 40 mM tris(hydroxymethyl)aminomethane
BGE (pH 8.2) with (+) to (-) polarity. Purification of the crude material was accomplished
with six precipitations from a 6:1 EtOH : H2O mixture by dissolving the crude material in a
minimum volume of water followed by addition of six times the water volume of ethanol. The
final isomeric purity of the white powder obtained was 
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Figure 27. Chromatograms of crystalline (6) and its mother liquor. Purity of the product > 99
%. Conditions: H2O : MeOH = 25 : 75, F = 1.2mL / min, T = 50oC, C18 column.
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Figure 28. 2D COSY of (6) in CDCl3 using 500 mHz NMR.
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Figure 29. 2D HETCOR of (6) in CDCl3 using 500 mHz NMR.
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found to be > 98 % by indirect UV detection CE as indicated in Figure 31 (assuming identical
response factors). The assigned 1H-1H 2D COSY and 1H-13C 2D HETCOR NMR spectra of
HxDMS are including in Figures 32 and 33, respectively. 
The high resolution ESI-TOF mass spectra of the Na+ ion-adduct and Na+ ion-loss
portion of the parent molecule, HxDMS from which two to five Na+ dissociated are shown in
Figure 34. The measured m/z values agree well with the calculated values.
2.3 Summary
The  sodium salt of hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-CD (HxDAS), hexakis(6-O-
sulfo)-a-CD (HxS), and hexakis(2,3-di-O-methyl-6-O-sulfo)-a-CD (HxDMS) have been
synthesized on a large scale via regioselective protecting group chemistry and analytically
characterized. Their purity was monitored by isocratic reversed phase HPLC and indirect UV
detection CE, respectively. The structural identity of each intermediate and final product was
determined by 1H NMR, 13C NMR, 1H-1H 2D COSY NMR, and 1H- 13C 2D HETCOR NMR
spectra, mass spectrometry, and x-ray crystallography.
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Figure 31. Indirect UV detection CE electropherogram of HxDMS. Purity > 98.9 %.
Conditions: 20 mM pTSA / 40 mM Tris, pH = 8.0, (+) to (-) polarity, Lt / Ld =26.4 / 19.6
cm, 214 nm, 10 kV, T = 20oC.
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Figure 32. 2D COSY HxDMS in D2O using 500 mHz NMR.
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Figure 33. 2D HETCOR HxDMS in D2O using 500 mHz NMR.
58
8 4 5 8 5 0 8 5 5 8 6 0 8 6 5 8 7 0 8 7 5
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
5 5 5 5 6 0 5 6 5 5 7 0 5 7 5
0
7 5 0
1500
2250
3000
3750
4 1 2 4 1 4 4 1 6 4 1 8 4 2 0 4 2 2
0
2000
4000
6000
8000
1 0 0 0 0
3 2 6 3 2 8 3 3 0 3 3 2
0
4 0 0
8 0 0
1200
1600
2000
8 9 2 8 9 6 9 0 0 9 0 4 9 0 8 9 1 2
0
2 0 0
4 0 0
6 0 0
8 0 0
1000
Positive Ion Mode
M e a s u r e d   ( M + K
+
- 3 N a
+
) / 2 = 8 6 1 . 1 0
C a l c u l a t e d  ( M + K
+
- 3 N a
+
) / 2 = 8 6 1 . 0 7Io
n
 I
n
te
n
si
ty
m / z
M e a s u r e d   ( M - 2 N a
+
) / 2 = 8 5 3 . 1 1
C a l c u l a t e d  ( M - 2 N a
+
) / 2 = 8 5 3 . 0 8
M e a s u r e d   ( M + K
+
- 4 N a
+
) / 3 = 5 6 6 . 4 0
C a l c u l a t e d  ( M + K
+
- 4 N a
+
) / 3 = 5 6 6 . 3 8
Io
n
 i
n
te
n
si
ty
m / z
M e a s u r e d   ( M - 3 N a
+
) / 3 = 5 6 1 . 0 8
C a l c u l a t e d  ( M - 3 N a
+
) / 3 = 5 6 1 . 0 6
Negative Ion Mode
M e a s u r e d   ( M + K
+
- 5 N a
+
) / 4 = 4 1 9 . 0 6
C a l c u l a t e d  ( M + K
+
- 5 N a
+
) / 4 = 4 1 9 . 0 4
Io
n
 I
n
te
n
si
ty
m / z
M e a s u r e d   ( M - 4 N a
+
) / 4 = 4 1 5 . 0 7
C a l c u l a t e d  ( M - 4 N a
+
) / 4 = 4 1 5 . 0 4
M e a s u r e d   ( M + K
+
- 6 N a
+
) / 5 = 3 3 0 . 6 5
C a l c u l a t e d  ( M + K
+
- 6 N a
+
) / 5 = 3 3 0 . 6 3Io
n
 I
n
te
n
si
ty
m / z
M e a u s r e d   ( M - 5 N a
+
) / 5 = 3 2 7 . 4 5
C a l c u l a t e d  ( M - 5 N a
+
) / 5 = 3 2 7 . 4 4
M e a s u r e d   ( M + N a
+
+ K
+
) / 2 = 9 0 7 . 0 3
C a l c u a l t e d  ( M + N a
+
+ K
+
) / 2 = 9 0 7 . 0 5
Io
n
 I
n
te
n
si
ty
m / z
M e a s u r e d   ( M + 2 N a
+
) / 2 = 8 9 9 . 0 4
C a l c u l a t e d  ( M + 2 N a
+
) / 2 = 8 9 9 . 0 6  
Figure 34. Portions of the high resolution ESI-TOF-MS spectrum of HxDMS.
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CHAPTER III
ENANTIOMER SEPARATIONS WITH HxDAS* 
The effects of the size of the cyclodextrins, and the polarity of the substituents, on the
chiral recognition processes are very significant. Hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-CD
(HxDAS) possesses moderately hydrophobic acetyl substituents at the 2 and 3- positions on
each glucose unit of native a-CD. It was the first choice to synthesize and to use as a chiral
resolving agent in different BGEs. 
3.1 Enantiomer Separations with HxDAS in Low pH BGEs
According to the CHARM model, when a strong electrolyte resolving agent, such as
HxDAS is used, only two BGE pH, one at a low pH and another at a high pH are required
[119]. According to previous work, low pH BGEs will provide good resolution values
because more favorable b values can be obtained than in high pH BGEs. Therefore,
investigations of  enantiomer separations with HxDAS started in a low pH BGE.
3.1.1 Materials
The analytes were obtained from Sigma (St. Louis, MO). Phosphoric acid, hydrochloric
acid and lithium hydroxide were purchased from Aldrich Chemical Company (Milwaukee, WI).
Hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-CD (HxDAS) was synthesized and
______________
Part of the material in this chapter is reprinted with permission from:
S. L. Li and Gy. Vigh, Electrophoresis 21 (2003) 2487-2498; Copyright 2003-Wiley-VCH.
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analytically characterized in our laboratory as described in Chapter II. Deionized water from
a Milli-Q unit (Millipore, Milford, MA) was used to prepare all the solutions that were used
in the experiment. The stock buffer was prepared by titrating of 25 mM H3PO4 to pH 2.5 with
LiOH. The 0-75 mM HxDAS BGEs were prepared immediately prior to use by weighing out
the required amounts of the sodium salt of HxDAS into 25mL volumetric flasks and bringing
the volumes to mark with the pH 2.5 stock BGE solution. 
3.1.2 Finding an EOF Marker
Nitromethane (NM), which proved to have zero effective mobility with the previously
tested sulfated CDs was selected for HxDAS as well. Its suitability was determined according
to Ref. [125]. Figure 35 shows two detector traces of NM in 50 mM HxDAS BGE during the
first and second pressure mobilization steps and in superimposition. The first pass shows the
NM position inside the 50 mM HxDAS BGE band before electrophoresis. On both sides of the
HxDAS BGE band, there was plain, pH 2.5 H3PO4 / LiOH buffer. NM was injected into the 50
mM HxDAS BGE and base BGE portion. The second detector trace shows each analyte after
a short electrophoresis step as they are mobilized pass the detector by nitrogen pressure. The
relative movement of NM in the 50 mM HxDAS BGE before and after electrophoresis, with
respect to NM in the base BGE bands, is identical indicating that NM does not complex with
HxDAS. Since NM will have zero effective mobility in all HxDAS BGEs used in this work,
it can be used as neutral marker to calculate the electroosmotic flow (EOF) mobilities [125].
3.1.3 CE Conditions
 All enantiomer separations were performed on a P/ACE 2000 capillary
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electrophoresis instrument using a 27mm i.d., bare fused silica capillary (Polymicro
Technologies, Phoenix, AZ, USA) with a total length (Lt) of 26.4 cm, and 19.6 cm from
injection to detector (Ld). A window for UV detection was prepared by removing a section of
the polyimide coating with a flame, and then wiped clean with a methanol-soaked Kimwipe.
All separations were obtained at 2-10 kV applied potential, positive to negative electrode
polarity, at 214 nm UV wavelength, and 20oC cartridge coolant temperature. Between runs, the
capillary was flushed with deionized water for 4mins, followed by the  running buffer for
2mins. The analytes were pressure injected by 2 psi nitrogen for 1 s. All solutions used were
passed through a 0.2mm pore size disc filter prior to use.
 3.1.4 Materials and Methods
In order to test the hydrolytic stability of  HxDAS in the stock BGE, a 50 mM HxDAS
solution was prepared, stored in the refrigerator at 4oC for a week and repeatedly analyzed by
the indirect UV detection CE method used during the synthesis of HxDAS. Acetate loss was
first detected on the third day indicating that BGEs prepared freshly daily were safe to use.
Since NM has zero effective mobility in all HxDAS BGEs used in this work, it can be
used as a neutral marker to calculate the electroosmotic flow (EOF) mobility. NM was co-
injected with each sample to obtain effective mobilities of the enantiomers as: 
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Figure 35. HxDAS does not complex with nitromethane. Trace A shows NM pass through
detector before electrophoresis; trace B  show NM pass through detector after electrophoresis.
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          mieff=miobs-mEOF                       (13)
The peak resolution, Rs, values was calculated using the following Equation:           
    R s = 2 ( t 2 - t 1 ) / (w1 + w2 )                 ( 1 4 )
where, subscript 2 refers to the enantiomer which has a lower effective mobility in the lowest
HxDAS BGE that was used, t1 and t2  are the observed migration times of the enantiomers and
w1 and w2 are the baseline peak widths of the respective enantiomer peaks. According to the
Rs equation (see equation 10) [119, 126], the higher the applied electric field, the higher the
Rs value that can be obtained. However, due to Joule heating effects, the applied potential must
be in the linear region of  Ohm’s plot. In order to determine the highest potentials where Ohm’s
plots were still linear, the true electrophoretic currents were measured as a function of the
applied potential value over the 0 to 75 mM HxDAS concentration range in 5 mM increment.
All effective mobility values of the analytes reported in this dissertation were measured in the
linear region of the Ohm’s plots. The viscosities of the 0-75 mM HxDAS BGEs were measured
using the P/ACE 2000 unit as a viscometer [127]. The results are shown in Figure 36, in which
viscosities are plotted as a function of the concentration of HxDAS. The viscosity of the
solution increased by about 40 % over the concentration range studied.
3.1.5 Effects of Analyte Mobilities
Since the effective mobilities of the polyanionic analyte-cyclodextrin complexes depend
very strongly on the ionic strength of the BGE [119], the measured meff values can only be used
for qualitative comparison of the migration behavior. The concentration of HxDAS in the
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system can affect the meff values of the analyte-negatively charged CD complexes through three
ways. First of all, the higher concentration of HxDAS used, the higher the mole fraction of the
analyte that is present as an analyte-negatively charged CD complex.  This, in turn, increases
the anionic effective mobility of the analyte species. The second effect is based on the
relationship between the mobility of the analyte and the viscosity of the solution, which 
can be approximated according to Walden’s rule [128]:  
       m(CHxDAS)×h(CHxDAS)=constant            (15)
where, h(CHxDAS) refers to viscosity of the solution with a certain concentration of HxDAS. The
mobility of the analyte decreases as the viscosity of the solution increases. Figure 36 shows that
the higher concentration of HxDAS used in the system, the higher the viscosity of the solution,
which will reduce the effective mobility of the analyte.
          The third factor is based on the relation between the effective mobility of the analyte and
the ionic strength of the solution. Increasing the concentration of HxDAS will significantly
increase the ionic strength I, which was expressed as equation 8 [52-54]. The increasing ionic
strength, in turn will decrease the meff of the  charged species,  according to the equation 7 when
the charge is lesser than or equal to 6 and I < 0.1 [52-54].
The mobility of the analyte then can be determined by both increasing the degree of
complexation of the analyte with HxDAS and the mobility-reducing effects of both higher ionic
strength and higher viscosity as the concentration of HxDAS was increased.
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Figure 36. Viscosity of 25 mM H3PO4 / LiOH (pH = 2.5) buffers with different concentration
of HxDAS.
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3.1.6 Results and Discussion
A series of nonionic, weak acid, weak base and ampholytic enantiomers (shown in
Figures 37-40, respectively)  were separated with the pH 2.5 HxDAS BGEs. Table 1 lists the
effective mobilities of the less mobile enantiomers, m, the separation selectivities, a, the
measured peak resolution values, Rs, the corresponding dimensionless EOF mobility values,
b, and the injector-to-detector potential drop values, U, for the nonionic, weak acid, weak base
and ampholytic enantiomers, respectively. An entry of N/A indicates that a value could not be
calculated due to overlap with either a non-comigrating system peak or the neutral marker peak.
The applied potential was limited to 8 kV in the 5 mM HxDAS-containing BGE and decreased
with increasing HxDAS concentration to 2 kV in the 75 mM HxDAS containing BGE. Over the
5 to 75 mM HxDAS concentration range, the m EOF values were between (3 to 35)×10-5 cm2/Vs.
3.1.6.1 Separation of the Enantiomers of Neutral Analytes
 The enantiomers of nine of the sixteen nonionic compounds tested could be separated.
For the weakly complexing nonionic analytes, the effective anionic mobilities increased as the
concentration of HxDAS is increased, but remained low, only reaching 11x10-5 cm2/Vs, similar
to what was observed with the b-CD analog, HDAS [103], and the g-CD analog, ODAS [107].
Three typical effective mobility plots are shown in the top panel of Figure 41. The  increasing
degree of complexation of the nonionic analyte with  HxDAS overrides the mobility-reducing
effects of both higher ionic strength and higher viscosity as the concentration of HxDAS was
increased. However, these nonionic enantiomers
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Figure 37. Names and structures of the nonionic analytes.
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Figure 39. Names and structures of weak base analytes.
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Table 1. Separation data in pH=2.5 HxDAS BGEs. (m, in 10-5 cm2 / Vs units)
HxDAS
(mM)
5 10
U (kV) 8 8
Analyte m a b Rs m a b Rs
N02 -0.4 1.00 -24 0 -0.6 1.00 -23 0
N10 N/A -0.2 1.00 -73 0
N12 -2.0 1.09 -7.2 1.1 -3.6 1.05 -4.0 <0.6
N13 -0.7 1.05 -20 <0.6 -1.6 1.07 -7.8 <0.6
N15 -0.2 1.03 -76 <0.6 -0.4 1.05 -36 <0.6
N21 N/A N/A
N22 -0.4 1.29 -26 1.1 -0.7 1.76 -13 1.6
N24 N/A -0.2 1.00 -62 0
N25 -1.1 1.09 -25 0.8 -4.9 1.07 -3.1 0.8
N26 -0.6 1.06 -19 <0.6 -1.1 1.12 -9.1 0.8
N27 N/A -0.1 1.00 -77 0
N28 N/A -0.5 1.00 -12 0
N30 -0.6 1.03 -24 <0.6 -1.0 1.04 -11 <0.6
N34 -0.3 1.00 -37 0 -0.7 1.00 -21 0
N36 N/A -0.3 1.20 -48 <0.6
N38 -0.2 1.00 -42 0 -0.4 1.00 -33 0
N39 -0.2 1.00 -42 0 -0.5 1.00 -20 0
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Table 1. Continued.
HxDAS
(mM)
20 35
U (kV) 8 6
Analyte m a b Rs m a b Rs
N02 -2.3 1.00 -7.2 0 -3.5 1.00 -3.2 0
N10 -1.9 1.00 -8.4 0 -2.1 1.00 -5.1 0
N12 -4.4 1.04 -3.7 <0.6 -5.4 1.04 -2.7 0.7
N13 -4.2 1.05 -3.8 <0.6 -6.6 1.03 -3.0 0.7
N15 -0.6 1.17 -21 <0.6 -0.9 1.22 -9.8 <0.6
N21 N/A N/A
N22 -1.8 1.51 -4.1 3.8 -2.9 1.48 -2.3 3.5
N24 -0.6 1.00 -24 0 -1.2 1.00 -8.4 0
N25 -7.8 1.03 -2.1 0.9 -9.2 1.02 -1.6 0.7
N26 -3.0 1.10 -4.9 0.7 -4.7 1.09 -3.9 0.7
N27 -1.0 1.00 -16 0 -1.6 1.00 -4.8 0
N28 -0.9 1.00 -7.3 0 -1.3 1.00 -5.2 0
N30 -3.2 1.03 -4.6 <0.6 -3.9 1.03 -3.1 <0.6
N34 -3.6 1.00 -4.2 0 -3.9 1.00 -3.4 0
N36 -1.1 1.18 -4.1 0.8 -1.3 1.11 -4.2 0.7
N38 -2.1 1.00 -7.0 0 -2.5 1.00 -6.4 0
N39 -1.5 1.00 -9.3 0 -1.9 1.00 -4.0 0
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Table 1. Continued.
HxDAS
(mM)
50 75
U (kV) 4 4
Analyte m a b Rs m a b Rs
N02 -3.9 1.00 -3.7 0 -4.7 1.00 -1.5 0
N10 -2.5 1.00 -4.6 0 -2.8 1.00 -2.9 0
N12 -5.8 1.03 -2.4 <0.6 -4.8 1.04 -2.1 <0.6
N13 -8.4 1.03 -1.8 1.3 -9.6* 1.03 -1.3 <0.6
N15 -1.1 1.27 -9.4 <0.6 -1.2 1.33 -6.7 2.3
N21 -9.0 1.03 -1.6 0.8 N/A
N22 -3.8 1.42 -4.1 2.5 -4.6* 1.38 -2.4 3.2
N24 -1.6 1.00 -6.0 0 -1.9* 1.00 -5.2 0
N25 -10.9 1.02 -1.7 <0.6 -11.0** 1.00 -0.9 0
N26 -7.4 1.06 -2.6 0.6 -8.9 1.04 -1.3 1.7
N27 -2.3 1.00 -7.7 0 -2.9* 1.00 -2.3 0
N28 -1.7 1.00 -3.2 0 -1.9* 1.00 -4.3 0
N30 -4.5 1.02 -2.0 <0.6 -5.0* 1.02 -2.2 <0.6
N34 -4.3 1.00 -3.6 0 -4.8 1.00 -2.5 0
N36 -2.1 1.00 -4.7 0 -2.9* 1.00 -4.2 0
N38 -2.9 1.00 -5.2 0 -3.2 1.00 -2.2 0
N39 -2.1 1.00 -6.9 0 -2.9 1.00 -4.0 0
* U = 3 kV   ** U = 2 kV
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Table 1. Continued.
HxDAS
(mM)
0 5 10
U (kV) 8 8
Analyte m m a b Rs m a b Rs
A02 0 -0.8
-3.7
4.63
1.78
-24 10
25
-1.2
-5.1
4.25
1.63
-7.5 26
29
A22 0 -1.9 1.00 -6.4 0 -3.5 1.00 -1.7 0
A23 0 -1.7 1.00 -5.8 0 -3.1 1.00 -2.2 0
A27 0 -1.3 1.00 -5.1 0 -2.0 1.00 -2.3 0
.A28 0 -1.4 1.00 -7.1 0 -1.8 1.00 -3.6 0
A29 0 -0.6 1.03 -15 <0.6 -0.9 1.12 -6.2 1.8
A30 0 -1.3 1.40 -4.2 1.6 -1.9 1.50 -2.7 11
A31 0 -1.5 1.53 -4.3 2.9 -1.8 1.58 -2.8 3.0
A32 0 -2.5 1.08 -3.5 <0.6 -3.3 1.12 -2.2 0.9
A36 0 -0.7 1.00 -9.6 0 -1.6 1.00 -4.1 0
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Table 1. Continued. 
HxDAS
(mM)
20 30
U (kV) 8 6
Analyte m a b Rs m a b Rs
A02 -1.6
-6.6
4.12
1.47
-9.6 18
20
-1.7
-6.8
3.98
1.41
-3.9 12
15
A22 -3.9 1.00 -5.7 0 -4.1 1.00 -1.5 0
A23 -4.3 1.00 -5.1 0 -4.9 1.00 -1.1 0
A27 -2.5 1.00 -6.8 0 -3.1 1.00 -2.7 0
.A28 -2.3 1.00 -9.1 0 -2.8 1.00 -3.1 0
A29 -1.7 1.08 -4.1 0.9 -2.5 1.07 -3.4 1.0
A30 -2.5 1.47 -4.5 4.8 -3.2 1.44 -3.4 5.3
A31 -2.4 1.59 -2.2 3.1 -2.8 1.57 -2.4 2.9
A32 -3.9 1.08 -1.3 2.4 -4.3 1.07 -1.7 2.3
A36 -2.0 1.00 -3.4 0 -2.3 1.00 -3.9 0
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Table 1. Continued.
HxDAS
(mM)
0 5 10
U (kV) 10 8 8
Analyte m m a b Rs m a b Rs
B02 24.7 9.4  1.08 0.7 <0.6 4.3 1.09 1.7 <0.6
B03 24.3 10.8  1.00 0.3 0 8.3 1.00 0.9 0
B04 33.2 15.7 1.01 0.3 <0.6 14.7 1.02 0.5 <0.6
B06 32.8 16.4 1.01 0.1 <0.6 15.8 1.03 0.5 <0.6
B08 21.1 9.6 1.04 0.5 <0.6 6.9 1.07 1.0 <0.6
B10 19.8 7.5 1.07 0.6 <0.6 5.2 1.15 1.4 0.9
B11 21.7 7.3 1.04 0.6 <0.6 2.1 1.17 4.0 1.1
B12 17.0 -2.1 0.41 -2.3 8.7 -3.4 0.50 -1.7 8.3
B13 27.9 6.0 1.11 0.8 <0.6 3.0 1.30 2.3 0.7
B14 23.4 N/A 2.6 1.00 3.1 0
B16 25.8 9.5 1.04 0.6 0.8 3.9 1.12 2.1 0.8
B18 18.5 -1.5 -0.66 -4.0 7.4 -3.3 0.33 -1.8 3.3
B21 24.1 8.2 1.02 0.6 <0.6 3.6 1.05 2.1 <0.6
B22 25.6 12.5 1.01 0.3 <0.6 9.0 1.01 0.8 <0.6
B23 21.4 N/A N/A
B24 18.4 N/A N/A
B26 23.7 5.2 1.07 0.9 <0.6 N/A
B28 28.3 14.7 1.00 0.3 0 9.7 1.01 0.7 <0.6
B31 18.9 6.3 1.05 0.7 <0.6 3.4 1.14 1.9 0.8
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Table 1. Continued.
HxDAS
(mM)
20 30
U (kV) 8 7
Analyte m a b Rs m a b Rs
B02 2.0 1.18 2.6 1.5 2.2 1.33 4.2 1
B03 5.3 1.00 1.0 0 2.3 1.17 6.4 1
B04 12.0 1.03 0.5 <0.6 11.3 1.03 1.3 <0.6
B06 13.6 1.03 0.5 <0.6 11.4 1.06 1.2 <0.6
B08 4.7 1.11 2.6 <0.6 2.8 1.15 5.6 1
B10 3.6 1.21 3.2 1.1 2.7 1.32 1.6 2.6
B11 2.0 1.11 3.9 0.7 1.8 1.16 2.5 1.6
B12 -9.7 0.54 -1.6 7.6 N/A
B13 0.5 1.60 14 0.7 -0.6 0.72 -10 0.6
B14 2.4 1.00 6.8 0 N/A
B16 3.4 1.11 4.5 0.6 3.6 1.14 4.1 <0.6
B18 -4.4 0.46 -4.2 8.0 -4.6 0.58 -2.7 11
B21 4.5 1.04 1.4 <0.6 5.6 1.04 1.8 <0.6
B22 8.2 1.01 1.0 <0.6 7.9 1.01 0.8 <0.6
B23 N/A N/A
B24 N/A N/A
B26 2.0 1.13 3.8 1.1 2.1 1.15 3.5 1.2
B28 9.0 1.02 0.8 <0.6 8.5 1.02 0.8 <0.6
B31 2.1 1.14 2.7 1.1 1.8 1.15 2.9 1.4
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Table 1. Continued.
HxDAS
(mM)
40 50
U (kV) 6 6
Analyte m a b Rs m a b Rs
B02 1 1.36 7.5 1.6 0.6 1.61 32 1.1
B03 4.5 1.18 1.6 1.7 4.8 1.53 3.9 2.4
B04 8.9 1.04 2.8 <0.6 10.6 1.03 1.7 <0.6
B06 12.9 1.04 1.4 <0.6 11 1.04 1.7 <0.6
B08 2.5 1.16 2.8 1.5 3.3 1.15 6.3 0.8
B10 2 1.47 3.6 4.1 1.6 1.62 11 2.6
B11 1.6 1.21 4.8 1.4 1.4 1.26 13 0.9
B12 N/A -7.6 0.65 -2.2 8.2
B13 0.7 1.57 7.5 1.2 0.5 1.4 39 0.9
B14 2.6 1 3 0 1.8 1 10 0
B16 4.2 1.07 1.7 1 4.4 1.09 3.6 0.9
B18 -4.7 0.66 -4.9 4.9 -4.6 0.65 -3.9 7.3
B21 4 1.03 3.5 <0.6 3.6* 1.03 2.9 <0.6
B22 7.8 1.01 1.8 <0.6 9.1 1.01 3.9 <0.6
B23 -7.9 0.99 -1.8 <0.6 -7.4 0.76 -2.5 1
B24 -4 0.89 -3.2 1.5 -3.7 0.97 -3.1 <0.6
B26 1.7 1.2 7 1.3 0.9 1.18 15 1
B28 7.7 1.03 1.5 <0.6 8.2 1.02 2.1 <0.6
B31 1.5 1.19 4.1 2 1.8 1.18 10 0.9
* U = 5 kV
81
Table 1. Continued.
HxDAS
(mM)
0 5 10
U (kV) 10 8 8
Analyte m m a b Rs m a b Rs
B32 17.7 -2.2 0.87 -3.4 3.5 N/A
B33 28.3 8.8 1.13 0.5 1.2 5.3 1.19 1.2 1.7
B34 27.5 15.7 1.00 0.2 0 12.3 1.01 0.6 <0.6
B35 18.0 6.9 1.00 0.5 0 4.1 1.05 1.7 0.7
B36 18.9 5.0 1.05 1.0 <0.6 1.6 1.16 5.7 0.9
B37 21.8 7.8 1.07 0.5 0.7 5.5 1.10 1.2 0.7
B38 24.5 4.7 1.26 0.9 3.5 3.3 1.45 1.7 3.6
B39 30.5 16.0 1.03 0.3 <0.6 11.7 1.06 0.5 1.0
B41 23.2 11.6 1.06 0.5 1.0 5.3 1.20 1.6 0.8
B42 24.3 -2.1 0.86 -3.0 1.4 -3.6 0.90 -1.6 1.9
B45 19.5 10.0 1.02 0.4 <0.6 9.3 1.03 1.3 <0.6
B47 21.0 N/A N/A
B49 18.6 5.7 1.04 0.9 <0.6 3.1 1.10 2.2 1.2
B51 20.6 8.5 1.04 0.5 <0.6 5.4 1.11 1.2 <0.6
B53 18.1 5.4 1.02 0.7 <0.6 1.3 1.18 5.3 0.7
B54 17.6 N/A N/A
B58 25.9 11.6 1.04 0.3 <0.6 8.1 1.05 1.0 <0.6
B61 24.2 10.6 1.02 0.4 <0.6 7.6 1.05 1.2 <0.6
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Table 1. Continued.
HxDAS
(mM)
20 30
U (kV) 8 7
Analyte m a b Rs m a b Rs
B32 N/A N/A
B33 3.9 1.21 1.9 1.5 3.0 1.32 2.8 1.7
B34 11.5 1.01 0.7 <0.6 10.6 1.02 1.0 <0.6
B35 2.9 1.06 2.8 <0.6 2.6 1.08 3.8 0.7
B36 1.0 1.34 6.6 1.4 N/A
B37 6.4 1.07 2.8 <0.6 3.2 1.11 2.4 1.1
B38 1.2 1.82 6.9 4.2 0.6 2.09 7.2 5.9
B39 11.7 1.06 0.7 1.4 10.9 1.07 0.4 2.1
B41 -0.3 -1.34 -32 1.9 -0.7 -0.18 -4.8 6.0
B42 -4.8 0.93 -1.6 <0.6 -5.1 0.94 -2.5 1.4
B45 7.9 1.04 1.0 <0.6 N/A
B47 N/A 6.4 1.04 0.6 0.8
B49 1.0 1.24 7.4 1.3 0.4 1.61 8.5 1.7
B51 2.2 1.32 5.2 1.4 1.0 1.59 3.1 3.5
B53 -2.3 0.61 -7.1 <0.6 -4.3 0.93 -3.0 0.9
B54 N/A N/A
B58 7.2 1.07 1.1 0.7 5.8 1.08 0.6 0.9
B61 6.8 1.05 1.1 <0.6 5.4 1.09 0.8 <0.6
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Table 1. Continued.
HxDAS
(mM)
40 50
U (kV) 6
Analyte m a b Rs m a b Rs
B32 N/A -8.2 0.96 -2.2 1.3
B33 2.0 1.43 3.5 4.0 1.2 1.95 6.6 3.4
B34 9.3 1.03 0.8 0.6 10.9 1.02 1.4 <0.6
B35 2.0 1.10 3.2 0.8 1.8 1.16 8.6 <0.6
B36 -0.9 0.59 -8.8 <0.6 -0.5 0.88 -30 <0.6
B37 2.5 1.24 2.6 3.0 2.4 1.17 6.2 1.1
B38 0.3 4.52 25 5.2 0.5 3.10 30 3.1
B39 9.0 1.09 0.8 1.9 6.2 1.08 1.3 1.6
B41 -1.2 0.52 -5.8 3.3 -1.7* 0.65 -11 1.5
B42 -5.3 0.95 -4.7 0.7 -5.7 0.95 -3.0 1.0
B47 1.4 1.00 14 0.0 1.8 1.00 9.1 0
B45 5.3 1.04 3.6 <0.6 7.7 1.00 1.0 0
B49 -0.2 -0.09 -85 0.8 -0.8 0.57 -20 <0.6
B51 0.3 3.64 25 4.9 0.6* 1.83 17 1.5
B53 -2.5 0.66 -9.1 3.1 -1.3 1.00 -12 0
B54 N/A -11.8* 0.94 -1.7 2.8
B58 4.6 1.08 3.7 1.0 5.5 1.07 1.5 0.8
B61 4.7 1.20 1.6 2.4 5.7* 1.05 13 <0.6
* U = 5 kV  ** U = 3 kV
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Table 1. Continued.
HxDAS (mM) 0 10
U (kV) 10 8
Analyte m m a b Rs
Z01 16.0 1.3 1.22 12 <0.6
Z02 13.4 1.1 1.00 16 0
Z03 14.6 0.9 1.00 21 0
Z04 15.3 1.0 1.04 12 <0.6
Z05 15.0 0.8 1.00 14 0
Z06 16.5 0.14 1.90 81 0.7
Z07 16.0 0.6 1.00 18 0
Z08 15.2 0.4 1.00 38 0
Z09 14.7 1.5 1.23 6.3 1.1
Z10 15.4 1.7 1.09 8.8 <0.6
Z11 16.0 -2.5 0.91 -3.2 1.4
Z12 17.6 1.5 1.11 6.1 <0.6
Tryptophan 10.5 5.1 1.04 2.1 <0.6
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Table 1. Continued.
HxDAS
(mM)
20 35
U (kV) 8 7
Analyte m a b Rs m a b Rs
Z01 1.7 1.12 5.0 0.9 1.9 1.09 5.8 0.7
Z02 1.7 1.00 3.4 0 5.7 1.00 2.3 0
Z03 0.7 1.00 8.4 0 2.2 1.08 4.9 0.6
Z04 1.4 1.09 4.9 0.6 1.5 1.07 4.0 <0.6
Z05 1.1 1.00 5.2 0 1.8* 1.00 5.3 0
Z06 -0.8 0.88 -22 <0.6 -1.4* 0.91 -7.8 <0.6
Z07 0.8 1.00 7.7 0 1.7 1.12 7.0 0.6
Z08 0.2 1.00 12 0 2.4 1.00 3.3 0
Z09 2.0 1.18 3.7 1.1 2.2 1.13 4.9 0.6
Z10 2.2 1.03 3.3 <0.6 0.9* 1.16 11 0.7
Z11 -3.7 0.93 -5.0 0.8 -4.8* 0.96 -2.9 1.1
Z12 0.9 1.31 10 0.7 0.36* 1.49 19 0.9
Tryptop-
han
4.7 1.06 1.8 <0.6 4.0* 1.07 1.2 0.6
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Table 1. Continued.
HxDAS
(mM)
50 75
U (kV) 4 2
Analyte m a b Rs m a b Rs
Z01 1.6 1.06 8.0 <0.6 1.3 1.03 6.0 <0.6
Z02 3.5 1.00 2.4 0 2.7** 1.00 3.8 0
Z03 0.8 1.28 11 1.0 0.4 1.00 25 0
Z04 1.3 1.05 11 <0.6 1.2 1.03 8.3 <0.6
Z05 1.5 1.00 4.9 0 1.4 1.00 7.5 0
Z06 -1.2 0.94 -14 <0.6 -0.4 1.00 -16 0
Z07 0.5 1.42 18 0.9 0.3 1.00 33 0
Z08 2.2 1.00 3.5 0 0.2** 1.00 44 0
Z09 2.1 1.06 5.7 0.7 2.3 1.00 4.7 0
Z10 0.4 1.00 5.7 0 0.5 1.00 20 0
Z11 -3.8 0.97 -5.1 0 -1.9 1.00 -5.2 0
Z12 1.5 1.32 6.1 0.7 1.1 1.08 10 <0.6
Trypto-
phan
3.0 1.08 3.9 0.6 2.4 1.00 4.3 0
* U = 6 kV   ** U = 3 kV
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complexed moderately weakly with HxDAS, which leads to unfavorable b values (in the -70
to -2 range) and, consequently, inadequate peak resolution. The corresponding separation
selectivities increase to a maximum and then slowly decrease as the concentration of HxDAS
is increased (Figure 41, bottom panel), in agreement with the predictions of the CHARM model
[119]. 
 A very small structural change in the nonionic analytes can affect the chiral recognition
processes with HxDAS. The small change of the carbon numbers in the long hydrophobic chain
that contain the chiral center can affect the separation significantly. For example, the
enantiomers of methylmandelate, 3-phenylbutyraldehyde, 1-phenylbutanol, 1-phenylpentanol
and 2-phenyl-2-pentanol obtained enantiomer separations in pH 2.5 BGE with HxDAS;
however, the enantiomers of ethylmandelate, 2-phenylpropionaldehyde, 1-phenylpropanol and
2-phenyl-2-propanol were not separated in pH 2.5 BGE with HxDAS.  Changing the position
of the chiral center along a chain while keeping the C number in the long chain constant also
affects the chiral recognition processes dramatically. For example, the enantiomers of 1-
phenylbutanol were separated, those of 2-phenylbutanol and 2-phenyl-2-butanol were not.
The cavity size of the cyclodextrins affects the enantiomer separations for the neutral
analytes significantly. Figure 42 shows the effective mobility plots (top panel) and the
corresponding separation selectivities (bottom panel) for methylmandelate with HxDAS,
HDAS and ODAS as the chiral resolving agents. The strength of the inter-molecular
interactions between methylmandelate and the three CD derivatives follows the order of
ODAS @ HDAS > HxDAS. This can be explained by considering that the cavity size of ODAS
and HDAS are suitable for methylmandelate to dip in.
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3.1.6.2 Separation of the Enantiomers of Weak Acids
          Of the ten weak acids studied, enantiomer separations were observed for five. Figure 43
shows a few typical effective mobility (top panel) and separation selectivity (bottom panel)
plots for some of the weak acid enantiomers. The effective mobilities of the weak acid analytes
in the HxDAS-free low pH BGE are initially close to zero and become increasingly anionic
as the HxDAS concentration is increased, but only reach values as high as -(4 - to - 11)x10-5
cm2/Vs. The observed separation selectivities pass through a shallow maximum at 
low HxDAS concentrations: whenever there is a separation, the a maximum values are
generally much higher ( in the 1.1 < a <1.6 range) than what were observed with the b- and g-
CD analogs, HDAS [103] and ODAS [107].
3.1.6.3 Separation of the Enantiomers of Weak Bases
Enantiomer separations have been achieved for 35 of the 37 chiral weak bases tested.
As with the g-CD analog, ODAS [107], the weak base enantiomers can be divided into three
groups: weakly binding, moderately strongly binding and strongly binding weak bases [113].
We consider a weak base to be a weakly binding weak base when its effective mobility
remains cationic over the entire HxDAS concentration range tested [113]. The top panels in
Figure 44 show the mobility (left panel) and separation selectivity (right panel) curves for four
typical, weakly binding weak base enantiomers. In each case, the initially cationic effective
mobility of the weak base is between 18x10-5 and 27x10-5 cm2/Vs. As the HxDAS
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Figure 42. Effects of the cyclodextrin cavity size on the separation for the enantiomers of
Methylmandelate in pH = 2.5 BGE with HxDAS, HDAS, ODAS.
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Figure 44. Effective mobilities and separation selectivities for weak base analytes in pH=2.5
BGEs with HxDAS. Weakly binding (top panels), moderately strongly binding (middle panels)
and strongly binding (bottom panels).
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concentration is increased, the effective mobilities of the weak bases approach zero, but do not
become anionic, due to the combined effects of increased complexation with HxDAS and the
ionic strength-related differential depression of the mobilities of the free and the complexed
forms of the weak base [113]. For the weakly binding weak base enantiomers, separation
selectivities pass a maximum as the HxDAS concentration is increased, as predicted by Ref.
[113]. 
For this discussion, we consider a base to be a moderately strongly binding base when
the effective mobilities of the enantiomers do become anionic, but remain close to zero [113].
The middle panels in Figure 44 show the mobility (left panel) and separation selectivity (right
panel) curves for typical, moderately strongly binding weak bases. Separation selectivities
become more favorable as the HxDAS concentration approaches the point where the effective
mobility of one of the enantiomers changes from cationic to anionic, as also predicted by Ref.
[113].
We consider a weak base to be a strongly binding weak base when its effective
mobilities become more anionic than -5x10-5 cm2/Vs in the HxDAS concentration range tested.
The bottom panels in Figure 44 show the mobility (left panel) and separation selectivity (right
panel) curves for three typical, strongly binding weak bases. As predicted by Ref. [113], their
effective mobilities pass an anionic mobility extremum as the HxDAS concentration is
increased, caused by the combined effects of increased complexation with HxDAS and the
ionic strength-related differential depression of the mobilities of the free and the complexed
forms of the weak base [113]. For some of these strongly binding weak bases, the effective
mobilities become anionic in the 0 < CHxDAS < 5 mM range where no measurements were made.
Therefore, the a > 1 portions of the separation selectivity curves predicted by Ref. [113] are
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not observed for them.
The cyclodextrin cavity size also dramatically affects the enantiomer separations for
the weak base analytes at pH 2.5 with HxDAS. Figure 45 shows the effective mobility plots
(top panel) and the corresponding separation selectivities (bottom panel) for piperoxan (B38)
with HxDAS, HDAS and ODAS as the chiral resolving agents. The strength of the interactions
between piperoxan and the three CD’s derivatives also follows the order of ODAS @ HDAS
> HxDAS. Piperoxan binds to HxDAS weakly (without crossing the zero mobility line), but it
binds to ODAS and HDAS strongly.
3.1.6.4 Separation of the Enantiomers of Ampholytic Analytes
Of the fourteen ampholytic components tested, enantiomer separations were observed
for ten. As shown in the top panels of Figure 46, these analytes can also be divided into weakly
(in Figure 46, left panels) and strongly binding (in Figure 46, right panels) groups, and their
migration (top panels) and separation selectivity (bottom panels) patterns follow trends similar
to those of the weak base enantiomers. This is not surprising, because in the pH 2.5 BGE used,
almost all of the ampholytic analytes are fully protoned cations. 
A small change of the analyte structure, not only affects whether or not a separation is
obtained, but it also affects the separation behavior. For example, the structures of Dansyl-
leucine (Z04) and Dansyl-norleucine (Z06) are very similar, however, the former complexes
with HxDAS weakly, and the latter complexes with HxDAS strongly. Figure 47 shows the
effective mobility plots (top panel) and the corresponding separation selectivities (bottom
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Figure 45. Effects of the cyclodextrin cavity size on the separation of the enantiomers of
Piperoxan in pH = 2.5 BGEs with HxDAS, HDAS, ODAS.
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Figure 46. Effective mobilities and separation selectivities for the ampholytic analytes in pH
= 2.5 BGEs with HxDAS. Weakly binding (left panels) and strongly binding (right panels).
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Figure 47. Effects of analyte structure on the separation of the enantiomers of ampholytic
analytes in pH = 2.5 BGEs with HxDAS.
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panel) for Z04 and Z06 with HxDAS as chiral resolving agent.
 The cyclodextrin cavity size also affects the separation of the enantiomers of
ampholytic analytes. Figure 48 shows the effective mobility plots (top panel) and the
corresponding separation selectivities (bottom panel) for tryptophan with HxDAS, HDAS and
ODAS as chiral resolving agents. The strength of the inter-molecular interactions between
tryptothan and the three CD derivatives also follow the order: ODAS > HDAS > HxDAS.
Tryptophan complexes with HxDAS weakly, but it complexes with ODAS and HDAS strongly,
and the inter-molecular interactions between tryptophan and ODAS and HDAS are close to
each other.
A few typical enantiomer separations obtained with HxDAS are illustrated in Figure
49 (for nonionic, weak acid and ampholytic analytes) and Figure 50 (for weak base analytes).
The numbers under the compound codes (see Figures 37-40) show the concentration of HxDAS
(in mM) and the applied potential (in kV) used. When shown, the peak of NM is indicated by
N. Adequate peak resolutions were achieved, though with somewhat longer separation times
than with HDAS and ODAS, for a number of structurally quite different analytes.
3.2 Enantiomer Separations with HxDAS in High pH BGEs
The previous studies have shown that HxDAS has excellent enantioseparation ability
in low pH BGEs. Though the low pH buffer leads to favorable b values and therefore good
peak resolution [119], the enantiomers of some of the analytes still cannot be separated at low
pH. Therefore, it was interesting to investigate the separation behavior of HxDAS in high pH
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Figure 48. Effects of the cyclodextrin cavity size on the separation of the enantiomers of
Tryptophan in pH = 2.5 BGEs with HxDAS, HDAS, ODAS.
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Figure 49. Typical electropherograms of nonionic, ampholytic analytes in pH = 2.5 BGEs with
HxDAS.
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Figure 50. Typical electropherograms of weak base analytes in pH = 2.5 BGEs with HxDAS.
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BGEs.
3.2.1 Experimental Conditions and Methods
Dimethylsulfoxide (DMSO) was also found not to complex with HxDAS at high pH.
Therefore, it can be used as EOF marker. All CE separations were carried out in 25 mM
ethanolamine BGEs adjusted to pH 9.5 with methane sulfonic acid (MSA). The 5 to 50 mM
HxDAS BGEs were prepared by weighing out the required amounts of HxDAS into 25mL
volumetric flasks and bringing the volumes to mark with the pH 9.5 stock BGE solution. The
hydrolytic stability of HxDAS in the high pH stock BGE was also tested. Acetate loss was first
detected on the third day indicating that BGEs prepared freshly just prior to use were safe to
use. The other experimental details are the same as listed in 3.1.3-3.1.5.
3.2.2 Results and Discussion
HxDAS was used for the separation of the enantiomers of neutral, weak acid, weak
base, and ampholytic analytes whose structures are shown in Figures 37-40. The effective
mobilities of the slower enantiomer, m, separation selectivities, a, measured peak resolution
values, Rs, corresponding dimensionless EOF values, b, and applied potential drop values, U,
for the neutral, weak acid, weak base, and ampholytic analytes are listed in Table 2. An entry
of N/A indicates that a value could not be calculated due to overlap with either a non-
comigrating system peak or the neutral marker peak. The applied potential was limited to 13
kV in the 5 mM HxDAS-containing BGE. The potential decreased with increasing HxDAS
concentration to 4 kV in the 50 mM HxDAS containing BGES.
Over the 5 to 50 mM HxDAS concentration range, the mEOF values were between
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(10 to 35)x10-5 cm2/ Vs.
3.2.2.1 Separation of the Enantiomers of Neutral Analytes
Enantiomer separations were achieved for seven of the twelve nonionic compounds
tested. For the weakly complexing nonionic analytes, the effective anionic mobility increased
as the concentration of HxDAS increased, but remained low, only reaching 16 x 10-5 cm2 / Vs,
similarly to what was observed in low pH BGEs.  Four typical effective mobility plots are
shown in the top panel of Figure 51. Again, the increasing degree of complexation of the
nonionic analyte with  HxDAS did override the mobility - reducing effects of both the higher
ionic strength and the higher viscosity as the concentration of HxDAS is increased. The
nonionic enantiomers complexed moderately weakly with HxDAS, which lead to unfavorable
b values (in the range of -60 to -2) and, consequently, inadequate peak resolution. The
corresponding separation selectivities increased to a maximum and then slowly decreased as
the concentration of HxDAS was increased (Figure 51, bottom panel), in agreement with the
prediction of the CHARM model [119]. 
Again, as with the results obtained in low pH BGE, the structures of the analytes play
a very important role in the enantiomer separation process. Very small structural changes of the
nonionic analytes can affect the enantiomer separation results with HxDAS. For example, the
enantiomers of 1-phenylbutanol (N21) were separated in pH 9.5 BGE with HxDAS, those of
1-phenyl-2-propanol (N27) were not.
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Figure 51. Effective mobility and separation selectivities for the enantiomers of nonionic
analytes in pH = 9.5 BGEs with HxDAS.
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Table 2. Separation data in pH=9.5 BGEs. (m in 10-5 cm2 V-1 s-1 unit)
HxDAS
(mM)
0 5 10
U (kV) 13 12
Analyte m m a b Rs m a b Rs
N02 0 N/A -0.9 1.00 -32 0  
N21 0 -1.2 1.13 -15 <0.6 -2.6 1.09 -14 <0.6
N24 0 -0.7 1.05 -32 <0.6 -1.1 1.05 -25 <0.6
N25 0 -1.7 1.05 -21 <0.6 -3.7 1.05 -6.5 <0.6
N26 0 -1.0 1.00 -23 0  -2.2 1.00 -10 0
N27 0 -0.6 1.00 -37 0 -1.0 1.00 -23 0
N28 0 -0.5 1.00 -45 0 -1.0 1.00 -25 0
N30 0 -0.7 1.00 -36 0 -1.5 1.00 -17 0
N34 0 -1.0 1.00 -42 0 -2.3 1.00 -19 0
N36 0 -0.5 1.02 -61 <0.6 -0.8 1.04 -27 <0.6
N38 0 -0.7 1.00 -49 0 -1.1 1.00 -17 0
N39 0 -0.6 1.20 -29 <0.6 -1.4 1.27 -25 <0.6
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Table 2. Continued.
HxDAS
(mM)
20 30
U (kV) 10 8
Analyte m a b Rs m a b Rs
N02 -1.8 1.00 -7.2 0 -2.4 1.00 -10 0
N21 -5.7 1.05 -1.9 2.1 -6.4 1.04 -2.5 <0.6
N24 -1.3 1.05 -10 <0.6 -1.6 1.04 -19 <0.6
N25 -9.3 1.04 -1.6 2.7 -14.2 1.03 -5.4 0.6
N26 -5.9 1.06 -2.6 1.1 -9.1 1.04 -4.8 <0.6
N27 -1.6 1.00 -8.5 0 -2.0 1.00 -11 0
N28 -1.7 1.00 -6.9 0 -2.0 1.00 -11 0
N30 -3.1 1.00 -4.1 0 -3.7 1.00 -8.6 0
N34 -5.2 1.00 1.0 <0.6 -6.0 1.06 -2.8 <0.6
N36 -1.5 1.06 -7.8 <0.6 -1.8 1.04 -8.8 <0.6
N38 -1.9 1.00 -6.0 0 -2.2 1.00 -10 0
N39 -2.3 1.21 -7.1 <0.6 -2.4 1.13 -10 <0.6
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Table 2.  Continued.
HxDAS
(mM)
40 50
U (kV) 4 2
Analyte m a b Rs m a b Rs
N02 -2.9 1.00 -2.7 0 -3.2 1.00 -1.4 0
N21 -6.7 1.03 -1.8 <0.6 -6.8 1.03 -2.5 <0.6
N24 -1.7 1.04 -3.7 <0.6 -1.8 1.04 -32 <0.6
N25 -15.7 1.03 -1.2 2.3 N/A
N26 -11.0 1.03 -1.4 <0.6 N/A
N27 -2.3 1.00 -4.1 0 -2.5 1.00 -3.2 0
N28 -2.2 1.00 -4.2 0 -2.2 1.00 -3.4 0
N30 -3.9 1.00 -2.2 0 -4.1 1.00 -1.9 0
N34 -6.2 1.02 -1.3 <0.6 N/A
N36 -2.1 1.02 -3.0 <0.6 N/A
N38 -2.4 1.00 -2.4 0 -2.6 1.00 -3.2 0
N39 -2.5 1.05 -8.3 <0.6 N/A
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Table 2. Continued.
HxDAS
(mM)
0 5 10
U (kV) 13 12
Analyte m m a b Rs m a b Rs
A04 -18.9 -16.8 1.00 -1.4 0 -15.2 1.00 -1.9 0
A22 -21.1 -18.3 1.00 -1.2 0 -15.7 1.00 -1.8 0
A23 -22.7 -17.4 1.00 -1.2 0 -16.1 1.00 -1.6 0
A26 -23.2 -20.5 1.00 -1.1 0 -17.5 1.00 -1.8 0
A27 -19.6 -17.2 1.00 -1.4 0 -15.7 1.00 -2.1 0
A30 -24.0 -9.2 1.03 -2.5 <0.6 -7.4 1.03 -1.9 <0.6
A31 -20.9 -16.2 1.00 -2.4 0 -15.3 1.00 -1.8 0
A36 -23.9 -19.8 1.00 -1.6 0 -18.4 1.00 -1.4 0
Z01 -24.9 -17.6 1.00 -2.1 0 -13.8 1.00 -1.3 0
Z04 -24.6 -16.7 1.00 -2.3 0 -12.1 1.00 -1.4 0
Z05 -21.8 -14.2 1.02 -2.1 <0.6 -11.7 1.03 -1.4 <0.6
Z06 -24.7 -19.6 1.00 -2.2 0 -17.8 1.00 -1.2 0
Z09 -22.7 -19.2 1.00 -2.1 0 -17.8 1.00 -1.4 0
Z10 -21.5 -19.0 1.00 -2.1 0 -17.8 1.00 -1.4 0
Z11 -19.0 -15.8 1.00 -2.3 0 -11.8 1.00 -1.5 0
Z12 -24.3 -16.2 1.00 -2.2 0 -15.1 1.00 -1.4 0
* applied potential U=5 kV
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Table 2. Continued.
HxDAS
(mM)
20 30
U (kV) 10 8
Analyte m a b Rs m a b Rs
A04 -15.5 1.00 -1.4 0 -16.1 1.00 -1.1 0
A22 -14.4 1.00 -1.6 0 -14.0 1.00 -1.3 0
A23 -14.9 1.00 -1.5 0 -13.9 1.00 -1.2 0
A26 -15.5 1.00 -1.5 0 -13.8 1.00 -1.1 0
A27 -14.5 1.00 -1.6 0 -13.4 1.00 -1.1 0
A30 -11.1 1.02 -1.2 <0.6 -12.1 1.02 -1.2 <0.6
A31 -14.4 1.00 -1.4 0 -13.8 1.00 -1.1 0
A36 -19.3 1.00 -1.1 0 -19.8 1.00 -1.1 0
Z01 -14.3 1.00 -1.7 0 -15.2 1.00 -1.5 0
Z04 -14.0 1.00 -1.7 0 -14.4 1.00 -1.3 0
Z05 -13.1 1.02 -1.8 <0.6 -14.8* 1.01 -1.1 <0.6
Z06 -16.0 1.00 -1.5 0 -13.8 1.00 -1.1 0
Z09 -14.6 1.00 -1.2 0 -12.1 1.00 -1.4 0
Z10 -14.1 1.00 -1.3 0 -12.5 1.00 -1.4 0
Z11 -12.5 1.00 -1.5 0 -13.1 1.00 -1.2 0
Z12 -14.2 1.00 -1.4 0 -13.4 1.00 -1.2 0
* applied potential U=5 kV
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Table 2. Continued.
HxDAS
(mM)
0 5 10
U (kV) 14 13 12
Analyte m m a b Rs m a b Rs
B02 10.4 5.5 1.02 4.5 <0.6 3.0 1.10 5.5 <0.6
B03 8.6 N/A -0.8 0.92 -8.1 <0.6
B04 12.6 10.3 1.02 2.6 <0.6 9.1 1.04 0.8 0.6
B06 8.6 6.2 1.00 2.8 0 4.5 1.04 0.7 1.2
B08 10.9 5.8 1.06 4.0 0.6 2.6 1.26 2.4 2.7
B11 1.5 N/A 0.9 1.10 3.8 <0.6
B16 9.6 N/A 2.5 1.11 1.8 1.4
B18 10.3 N/A -2.7 0.68 -1.8 11
B24 7.0 -1.9
-1.9
-1.9
1.00
1.00
1.00
-10 0
0
0
-4.2
-4.4
-4.5
0.87
0.96
0.97
-1.7 6.2
2.1
1.5
B25 18.0 2.4 1.09 8.0 <0.6 -3.0 0.90 -1.5 8.3
B26 6.0 N/A 0.5 1.35 9.0 1.5
B28 21.5 N/A 4.3 1.04 1.1 0.6
B31 10.6 N/A 1.3 1.33 7.6 1.3
B33 9.6 N/A 3.5 1.20 2.7 1.9
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Table 2. Continued.
HxDAS
(mM)
20 30
U (kV) 10 6
Analyte m a b Rs m a b Rs
B02 0.6 1.33 8.8 <0.6 -0.1 -2.36 -310 2.0
B03 -0.9 0.94 -6.5 <0.6 -1.2 0.92 -10 <0.6
B04 7.5 1.05 1.1 0.8 5.6 1.07 1.7 1.2
B06 3.7 1.05 1.2 1.5 4.2 1.07 1.5 1.9
B08 0.8 1.51 10 1.7 0.6 1.67 20 1.9
B11 0.5 1.43 19 1.2 0.2 2.60 26 0.7
B16 3.0 1.13 2.7 0.7 3.3 1.13 4.1 1.7
B18 -6.6 0.88 -1.4 6.6 -6.5 0.81 -2.0 11
B24 -5.3
-5.4
-5.5
0.92
0.98
0.98
-1.8 3.5
1.2
<0.6
-6.1
-6.2
-6.3
0.92
0.97
0.98
-2.2 3.6
1.0
0.7
B25 N/A -2.9 0.56 -4.6 1.6
B26 0.4 1.77 19 2.0 0.3 1.80 25 1.4
B28 6.4 1.06 1.1 0.8 5.8 1.05 2.4 0.9
B31 0.8 1.56 15 1.8 0.3 2.13 16 3.3
B33 2.0 1.44 8.3 3.7 0.6 1.69 26 1.3
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Table 2. Continued.
HxDAS
(mM)
40 50
U (kV) 5 4
Analyte m a b Rs m a b Rs
B02 -0.7 0.41 -10 1.2 -1.0 0.64 -10 2.1
B03 -1.4 0.91 -9.8 <0.6 -1.1 0.90 -9.2 <0.6
B04 4.4 1.09 1.8 1.2 5.6 1.05 1.8 1.3
B06 N/A 3.2 1.08 1.6 1.6
B08 N/A -1.6 0.88 -6.4 1.0
B11 -0.3 -0.33 -23 1.2 -0.5 0.56 -22 1.0
B16 2.3 1.00 1.4 0 1.0 1.00 8.9 0
B18 -6.3* 0.77 -4.6 9.4 -6.1 0.73 -1.7 9.2
B24 N/A -5.7
-5.8
-5.9
0.94
0.98
0.98
-1.8 2.8
0.7
0.6
B25 -0.1 -1.92 -16 3.8 0.6 1.00 16 0
B26 0.4 1.00 19 0 0.6 1.00 17 0
B28 4.0* 1.07 3.5 <0.6 3.7 1.06 2.6 1.0
B31 -0.3 0.45 -16 1.5 -0.5 0.77 -20 2.1
B33 1.4 1.45 1.6 2.4 1.8 1.20 1.5 1.0
  * U=3 kV
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Table 2. Continued.
HxDAS
(mM)
0 5 10
U (kV) 14 13 12
Analyte m m a b Rs m a b Rs
B34 8.5 5.6 1.00 4.0 0.0 3.3 1.02 1.8 <0.6
B35 8.5 3.6 1.06 8.0 0.7 1.3 1.09 3.5 0.6
B36 16.0 0.5 1.09 19 <0.6 -0.7 0.83 -7.0 1.5
B37 10.5 5.5 1.06 3.6 0.6 2.0 1.11 3.2 1.2
B38 2.3 N/A 0.8 1.13 3.5 <0.6
B41 10.6 1.6 1.38 15 1.0 -0.3 -0.60 -51 3.4
B42 10.1 -2.8 0.83 -7.3 1.0 -4.4 0.89 -1.5 6.7
B45 6.0 N/A 4.9 1.06 1.4 1.3
B49 0.2 N/A -1.0 0.85 -72 <0.6
B51 7.8 3.2 1.19 8.0 <0.6 0.6 1.83 14 3.3
B53 0.8 N/A -1.4 0.64 -7.1 2.5
B54 0.0 N/A N/A
B56 9.9 N/A -5.4 0.98 -1.4 0.6
B58 20.2 N/A 6.5 1.07 1.5 1.0
B61 10.4 N/A 5.5 1.05 1.4 0.9
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Table 2. Continued.
HxDAS
(mM)
20 30
U (kV) 10 6
Analyte m a b Rs m a b Rs
B34 4.8 1.03 2.2 0.7 4.1 1.04 3.5 0.8
B35 0.9 1.23 12 1.0 0.8 1.29 18 0.7
B36 -2.4 0.90 -4.1 1.5 -2.7 0.93 -5.6 1.0
B37 1.5 1.00 10 0 0.8 1.00 17 0
B38 -0.2 -1.62 -7.4 8.9 -0.7 0.30 -23 4.5
B41 -1.7 0.73 -4.1 3.7 -2.2 0.78 -6.3 3.5
B42 -6.4 0.92 -1.4 5.1 -6.7 0.93 -2.3 2.8
B45 3.9 1.08 1.1 1.8 4.3 1.09 3.4 0.9
B49 -1.7 0.90 -4.2 1.4 -1.8 0.93 -8.7 0.7
B51 -0.9 0.30 -4.9 6.2 -1.8 0.50 -17 3.4
B53 -1.6 0.80 -2.1 2.1 -1.6 0.88 -7.5 1.1
B54 N/A N/A
B56 N/A N/A
B58 3.2 1.12 1.5 1.2 3.7 1.15 4.1 0.6
B61 2.2 1.09 2.1 1.5 2.9 1.13 3.3 1.3
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Table 2 Continued.
HxDAS
(mM)
40 50
U (kV) 5 4
Analyte m a b Rs m a b Rs
B34 3.4 1.03 2.3 0.7 2.9 1.03 3.2 0.7
B35 -0.2 -1.69 -20 6.0 -0.4 0.57 -24 1.5
B36 -2.7 0.96 -2.8 0.6 -2.4 0.94 -3.1 0.6
B37 0.4 1.00 13 0 0.3 1.00 33 0
B38 -1.4 0.50 -6.2 4.2 -1.3 0.39 -6.6 7.7
B41 -2.4 0.83 -5.3 2.9 -2.7 0.85 -3.4 3.1
B42 N/A -5.4 0.92 -1.7 2.8
B45 2.5 1.12 4.9 0.8 2.4 1.09 3.9 2.8
B49 -1.7 0.96 -9.9 <0.6 -1.6 0.94 -6.7 <0.6
B51 -2.7 0.64 -4.3 3.9 -2.1 0.61 -7.7 2.8
B53 -1.7 0.96 -2.6 0.7 -1.9 0.97 -4.8 <0.6
B54 N/A -6.8 0.98 -2.2 1.1
B56 N/A -6.2 0.99 -2.3 <0.6
B58 1.1 1.18 4.8 0.6 1.1 1.17 6.4 0.9
B61 1.5 1.16 4.0 0.7 1.3 1.12 7.7 0.7
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3.2.2.2 Separation of the Enantiomers of Weak Acid and Ampholytic Analytes
Because in the pH 9.5 BGE used almost all of the ampholytic analytes are fully
deprotoned anions, the separation behavior of ampholytic analytes are similar to those of the
weak acid analytes. Of the ten weak acids and eight ampholytic components studied, enantiomer
separation could be obtained only for one ampholytic analytes. This is not surprising, since the
b values are unfavorable (-16 to -2 ), which leads to inadequate peak resolution values. The
anionic mobilities are higher at low HxDAS concentration and become lower as the HxDAS
concentration is increased. This phenomenon is due to interplay of their increasing
complexation with HxDAS and the mobility suppressing effects of the increasing ionic strength
and viscosity of the BGE [113]. The corresponding separation selectivity increased to a
maximum and then slowly decreased as the concentration of HxDAS was increased, in
agreement with the prediction of the CHARM model [119]. 
3.2.2.3 Separation of the Enantiomers of Weak Bases
Enantiomer separations have been achieved for  29 of the 29 weak bases tested. The
effective mobilities and selectivities patterns are similar to those observed in the low pH BGE
[129] indicating that pH 9.5 is not high enough to render most of the tested weak base analytes
neutral. The weak base enantiomers can also be divided into three groups in the high pH BGEs:
weakly binding, moderately strongly binding and strongly binding weak bases. The top panels
in Figure 52 show the mobility (left panel) and separation selectivity (right panel) curves for
two typical, weakly binding weak bases, while the middle panels show the mobility (left panel)
and separation selectivity (right panel) curves for three typical, moderately strongly binding
116
weak bases. The bottom panels in Figure 52 show the mobility (left panel) and separation
selectivity (right panel) curves for four typical, strongly binding weak bases.
The peak resolution values depend not only on the separation selectivities, but also,
very sensitively, on the b values and the magnitude of the effective potential drop. Although the
dimensionless electroosmotic flow mobilities (the b values) are fairly large, and thus
unfavorable, adequate peak resolution values were obtained in less than 10 to 20 min for most
of the weak bases studied, as shown in Figure 53. The numbers under the compound codes (see
Figures 37) next to the electropherograms indicate the actual HxDAS concentrations (in mM)
and effective separation potentials in kV (the actual potential drop between the injection point
and the detector window).
3.3 Comparison of Separation Results in High pH and Low pH Aqueous BGEs
3.3.1 Neutral Analytes
The effective mobilities and separation selectivities of the neutral analytes in the high
pH BGEs are similar to those in the low pH BGEs. Even though the effective mobilities
increase anionically as the HxDAS  concentration is increased in both pH BGEs, for some of
the neutral analytes, the increase in pH 9.5 BGE with HxDAS is smaller than in the pH 2.5
HxDAS BGEs, indicating that the ethanolamine / MSA buffer components compete with the
neutral analytes for the HxDAS more strongly than the H3PO4 / LiOH buffer components.
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Figure 52. Effective mobility and separation selectivity for the enantiomers of weak base
analytes in pH = 9.5 BGEs with HxDAS. Weakly binding (top panels), moderately strongly
(middle panels) and strongly binding (bottom panels).
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Figure 53. Typical electropherograms of weak base analytes in pH = 9.5 BGEs with HxDAS.
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3.3.2 Weak Bases
Since  most of the weak bases maintained their cationic mobility in the low pH HxDAS
BGEs, the speed with which the separations were completed (generally under 30 min) was due
to the aid of the EOF and the weak binding between HxDAS and the enantiomers. The EOF
mobility is considerably higher at high pH than at low pH, due to the increased charge density
of the capillary wall. The enantiomers are much less cationic at high pH  because of their lower
degree of protonation.  Therefore, separations in the high pH BGEs were also fast. As the
HxDAS concentration was increased in the high pH BGEs, the enantiomers typically acquired
an anionic effective mobility at considerably lower HxDAS concentrations than in the low pH
BGEs, and migrated against the EOF mobility. This led to separation times between 5 and 25
min, depending on the applied potential.
The numbers of enantiomers for which favorable separation selectivity was found in
the high pH BGE and in the low pH BGE were almost equal. However, some weak base
enantiomers had dramatically different separation selectivity patterns in the high pH versus low
pH BGE. For example, labetalol, which could not be separated in the low pH BGE, was
baseline separated all four stereoisomers. Figure 54 shows the effective mobility plots (top
panel) and the corresponding separation selectivities (bottom panel) for piperoxan (B38) and
tolperisone (B51) in both high pH and low pH BGEs with HxDAS as the chiral resolving agent.
These weak base analytes were weakly binding with HxDAS in low pH BGEs; however,  in
high pH BGEs, they showed strongly binding behavior.
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3.3.3 Weak Acids
 At low pH, the acids became increasingly anionic with increasing HxDAS
concentration. Separation selectivities observed for the low pH weak acid separations passed
through a maximum at low HxDAS concentration. However, at high pH, the trend in the
mobility was opposite from that observed in the low pH separations. The anionic effective
mobilities of the enantiomers were high at low HxDAS concentration and became lower as the
HxDAS concentration was increased due to both complexation with HxDAS and the mobility
suppressing effects of the increasing ionic strength. Separation selectivities were poor at high
pH resulting in a lack of separation despite comparable b values to those seen in the low pH
measurements. 
3.3.4 Ampholytic Analytes
The ampholytic analytes have similar separation behavior to the weak bases in low pH
BGE, since almost all of the ampholytic analytes as fully protoned cations. The mobilities and
selectivities for these analytes in pH 9.5 BGE with HxDAS followed trends similar to those
of the weak acid enantiomers. This is not surprising, because in the pH 9.5 BGE used, almost
all of the ampholytic analytes are fully deprotoned anions. 
The change of the pH plays a complementary role in the ampholytic analyte enantiomer
separations. Figure 55 shows the effective mobility plots (top panel) and the corresponding
separation selectivities (bottom panel) for Dansyl-methionine (Z05) and Dansyl-norleucine
(Z06) in both high pH and low pH BGEs with HxDAS as the chiral resolving agent. Enantiomer
separations were obtained for Z06 in low pH BGE, but the enantiomers of Z05 were not
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separated. However, in high pH BGE, the results are opposite, the two enantiomers of Z05
were separated, but those of Z06 were not separated. 
3.4 Separation of the Enantiomers of Weak Bases with HxDAS in Acidic  Methanol BGE
The use of nonaqueous BGEs in CE can expand the range of enantiomer separations
since the solvent properties such as the dielectric constant, viscosity, polarity and
autoprotolysis are different, which in turn might change separation selectivity and peak
resolution [130-132]. The organic solvents that can be used for nonaqueous CE separation
include amides, such as formamide, N-methyl formamide, N, N - dimethyl formamide, N, N-
dimethyl acetamide, DMSO, acetonitrile, and methanol [109, 112, 130-139]. Since methanol
is UV transparent down to 200 nm, it is advantageous to choose methanol as the solvent. The
e/h ratio for methanol is 61, which is lower than water (90). Because the current generated by
CE in methanol will be lower than that in water at a given ionic strength, a higher field strength
can be applied, which can effectively shorten the analysis time.
3.4.1 Material and Conditions
An acidic methanolic buffer was prepared from 25 mM  H3PO4 and 12.5 mM LiOH for
use in nonaqueous measurements. The stock buffers were used to prepare the 0-30 mM HxDAS
BGEs for CE enantiomer separations. The enantiomers were dissolved in the BGE 
123
0 10 20 30 40 50
0.8
1.2
1.6
2.0
0.8
1.2
1.6
2.0
0 20 40 60
-20
-10
0
10
20
-20
-10
0
10
20
 
a
C 
HxDAS
 / mM
Z 0 5
Z 0 6
pH 9.5
pH 2.5
 
m
ef
f  /
 1
0-
5  
cm
2  
V
-1
 s
-1
C 
HxDAS
 / mM
Figure 55. Effects of the background electrolyte pH on the separation of the enantiomers of
ampholytic analytes with HxDAS.
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and co-injected for 1 s by 2 psi nitrogen with the EOF marker from a solution approximately
0.5 mM in both the analyte and the EOF marker. In order to determine the highest potentials
where Ohm’s plots were still linear, the electrophoretic current was measured as a function of
the applied potential over the 0-30 mM HxDAS concentration range in 5 mM increments. 16
kV was the maximum applied potential that was still in the linear region of Ohm’s plots.  All
subsequent effective mobility measurements were carried out at 16 kV. All measurements were
repeated in triplicate. 
3.4.2 Results and Discussions
Table 3 lists the effective mobilities of the less mobile enantiomer, m, the separation
selectivity, a, the corresponding normalized electroosmotic flow mobility, b, the peak
resolution, Rs, and the injector-to-detector potential drop, U values. Mobility and separation
selectivity plots for some of the weak base enantiomers are shown in Figure56. 
Enantiomer separations were achieved for twenty eight of the thirty one weak bases.
The migration behavior of the weak bases followed one of two mobility patterns. The effective
mobilities of the weakly binding weak base analytes remained cationic throughout the HxDAS
concentration range,  and their cationic effective mobilities decreased at the low HxDAS
concentration used and then increased as the HxDAS concentration was increased further. This
can be explained by the  increasing ionic strength as the concentration of HxDAS was
increased: it significantly suppressed the effective mobility of the charged analyte-CD
complexes. The separation selectivity patterns were similar to what was seen for the weak
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Table 3. Separation data in acidic methanol HxDAS BGEs. (m, in 10-5 cm2 / Vs units)
HxDAS
(mM)
5 10
U (kV) 16 16
Analyte m a b Rs m a b Rs
B02 9.3 1.02 0.5 <0.6 7.2 1.04 0.6 1.1
B05 15.3 1.16 0.5 8.9 10.7 1.22 0.3 6.3
B06 7.8 1.03 0.7 1.0 7.4 1.05 0.6 1.3
B08 6.3 1.03 0.7 <0.6 4.1 1.07 1.2 0.7
B10 9.7 1.03 0.6 <0.6 7.5 1.05 0.6 1.4
B11 13.2 1.00 2.7 0 11.9 1.02 0.4 <0.6
B12 -2.4 -2.54 -2.2 20 -2.9 -1.41 -1.7 17
B13 6.7 1.03 0.7 <0.6 3.7 1.08 1.4 1.7
B18 4.1 1.20 0.9 1.2 0.7 1.86 6.8 2.6
B20 11.0 1.02 0.4 <0.6 7.3 1.04 0.6 1.1
B22 12.9 1.00 0.3 0 10.6 1.01 0.4 <0.6
B24 3.2
2.9
1.4
1.03
1.10
2.07
41 0.7
1.8
3.6
2.3
2.0
1.2
1.04
1.15
1.37
3.3 1.0
0.7
2.1
B25 5.0 1.02 0.8 <0.6 0.7 1.16 5.9 0.9
B28 12.4 1.00 0.3 0 8.9 1.02 0.4 <0.6
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Table 3. Continued.
HxDAS
(mM)
20 30
U (kV) 16 16
Analyte m a b Rs m a b Rs
B02 7.9 1.03 0.4 1.0 8.6 1.01 0.2 <0.6
B05 8.0 1.24 0.2 3.8 7.3 1.26 0.2 4.7
B06 7.1 1.06 0.4 0.7 6.7 1.07 0.6 1.0
B08 4.6 1.04 0.5 <0.6 4.9 1.02 0.2 <0.6
B10 8.5 1.04 0.3 0.8 8.6 1.03 0.2 0.9
B11 12.9 1.00 0.2 0 13.4 1.00 0.2 0
B12 -1.3 -3.19 -1.3 38 -1.2 -3.67 -1.4 39
B13 4.0 1.07 0.6 1.5 4.3 1.04 0.2 1.5
B18 1.1 1.54 2.0 1.7 2.5 1.17 0.4 3.8
B20 7.8 1.03 0.3 <0.6 8.0 1.02 0.2 <0.6
B22 9.1 1.02 0.3 <0.6 8.6 1.03 0.2 <0.6
B24 1.6
1.5
1.1
1.06
1.07
1.36
2.4 1.3
0.6
1.4
1.8
1.7
1.5
1.05
1.06
1.13
3.8 1.4
0.6
1.4
B25 1.0 1.12 3.0 0.7 1.3 1.06 0.6 <0.6
B28 9.2 1.01 0.3 <0.6 9.4 1.00 0.2 0
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Table 3. Continued.
HxDAS
(mM)
5 10
U (kV) 16 16
Analyte m a b Rs m a b Rs
B31 7.0 1.03 1.0 <0.6 5.8 1.05 1.2 1.1
B32 6.5 1.03 1.1 <0.6 5.6 1.04 0.7 1.3
B33 8.9 1.04 0.8 <0.6 6.8 1.06 0.5 0.6
B34 7.4 1.03 1.0 <0.6 5.7 1.05 0.6 1.2
B37 10.1 1.02 0.7 <0.6 9.7 1.03 0.5 <0.6
B38 4.3 1.05 1.7 <0.6 3.8 1.11 1.4 <0.6
B41 9.2 1.02 0.8 <0.6 8.8 1.03 0.6 <0.6
B42 6.6 1.05 1.1 <0.6 6.2 1.08 0.8 0.8
B43 5.1 1.06 1.4 <0.6 4.7 1.07 1.1 1.3
B46 2.5 1.04 2.8 <0.6 2.5 1.00 2.0 0
B49 4.7 1.02 1.5 <0.6 4.1 1.04 1.0 <0.6
B51 9.7 1.02 0.8 <0.6 9.1 1.03 0.5 0.9
B54 -0.6 0.75 -11 <0.6 -1.4 0.79 -3.2 1.2
B56 8.6 1.03 0.8 <0.6 8.0 1.04 0.5 1.0
B35 4.7 1.00 1.6 0 4.2 1.00 1.1 0
B36 7.9 1.00 0.9 0 7.1 1.00 0.7 0
B45 9.6 1.00 0.7 0 9.0 1.00 0.5 0
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Table 3. Continued.
HxDAS
(mM)
20 30
U (kV) 16 16
Analyte m a b Rs m a b Rs
B31 6.1 1.03 0.3 <0.6 6.4 1.02 0.2 <0.6
B32 5.8 1.04 0.4 1.0 6.1 1.03 0.3 1.1
B33 7.5 1.04 0.3 1.3 8.1 1.02 0.2 0.9
B34 6.6 1.03 0.4 0.9 7.1 1.02 0.3 1.1
B37 9.3 1.04 0.3 <0.6 9.0 1.05 0.2 <0.6
B38 4.1 1.05 0.7 1.6 4.4 1.02 0.5 1.4
B41 8.4 1.04 0.3 <0.6 8.3 1.04 0.1 0.9
B42 6.5 1.05 0.4 1.1 6.8 1.03 0.2 0.8
B43 4.4 1.09 0.7 1.2 4.8 1.05 0.3 1.0
B46 2.9 1.00 0.9 0 3.1 1.00 0.8 0
B49 3.8 1.05 0.8 <0.6 3.6 1.06 0.3 <0.6
B51 8.7 1.04 0.4 1.1 8.5 1.04 0.2 0.7
B54 -0.8 0.78 -5.4 1.0 -0.6 0.76 -2.0 1.0
B56 7.4 1.05 0.4 0.8 7.2 1.06 0.3 0.9
B35 4.4 1.00 1.0 0 4.5 1.00 0.9 0
B36 6.6 1.00 0.4 0 6.4 1.00 0.4 0
B45 8.5 1.00 0.3 0 8.3 1.00 0.4 0
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bases in aqueous BGEs.  The second mobility pattern is similar to what was seen for strongly
binding bases in the aqueous measurements. The effective mobilities of the enantiomers became
anionic at a low HxDAS concentration, then decreased at the higher HxDAS concentrations due
to the increasing ionic strength. A discontinuity was observed in the separation selectivity
patterns of the strongly binding weak bases. These behaviors are shown in Figure 56, bottom
panel. 
Like in the aqueous BGEs, the cyclodextrion cavity size also affects the enantiomer
separation behavior in NACE. Figure 57 shows the effective mobility plots (top panel) and the
corresponding separation selectivities (bottom panel) for piperoxan (B38) and propranolol
(B42) in acidic methanol BGEs with HxDAS, HDAS and ODAS as the chiral resolving agents.
The complexing strength for the two weak base analytes with HxDAS, HDAS and ODAS in
acidic methanol BGEs were similar to the results that we obtained in aqueous CE, following
the order: ODAS > HDAS > HxDAS. 
3.4.3 Comparison of NACE to ACE
There were four weak bases, 1-aminoindan (B05), hemicholinium-15 (B20),
propafenone (B43) and scopolomine (B46), which could not be separated in aqueous CE, but
could be separated in acidic methanol BGE. 
The BGE solvent  also affects the separation patterns. Pindolol (B41) and propranolol
(B42), which showed particularly strong binding and baseline separation in aqueous BGE,
showed weak binding and could not be baseline separated in NACE. In both low pH and high
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Figure 57. Effects of cyclodextrin cavity size on the separation of the enantiomers of the weak
base analytes in acidic methanol BGEs with HxDAS, HDAS, ODAS.
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pH aqueous BGEs, fluoxetine (B18) was strongly binding with HxDAS. However, in NACE,
it’s binding was weak.  Figure 58 shows the effective mobility plots (top panel) and the
corresponding separation selectivities (bottom panel) for fluoxetine (B18) and propranolol
(B42) in acidic aqueous and methanol BGEs with HxDAS as the chiral resolving agent.
Many enantiomers, whose mobilities were measured in both acidic aqueous and acidic
methanolic BGEs had a considerably more cationic mobility in the acidic methanolic BGEs
than in the low pH aqueous BGEs. These analytes could be separated both in acidic aqueous
and acidic methanolic BGEs and showed decreased binding strengths in the acidic methanolic
BGE. The same phenomena were observed with HDAS and ODAS containing BGEs. There
are two potential reasons leading to this phenomenon. (i)  Compared to the aqueous system, the
degree of dissociation of the charged HxDAS is significantly suppressed   in methanol, so
HxDAS behaves more like a neutral cyclodextrin; (ii) Compared to water, methanol acts as a
stronger competing agent of analytes, reducing the complexation constants of the HxDAS-
analyte complexes compared to those observed in an aqueous BGEs.
Favorable b values lead to baseline separation for the enantiomers of most of the weak
base analytes tested in acidic methanol BGEs (Figure 59). The numbers under the compound
codes (see Figure 37) next to the electropherograms indicate the actual HxDAS concentrations
(in mM) and the effective separation potentials in kV (the actual potential drop between the
injection point and the detector window). 
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3.5 Summary
The first new, single-isomer, a-CD, HxDAS, has been synthesized on a large scale with
a purity > 97.8 % and effectively used for the CE separations of the enantiomers of a large
number of neutral, weak acid, ampholytic and weak base analytes in both low and high pH
aqueous BGEs as well as for the separation of weak bases in an acidic methanolic BGE. The
effective mobilities and separation selectivities followed the predictions of the CHARM model
of CE enantiomer separations  and led to different peak resolution values than the
corresponding b-CD analogue, HDAS, and g-CD analogue, ODAS. The experimental results
show that the chiral recognition process depends on (i) the pH of the BGE; (ii) the type of BGE
solvent; (iii) the structure of the analytes; (iv) the size of the CD cavity; and (v) the type of the
ions in the background electrolyte.
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CHAPTER IV
ENANTIOMER SEPARATIONS WITH HxS
The previous experiments (Chapter III) showed us that HxDAS, which bears moderately
hydrophobic acetyl groups at the 2, 3- positions on the glucopyranose units, could be
successfully used to separate the enantiomers of neutral, weak base, weak acid and ampholytic
analytes in both aqueous (pH=2.5 and pH=9.5) and nonaqueous (acidic methanolic) BGEs.
Since different  substituents can provide different inter - molecular interactions with chiral
analytes, it seemed interesting to investigate the use of hexakis(6-O-sulfo)-a-CD (HxS), which
contains hydrophilic hydroxyl groups at the 2 and 3- positions on the glucopyranose unit for the
separation of pharmaceutically important compounds.
4.1 Separations in Low pH BGEs
According to the predictions of the charged resolving agent migration model (CHARM
model) of CE enantiomer separations [119], only two BGEs, one with a low pH and another
with a high pH are required to find the best possible separation selectivities for any weak
electrolyte and neutral analyte with a strong electrolyte chiral resolving agent, such as HxS. All
low pH measurements were carried out in the 25 mM phosphoric acid buffer whose pH was
adjusted to 2.5 with LiOH.
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4.1.1 Experimental Methods and Conditions
Except for the sodium salt of hexakis(6-O-sulfo)-a-cyclodextrin (HxS), which was
synthesized as described in Chapter II, all other chemicals were obtained from Aldrich
Chemical Company. Details of the other experimental conditions can be seen in Chapter III.
4.1.2 Results and Discussion
A series of neutral, weak acid and weak base enantiomers were separated with the pH
2.5 HxS BGEs. The effective mobilities of the less mobile enantiomers, m, the separation
selectivities, a, the measured peak resolution values, Rs, the corresponding dimensionless EOF
mobility values, b, and the injector-to-detector potential drop values, U, are listed in Table 4.
4.1.2.1 Separation of the Enantiomers of Nonionic and Weak Acid Analytes
For the weakly complexing noncharged analytes and weak acid analytes, the effective
anionic mobilities increased as the concentration of HxS was increased (top panels in Figure
60), indicating that complexation did override the mobility-reducing effects of both higher ionic
strength and higher viscosity. Except for the two lactones, g-(2-naphthyl)-g-butyrolactone (N12)
and g-(2-phenyl)-g-butyrolactone (N13), the increase in meff for most noncharged and weak acid
analytes is larger with HxS than with HxDAS [129] indicating stronger interactions with HxS
than with HxDAS. There are also separation selectivity differences between HxDAS and HxS:
a is larger for the enantiomers of g-(2-phenyl)-g-butyrolactone (N13), carprofen (A04) and
fenoprofen (A22) with HxS than with HxDAS [129]. The differences, brought about by the
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removal of the acetyl groups from HxDAS, can be attributed to either size effects or polarity
effects. 
4.1.2.2 Separation of the Enantiomers of Weak Bases
Effective mobility and separation selectivity curves for some of the weak bases are
shown in Figure 61 as a function of the concentration of HxS. Just as with HxDAS (Chapter III),
the weak bases can be divided into two groups, weakly binding bases and strongly binding
bases, depending on the response of their effective mobilities to the increased HxS
concentration.
For the weakly binding bases, the effective mobilities remain cationic even for HxS
concentrations as high as 50 mM (left top panel in Figures 61). The corresponding separation
selectivities pass a relatively large local maximum (left bottom panel in Figure 61). According
to Reference [113], when complexation is weak, the mole fraction of the anionic analyte - HxS
complex is small, even for a relatively high HxS concentration. On the other hand, the high HxS
concentration leads to a high ionic strength in the BGE. The high ionic strength depresses the
mobility of the highly charged anionic complexes (irrespectively of their low mole fraction)
much more than that of the free, monoprotonated weak base analytes (irrespectively of their
high mole fraction). Consequently, the contribution of the anionic analyte - HxS complex to the
effective mobility of the weak base analyte band is smaller than 
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Table 4. Separation data in pH=2.5 HxS BGEs. (m, in 10-5 cm2 / Vs units). 
HxS (mM) 0 10
U (kV) 0 12
Analyte m m a b Rs
NSA- 0 -27.8
N12 0 -1.3 1.00 -3.7 0
N13 0 N/A
N21 0 -11.3* 1.03 -0.5 1.0
N25 0 -14.0* 1.03 -0.4 1.2
N26 0 -6.61* 1.05 -0.5 2.5
N27 0 -0.8 1.00 -19 0
N28 0 -1.24 1.08 -2.0 0.7
N30 0 -2.62 1.07 -3.9 0.8
N36 0 -1.07 1.00 -3.8 0
A02 0 -8.46* 1.08 -0.7 1.8
A04 0 -3.92 1.03 -3.4 0.7
A22 0 -5.2 1.05 -1.1 0.9
A28 0 -4.9 1.00 -1.2 0
A36 0 -4.1 1.00 -1.3 0
 * Polarity (-) to (+), NSA- as secondary EOF marker
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Table 4. Continued.
HxS
(mM)
20 30
U (kV) 10 8
Analyte m a b Rs m a b Rs
NSA- -28.0 -28.2
N12 -2.78 1.00 -2.1 0 -3.9 1.00 -1.0 0
N13 N/A -3.53 1.15 -4.8 1.7
N21 N/A N/A
N25 -15.1* 1.01 -0.4 0.8 -16.1* 1.01 -0.6 0.7
N26 -9.9* 1.03 -0.5 1.1 -12.5* 1.01 -0.9 1.2
N27 -1.8 1.00 -3.0 0 -2.92* 1.00 -0.6 0
N28 -2.0 1.05 -2.6 1.0 -2.48* 1.04 -0.2 <0.6
N30 -4.22 1.06 -1.0 1.1 -5.27* 1.04 -0.2 1.2
N36 -2.4 1.00 -2.1 0.0 -3.31* 1.00 -0.5 0
A02 -15.1* 1.05 -0.4 2.3 -19.6 1.03 -2.7 0.7
A04 -8.16* 1.02 -0.8 0.6 -12.9* 1.01 -0.2 0.6
A22 -9.64* 1.04 -0.5 0.7 -13.8* 1.04 -0.2 1.6
A28 -8.66* 1.00 -0.6 0 -11.0* 1.00 -0.1 0
A36 -7.44* 1.00 -0.6 0 -10.4* 1.00 -0.3 0
141
Table 4. Continued.
HxS
(mM)
0 5 10
U (kV) 18 14 13
Analyte m m a b Rs m a b Rs
B02 24.7 6.6 1.00 3.4 0 5.4 1.00 3.2 0
B03 24.3 5.5 1.02 4.1 <0.6 4.1 1.04 4.6 <0.6
B08 21.1 5.2 1.00 4.2 0 N/A
B09 21.7 5.7 1.00 3.9 0 2.9 1.00 3.8 0
B10 19.8 6.1 1.00 3.6 0 4.2 1.00 3.4 0
B11 21.7 6.7 1.03 3.4 <0.6 4.5 1.05 7.0 0.6
B13 27.9 6.6 1.00 3.3 0 3.1 1.03 4.4 <0.6
B14 27.3 5.5 1.00 4.2 0 N/A
B18 18.6 9.9 1.08 1.7 5.3 6.8 1.15 2.2 0.9
B19 24.2 6.3 1.05 2.6 0.6 3.2 1.16 0.8 2.0
B21 24.1 9.0 1.00 1.3 0 N/A
B22 25.6 6.7 1.00 3.0 0 N/A
B25 21.9 4.1 1.09 4.0 <0.6 2.0 1.23 5.0 0.6
B26 23.7 4.8 1.00 3.8 0 5.5 1.00 3.0 0
B28 28.3 5.4 1.00 3.9 0 4.7 1.00 3.6 0
B31 18.9 3.6 1.00 5.8 0 1.7 1.00 6.8 0
B32 17.7 4.0 1.00 5.6 0 1.7 1.00 6.8 0
B34 27.5 6.7 1.01 2.4 <0.6 4.6 1.02 3.1 <0.6
B35 18.0 3.4 1.00 6.0 0 4.7 1.00 3.2 0
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Table 4. Continued.
HxS (mM) 20 30
U (kV) 12 8
Analyte m a b Rs m a b Rs
B02 4.8 1.00 2.6 0 4.4 1.00 2.5 0
B03 3.7 1.06 8.0 <0.6 4.7 1.10 1.5 <0.6
B08 3.9 1.00 2.9 0 4.2 1.00 2.9 0
B09 2.2 1.00 4.8 0 1.5 1.00 6.2 0
B10 3.4 1.00 3.9 0 2.8 1.00 4.3 0
B11 3.7 1.06 0.8 1.5 2.5 1.08 4.4 <0.6
B13 1.2 1.05 8.0 <0.6 -0.6 0.92 -15 0.7
B14 4.3 1.00 4.3 0 10.9 1.00 0.7 0
B18 2.8 1.26 0.9 4.9 0.6 1.58 14 3.8
B19 2.8 1.09 2.7 0.6 2.3 1.06 2.8 1.0
B21 5.5 1.00 2.8 0 3.9 1.00 1.5 0
B22 N/A 2.5 1.09 2.4 <0.6
B25 N/A 0.7 1.60 3.5 3.9
B26 6.2 1.00 2.2 0 7.3 1.00 1.7 0
B28 N/A 4.0 1.00 4.2 0
B31 0.9 1.00 10 0 -0.6 0.74 -9.9 1.1
B32 3.5 1.00 3.2 0 5.9 1.00 1.2 0
B34 3.2 1.06 2.4 <0.6 2.1 1.05 2.7 <0.6
B35 3.6 1.00 2.1 0 2.2 1.00 1.5 0
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Table 4. Continued.
HxS (mM) 40 50
U (kV) 6 5
Analyte m a b Rs m a b Rs
B02 5.0 1.00 1.6 0 N/A
B03 3.5 1.08 1.6 0.9 N/A
B08 3.7 1.00 2.9 0 3.4 1.00 1.9 0
B09 N/A -0.3 0.94 -37 <0.6
B10 3.2 1.00 2.8 0 2.3 1.00 2.4 0
B11 1.1 1.11 9.0 <0.6 -0.8 0.95 -11 0.8
B13 -2.2 0.95 -3.8 <0.6 -1.2 0.91 -4.6 <0.6
B14 13.6 1.00 0.9 0 N/A
B18 -1.6 0.86 -6.9 1.0 -1.1 0.92 -6.4 0.9
B19 1.8 1.03 3.6 0.7 N/A
B21 3.4 1.00 2.1 0 4.1 1.00 0.8 0
B22 1.4 1.06 8.2 <0.6 N/A
B25 1.0 1.42 4.0 0.9 1.3 1.32 5.5 1.3
B26 8.3 1.00 1.2 0 N/A
B28 4.9 1.00 3.4 0 5.6 1.00 0.6 0
B31 -1.4 0.92 -9.8 0.7 N/A
B32 4.1 1.00 2.4 0 N/A
B34 1.4 1.03 9.2 <0.6 1.8 1.00 3.2 0
B35 1.6 1.00 2.3 0 N/A
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Table 4. Continued.
HxS
(mM)
0 5 10
U (kV) 14 12 11
Analyte m m a b Rs m a b Rs
B37 21.8 N/A 4.7 1.04 4.1 <0.6
B38 24.5 6.2 1.02 3.6 <0.6 3.0 1.04 2.8 <0.6
B39 30.5 10.6 1.05 1.4 2.2 4.1 1.15 2.8 2.4
B41 23.2 6.0 1.02 2.3 <0.6 3.8 1.05 1.2 1.2
B42 24.3 6.6 1.00 3.3 0 4.1 1.02 2.1 <0.6
B43 18.8 3.9 1.15 3.4 <0.6 2.2 1.27 40 2.9
B44 35.3 N/A 5.0 1.06 2.1 0.7
B45 19.5 8.1 1.00 2.1 0
B46 22.2 7.7 1.00 2.0 0
B47 35.3 5.6 1.00 3.4 0 3.7 1.00 4.3 0
B48 12.4 N/A 6.6 1.03 2.2 <0.6
B49 18.6 5.1 1.02 3.5 <0.6
B51 20.6 6.6 1.02 1.7 <0.6 1.9 1.06 3.6 0.9
B53 18.1 3.8 1.06 3.0 0.7 -3.3 0.91 -3.8 <0.6
B54 17.6 2.78 1.12 3.8 4.1 1.3 1.20 6.6 1.0
B56 41.7 2.7 1.10 6.4 1.2 1.5 1.17 3.6 0.6
B57 17.0 3.5 1.02 4.8 <0.6 1.7 1.06 3.5 <0.6
B58 25.9 8.1 1.02 2.3 <0.6 3.7 1.06 3.6 0.7
B61 24.2 5.2 1.02 3.6 <0.6 1.72 1.04 5.4 <0.6
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Table 4. Continued.
HxS
(mM)
20 30
U (kV) 10 8
Analyte m a b Rs m a b Rs
B37 2.6 1.12 3.6 <0.6 1.1 1.35 2.4 1.6
B38 -0.3 0.62 -5.3 1.0 -1.0 0.72 -8.5 1.3
B39 N/A 1.4 1.08 6.2 0.7
B41 N/A 2.5 1.09 1.6 0.9
B42 3.4 1.04 3.1 <0.6 2.2 1.07 8.3 <0.6
B43 N/A 0.2 1.91 28 1.1
B44 1.3 1.17 4.2 2.8 -0.1 0.89 -23 0.8
B45 3.9 1.00 7.0 0 0.7 1.00 9.4 0
B46 3.8 1.00 4.5 0 2.0 1.00 4.0 0
B47 2.2 1.00 4.4 0 1.2 1.00 5.4 0
B48 N/A 2.4 1.08 3.4 0.8
B49 1.8 1.05 5.6 <0.6 -0.7 0.75 -7.1 0.8
B51 N/A 2.8 1.14 5.7 <0.6
B53 N/A -10.1* 0.95 -1.7 1.1
B54 N/A -1.7 0.94 -12 0.6
B56 N/A 1.2 1.25 15 <0.6
B57 <-0.1 0.75 -325 1.1 -0.5 0.82 -43 <0.6
B58 4.8 1.11 2.4 1.1 5.3 1.16 4.6 1.1
B61 N/A 2.9 1.06 3.4 <0.6
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Table 4. Continued.
HxS
(mM)
40 50
U (kV) 6 5
Analyte m a b Rs m a b Rs
B37 0.6 1.28 10 0.9 0.9 1.20 3.4 0.7
B38 -1.6 0.80 -4.3 0.9 -1.0 0.88 -3.0 1.2
B39 2.2 1.04 6.0 0.6 3.2 1.00 1.1 0
B41 N/A 4.1 1.02 0.8 <0.6
B42 N/A 1.6 1.08 1.9 <0.6
B43 -0.3 0.83 -6.6 0.8 -1.2 0.95 -2.5 <0.6
B44 -1.5 0.91 -2.5 0.6 N/A
B45 0.5 1.00 6.5 0 N/A
B46 3.6 1.00 1.6 0 N/A
B47 3.0 1.00 3.3 0 2.1 1.00 2.8 0
B48 2.7 1.07 4.2 <0.6 N/A
B49 -2.1 0.82 -4.2 <0.6 N/A
B51 3.7 1.11 2.4 <0.6 3.5 1.09 0.8 <0.6
B53 -8.0 0.90 -2.1 0.9 -6.3 0.86 -3.2 0.8
B54 -2.5 0.96 -2.9 0.6 -2.1 0.93 -2.1 0.7
B56 1.7 1.12 3.2 <0.6 2.3 1.04 2.4 <0.6
B57 -0.3 0.89 -50 0.7 -0.3 0.86 -38 <0.6
B58 4.6 1.12 1.3 0.9 3.4 1.07 1.4 0.7
B61 3.6 1.05 2.4 <0.6 3.1 1.03 1.8 <0.6
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Figure 60. Effective mobilities and separation selectivities for the enantiomers of nonionic and
weak acid analytes in pH = 2.5 BGEs with HxS.
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Figure 61. Effective mobilities and separation selectivities for the enantiomers of weak base
analytes in pH = 2.5 BGEs with HxS. Weakly binding (left panels) and strongly binding (right
panels).
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that of the free, monoprotonated weak base analytes and the effective mobility of the weak base
analyte band remains cationic, albeit low. 
For the strongly binding weak bases, the effective mobilities become anionic as the
concentration of HxS is increased (right top panel in Figure 61). However, for this group, the
anionic effective mobilities are larger at a moderate HxS concentration than at a high HxS 
concentration. The cause of the phenomenon is once again the interplay between the increased
mole fraction of the anionic analyte - HxS complex and the increased ionic strength that are
brought about by the increased HxS concentration [113]. The former  of these increases the
contribution of the anionic complex to the effective mobility of the band, and its effect is greater
at relatively low HxS concentrations, while the latter decreases the effective mobility of the
anionic complex and its effect is greater at relatively high HxS concentrations. As expected
[113], separation selectivities are larger in the vicinity of the HxS concentration where the
effective mobility of one of the enantiomers changes sign from cationic to anionic (right bottom
panel in Figure 61).
The interactions between HxS and three of the test weak base analytes, fluoxetine
(B18), miconazole (B32) and propranol (B42)were much weaker than with HxDAS [129]. For
about 25 % of the test analytes, interactions with HxS and HxDAS were about equally strong.
For about one third of the weak bases (alprenolol (B02), aminogluetimide (B03), atenolol
(B08), ketamine (B22), methoxyphenamine (B28), metoprolol (B31), norephedrine (B34),
oxybutynin (B35), phenylglycinonitrile (B39), pindolol (B41), and synephrine (B61)), the
interaction were much stronger with HxS than with HxDAS [129]. Only for analytes,
aminogluthetimide (B03), norephedrine (B34), phenylglycinonitrile (B39) and artane (B53) had
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higher separation selectivities with HxS than with HxDAS (at an identical BGE concentration,
e. g., at 5 mM). The differences must be due to multiple, subtle interplays between analyte
structure and both the polarity and size difference of HxS and HxDAS.
The cyclodextrin cavity size also affects the chiral recognition process significantly.
Figure 62 shows the effective mobility plots (top panel) and the corresponding separation
selectivities (bottom panel) for pindolol (B41) with HxS, HS and OS as the chiral resolving
agents. Just as with HxDAS, HDAS and ODAS, the strength of the interactions between
piperoxan (B41) and the three CDs also follows the orders OS @ HS > HxS.
The peak resolution values (Table 4) depend not only on the separation selectivities,
but also on the b values and the magnitude of the effective potential drop. A few typical
separations obtained with HxS are shown in Figures 63 and 64. The numbers next to the
electropherograms indicate the actual HxS concentrations. Figure 63 shows the separation of
the enantiomers of noncharged and weak acid analytes, Figure 64 those of the basic analytes.
In general, the peak resolution values are quite adequate, even when the separations take only
10-15 minutes.
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Figure 62. Cavity size effects on the effective mobilities and separation selectivities of the
enantiomers of B41 in pH = 2.5 BGEs with HxS, HS, OS.
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Figure 63. Typical electropherograms of separation of the enantiomers of the nonionic and
weak acid analytes in pH = 2.5 BGEs with HxS.
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Figure 64. Typical electropherograms of separation of the enantiomers of the weak base
analytes in pH = 2.5 BGEs with HxS.
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4.2 Separations in High pH BGEs
4.2.1 Experimental Conditions and Methods
All CE separations were carried out in 25 mM ethanolamine which were titrated to pH
9.5 with methane sulfonic acid (MSA). The HxS BEs were prepared by weighing out the
required amounts of the sodium salt of HxS into 25mL volumetric flasks and bringing the
volumes to mark with the pH = 9.5 stock BGE solution. The other experimental details are the
same as described in Chapter III.
4.2.2 Results and Discussion
A series of neutral, weak acid and weak base enantiomers were separated with the
pH=9.5 HxS BGEs. Table 5 lists the observed effective mobilities of the less mobile
enantiomers, m, the separation selectivities, a, the measured peak resolution values, Rs, the
corresponding dimensionless EOF mobility values, b, and the injector-to-detector potential
drop values, U. 
4.2.2.1 Separation of the Enantiomers of Nonionic Analytes
For the nonelectrolyte analytes, typical effective mobility and separation selectivity
curves are shown in Figure 65. Though the anionic effective mobilities become larger as the
HxS concentration is increased, the increase is not as rapid as in the pH = 2.5 BGEs indicating
that components of the ethanolamine - MSA buffer compete with the nonelectrolyte analytes for
HxS more strongly than components of the H3PO4 - LiOH buffer did. However,
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Table 5. Separation data in pH=9.5 HxS BGEs. (m, in 10-5 cm2 / Vs units)
HxS (mM) 0 10
U (kV) 8
Analyte m m a b Rs
N02 0 -1.5 1.00 -34 0
N12 0 -1.2 1.00 -28 0
N13 0 -1.0 1.00 -38 0
N21 0 -7.0 1.00 -7.2 0
N24 0 -0.8 1.00 -33 0
N25 0 -9.8 1.00 -5.2 0
N26 0 -5.0 1.00 -10 0
N27 0 -0.7 1.00 -67 0
N28 0 -1.4 1.00 -37 0
N30 0 -2.3 1.00 -22 0
N34 0 -2.6 1.00 -20 0
N36 0 -1.1 1.00 -29 0
N38 0 -1.5 1.00 -33 0
N39 0 -1.1 1.00 -46 0
A02 -23.0 -30.3 1.00 -1.5 0
A22 -21.1 -24.8 1.00 -1.9 0
A23 -22.7 -27.0 1.00 -1.8 0
A30 -24.0 -25.5 1.03 -1.6 0.9
1.02 0.8
A31 -20.9 -26.0 1.00 -1.9 0
A36 -23.9 -31.6 1.03 -1.5 <0.6
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Table 5. Continued.
HxS (mM) 20 30
U (kV) 10 8
Analyte m a b Rs m a b Rs
N02 -2.9 1.03 -14 <0.6 -3.9 1.06 -8.2 <0.6
N12 -2.0 1.12 -21 <0.6 -2.7 1.18 -12 0.7
N13 -2.0 1.00 -21 0 -3.1 1.00 -10 0
N21 -11.2 1.03 -3.8 <0.6 -14.1 1.03 -2.4 0.6
N24 -1.5 1.00 -27 0 -2.3 1.00 -14 0
N25 -14.2 1.02 -2.9 <0.6 -17.4 1.02 -2.0 0.6
N26 -9.1 1.03 -4.6 <0.6 -12.4 1.04 -2.7 0.6
N27 -1.4 1.00 -30 0 -2.1 1.00 -16 0
N28 -2.2 1.00 -19 0 -3.2 1.00 -10 0
N30 -3.9 1.00 -11 0 -5.8 1.00 -5.7 0
N34 -5.0 1.00 -8.2 0 -6.3 1.00 -5.3 0
N36 -1.9 1.00 -22 0 -2.6 1.00 -7.9 0
N38 -2.7 1.00 -15 0 -4.2 1.00 -7.9 0
N39 -2.0 1.00 -21 0 -2.8 1.08 -12 <0.6
A02 -31.0 1.00 -1.5 0
A22 -25.0 1.00 -1.8 0 -24.6 1.00 -1.5 0
A23 -27.3 1.00 -1.5 0 -25.9 1.00 -1.2 0
A30 -28.5 1.03 -1.5 1.4 -27.4 1.04 -1.3 4.3
1.01 0.7 1.02 1.7
A31 -25.4 1.00 -1.8 0 -23.7 1.00 -1.4 0
A36 -31.8 1.03 -1.4 <0.6 -31.1 1.03 -1.1 <0.6
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Table 5. Continued.
HxS
(mM)
40 50
U (kV) 6 6
Analyte m a b Rs m a b Rs
N02 -4.9 1.09 -5.4 <0.6 -6.0 1.08 -4.0 <0.6
N12 -3.4 1.16 -8.1 0.8 -3.8 1.13 -5.5 <0.6
N13 -4.0 1.00 -6.7 0 -4.6 1.00 -4.1 0
N21 -14.8 1.03 -1.8 <0.6 -15.3 1.02 -3.4 <0.6
N24 -3.1 1.00 -8.4 0 -3.5 1.00 -5.1 0
N25 -18.2 1.02 -1.4 0.7 -18.6 1.02 -1.2 <0.6
N26 -14.3 1.04 -1.9 <0.6 -15.4 1.03 -1.4 <0.6
N27 -2.9 1.00 -7.6 0 -3.3 1.00 -3.5 0
N28 -4.0 1.00 -5.5 0 -4.6 1.02 -3.0 <0.6
N30 -6.9 1.02 -2.9 <0.6 -8.0 1.07 -3.2 <0.6
N34 -7.5 1.02 -3.6 <0.6 -8.1 1.02 -3.2 <0.6
N36 -3.1 1.00 -8.8 0 -3.7 1.00 -7.1 0
N38 -5.2 1.00 -5.2 0 -5.8 1.00 -4.6 0
N39 -3.6 1.14 -7.6 0.7 -4.3 1.14 -6.5 <0.6
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Table 5. Continued.
HxS
(mM)
0 5 10
U (kV) 18 12 10
Analyte m m a b Rs m a b Rs
B02 10.4 2.0 1.19 23 0.9
B03 8.6 -2.4 0.92 -41 <0.6 -5.5 0.93 -7.9 <0.6
B04 12.6 10.1 1.00 4.0 0
B08 10.9 7.1 1.00 5.8 0
B09 11.3 6.8 1.00 6.1 0
B11 1.5 N/A -3.2 0.75 -14 0.7
B13 14.8 N/A N/A
B14 5.9 2.0 1.10 51 <0.6
B18 10.3 N/A -9.8 0.28 -4.3 8.0
B19 11.2 7.0 1.04 6.4 <0.6
B22 10.0 N/A -3.5 0.93 -9.5 <0.6
B23 9.0 1.17 1.69 43 <0.6 -0.4 0.64 -117 0.8
B24 7.0 N/A -2.1 0.95 -20 <0.6
B25 18.0 4.0 1.05 10 <0.6
B37 10.5 6.9 1.00 6.2 0
B39 0.0 N/A -2.1 1.22 -20 0.7
B46 1.1 N/A N/A
B51 8.0 3.9 1.07 11 <0.6
B54 0.0 -9.86 1.25 -5.0 1.0 -10.5 1.20 -4.1 3.0
B58 20.2 9.5 1.03 4.7 <0.6
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Table 5. Continued.
HxS (mM) 20 30
U (kV) 10 8
Analyte m a b Rs m a b Rs
B02 -2.7 0.74 -15 0.8 -4.3 0.88 -8.3 0.9
B03 -7.9 0.94 -5.0 0.7 -8.7 0.94 -4.0 1.1
B04 8.3 1.00 4.7 0 6.7 1.00 6.8 0
B08 5.1 1.00 7.6 0 3.7 1.00 8.6 0
B09 4.1 1.00 9.1 0 2.7 1.00 12 0
B11 -5.7 0.89 -6.9 0.9 -7.4 0.92 -4.3 1.4
B13 N/A -9.7 0.97 -3.2 <0.6
B14 -1.1 0.91 -36 <0.6 -3.9 0.97 -8.1 <0.6
B18 -11.3 0.44 -3.5 10.5 -11.5 0.56 -2.7 12
B19 4.7 1.06 8.1 <0.6 2.5 1.08 16 <0.6
B22 -8.3 0.95 -4.8 <0.6 -10.8 0.96 -3.0 0.7
B23 -2.7 0.79 -14 0.7 -4.5 0.95 -7.3 <0.6
B24 -5.5 0.96 -7.1 <0.6 -7.7 0.97 -4.3 <0.6
B25 1.5 1.16 26 <0.6 N/A
B37 5.3 1.00 7.4 0 4.2 1.00 11 0
B39 -3.3 1.19 -12 0.9 -4.4 1.23 -7.6 1.1
B46 N/A -2.1 0.95 -2.5 <0.6
B51 1.2 1.15 29 <0.6 0.5 1.26 127 <0.6
B53 N/A -5.0 1.07 -6.6 0.7
B54 -11.4 1.16 -3.5 3.3 -12.7 1.12 -2.6 4.3
B58 6.5 1.07 5.9 0.6 4.3 1.12 7.7 0.7
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Table 5. Continued.
HxS
(mM)
40 50
U (kV) 6 6
Analyte m a b Rs m a b Rs
B02 -1.4 0.65 -19 0.7 -1.2 0.57 -21 10
B03 -8.6 0.95 -3.1 0.8 -7.9 0.94 -3.1 1.2
B04 5.8 1.00 4.1 0 6.0 1.00 3.9 0
B08 3.4 1.00 5.9 0 3.2 1.00 6.2 0
B09 1.6 1.00 14 0 1.8 1.00 12 0
B11 -5.4 0.88 -4.5 0.9 -5.2 0.84 -5.1 1.1
B13 -6.9 0.96 -1.8 0.9 N/A
B14 -4.3 0.95 -7.7 <0.6 -4.2 0.93 -6.9 <0.6
B18 -10.7 0.47 -2.4 8.3 -10.1 0.34 -2.3 9.8
B19 2.3 1.12 6.7 1.0 2.8 1.06 7.5 0.7
B22 -9.6 0.97 -2.4 0.6 -8.7 0.96 -2.8 0.7
B23 -4.2 0.93 -5.9 <0.6 N/A
B24 -6.8 0.92 -2.0 <0.6 N/A
B25 4.0 1.12 1.7 1.3 4.3 1.09 1.5 0.9
B37 4.9 1.00 5.0 0 5.1 1.00 3.5 0
B39 -5.3 1.21 -4.5 0.9 -5.8 1.22 -3.8 0.8
B46 N/A N/A
B51 0.9 1.11 28 <0.6 1.53 1.04 16 <0.6
B53 N/A -6.7 1.06 -3.4 0.6
B54 -12.6 1.19 -2.0 2.0 -13.1 1.23 -1.8 2.8
B58 4.2 1.08 5.7 0.9 4.75 1.05 5.2 0.7
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Figure 65. Effective mobilities and separation selectivities for the enantiomers of nonionic
analytes in pH = 9.5 BGEs with HxS.
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by-and-large, separation selectivities are similar in both BGEs, indicating that there is no
preferred BGEs in terms of the pH of the BGE for this set of analytes.
4.2.2.2 Separation of the Enantiomers of Weak Acids
The previous studies have shown that HxS could separate enantiomers in low pH
background electrolytes. Due to their limited solubilities, only a few of the hydrophobic, acidic
pharmaceuticals could be studied in the low pH BGEs. Though acidic analytes become anionic,
and thus quite soluble, in high pH BGEs, their binding to the anionic HxS is expected to be
weak. Since HxS is hydrolytically very stable at pH=9.5, it was interesting to investigate the
separation behavior of weak acid analytes in the pH = 9.5 BGEs. In the absence of HxS, the
effective mobilities of the analytes are (-7 to -29)x10-5 cm2 V-1 s-1, indicating that the carboxylic
acid groups are fully dissociated. Just as the weak base analytes in low pH BGEs, the anionic
meff values pass a local maximum as the HxS concentration is increased. The effective mobility
trends can be explained by the interplay between the increasing degree of complexation
between HxS and weak acid analytes, and the increased BGE viscosity, as well as the
increased ionic strength of the BGEs, as the HxS concentration is increased. Increases in the
anionic effective mobilities of three of the analytes, trans-2-phenyl-1-cyclopropane carboxylic
acid (A02), carprofen (A04) and 2-phenylpropionic acid (A36) were about two times larger
than the mobility increases for the other weak acids and about three times larger than the
mobility increases for similar-size nonelectrolyte analytes. Flubiprofen (A26) stood out as the
weak acid for which the mobility increase uniquely low. Despite the relatively favorable b
values and the relatively strong interactions between the weak acids and HxS, only partial peak
163
resolution was achieved, and only for two of the weak acid analytes. 
The pH of the BGE may play a role in the separation of the enantiomers of the weak
acid analytes. For some of the weak acid, the enantiomers could not be separated in the low pH
BGEs with HxS, but could be separated in the high pH BGEs and vice verse. Figure 66 shows
the effective mobility plots (top panel) and the corresponding separation selectivities (bottom
panel) for fenoprofen (A22) and 2-phenylpropionic acid (A36) in both the high pH and the low
pH BGEs with HxS as the chiral resolving agent. The fenoprofen enantiomers could be
separated in the low pH BGE, but not in the high pH BGE, while the enantiomers of 2-
phenylpropionic acid could not be separated in the low pH BGE, but could be separated in the
high pH BGE.
 
4.2.2.3 Separation of the Enantiomers of Weak Bases
For weak bases, except B39, B53 and B54, the initial effective mobilities in the 0 mM
HxS BGE were still cationic, with effective mobilities from 1 to 20x10-5 cm2 V-1 s-1, indicating
that the pH was not high enough to completely deprotoned the amine groups in the weak base
molecules. As in the low pH BGEs, the weak base enantiomers can also be divided into two
groups: weakly binding and strongly binding weak bases. Figure 67 shows the mobility (left
top panel) and  separation selectivity (left bottom panel) curves for three typical, weakly
binding weak base enantiomers, as well as the mobility (right top panel) and separation
selectivity (right bottom panel) curves for three typical strongly binding weak
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Figure 67. Effective mobilities and separation selectivities for the weak base analytes in pH
= 9.5 BGEs with HxS. Weakly binding (left panels) and strongly binding (right panels).
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bases. In each case, the initially cationic effective mobility of the weak base is between 9x10-5
and 21x10-5 cm2/Vs.
The type of the CD substituents also affects the separation of the enantiomers of weak
base analytes in the high pH BGEs. The complexing strength of tolperisone (B51) with HxS is
much weaker than with HxDAS. This can be rationalized by noting that the hydrophobic
interactions between B51 and the hydrophilic HxS, are weaker than with HxDAS. 
The size of the cyclodextrin cavity also affects the chiral recognition process
significantly. Figure 68 shows the effective mobility plots (top panel) and the corresponding
separation. selectivities (bottom panel) for chlophedianol (B14) with HxS, HS and OS as the
chiral resolving agents. Just as in the low pH BGEs, the strength of the inter - molecular
interactions between B14 and the three CDs follow the order: OS @ HS > HxS. While at our
present level of knowledge the differences cannot be predicted a priori, they indicate that HxS
can play a unique role in the CE separation of enantiomers.
The pH of the HxS BGEs also influences the separation of the enantiomers of weak
base analytes. Figure 69 shows the effective mobility plots (top panel) and the corresponding
separation selectivities (bottom panel) for aminoglutethimide (B03) and bupropion (B11) in
both the high pH and the low pH BGEs with HxS as the chiral resolving agent. For both two
weak base analytes, the binding strength with HxS is low in the low pH BGEs; but high in the
high pH BGEs.
Finally,  Figure 70 show some typical electropherograms in the high pH BGEs with
HxS. The numbers next to the electropherograms indicate the actual HxS concentrations.
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170
4.3 Summary
The second single-isomer sulfated a-CD, the sodium salt of hexakis(6-sulfo)-a-cyclodextrin
(HxS) has been synthesized and used to separate the enantiomers of neutral, weak acid and
weak base analytes in both low and high pH aqueous BGEs. The effective mobilities and
separation selectivities followed the predictions of the CHARM model of CE enantiomer
separations and led to different peak resolution values than HxDAS and its corresponding b-
analogues and g-analogues. The experimental results also show that the inter - molecular
interactions of HxS with analytes B18 and B51 are weaker than with HxDAS. Compared to the
corresponding b-CD, g-CD derivatives, HS and OS, the complexing strength of HxS with chiral
analytes is much weaker. The  pH of the BGE also plays a very important role in the chiral
recognition process when HxS is used as the chiral  resolving agent. 
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CHAPTER V
ENANTIOMER SEPARATIONS WITH HxDMS
In order to complete the study of the effect of substituent structure on the separation of
enantiomers, hexakis(2,3-di-O-methyl-6-O-sulfo)-a-CD (HxDMS) was synthesized and
evaluated.
5.1 Materials and Methods
Except for the sodium salt of hexakis(2,3-di-O-methyl-6-O-sulfo)-a-cyclodextrin
(HxDMS) which was synthesized as described in Chapter II, all other chemicals were obtained
from Aldrich Chemical Company. The low pH BGE was prepared by titrating 25 mM H3PO4
with LiOH to pH = 2.5. The high pH BGE was prepared by titrating 25 mM ethanolamine with
methanesulfonic acid to pH = 9.5. Effective mobility measurements were carried out within the
linear region of Ohm’s law using DMSO as the neutral marker. Other details of the
experimental conditions were described in Chapter III. 
5.2 Enantiomer Separations in Low pH BGEs
A series of neutral, weak acid, weak base enantiomers were separated in the pH = 2.5
HxDMS BGEs. Table 6  lists the effective mobilities of the less mobile enantiomers, m, the
separation selectivities, a, the measured peak resolution values, Rs, the corresponding
dimensionless EOF mobility values, b, and the injector-to-detector potential drop values, U.
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N/A indicates that the aforementioned values could not be calculated due to either overlap with
non-comigrating system peaks or comigration of an enantiomer peak with the neutral marker.
5.2.1 Separation of the Enantiomers of Nonionic Analytes
Enantiomers of eleven of the fifteen nonionic analytes, mostly aromatic alcohols, could
be separated with HxDMS, with baseline separations, for seven of the eleven nonionic
analytes. The anionic mobilities of the non-charged enantiomers increased monototically with
increasing HxDMS concentration as shown in Figure 71 (top panel). The separation selectivity
plots (Figure 71,  bottom panel) are similar to those obtained for the separation of the
enantiomers of nonionic analytes with HxDAS (Chapter III) and HxS (Chapter IV). 
HxDMS complexed with all of the nonelectrolyte analytes tested quite strongly. Some
of the complexation strength differences can be easily rationalized by considering the structure
of the analyte: e. g., of the two g-butyrolactone, N12 that contains a naphthyl ring complexes
much more strongly with HxDMS than N13 that contain phenyl ring.  For other analyte pairs,
more subtle structural differences still lead to large complexation differences, e. g., 1-
phenylpentanol (N25) binds much more strongly than either 2-phenyl-2-pentanol (N26) or 1-
phenylbutanol (N21). The effects of the size of the CD in the identically substituted HxDMS,
HDMS and ODMS can be seen in Figure 72: the top panels compare the effective mobilities
for 1-phenylpentanol (N25) (left panel) and 2-phenyl-2-pentanol (N26) (right panel) with
HxDMs, HDMS [104] and ODMS [110] as the chiral resolving agent, the
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Table 6. Separation data in pH=2.5 HxS BGEs.  (m, in 10-5 cm2 / Vs units)
HxDMS (mM) 0 10
U (kV) 12
Analyte m m a b Rs
N02 0 -4.3 1.00 -2.8 0
N10 0 -3.3 1.03 -4.5 <0.6
N12 0 -13.7 1.03 -1.2 <0.6
N13 0 -5.1 1.00 -3.0 0
N15 0 -2.8 1.06 -5.4 <0.6
N21 0 -5.0 1.00 -3.4 0
N24 0 -2.1 1.00 -6.2 0
N25 0 -9.5 1.00 -1.9 0
N26 0 -4.3 1.04 -2.8 <0.6
N27 0 -2.8 1.00 -5.2 0
N28 0 -3.0 1.00 -5.1 0
N30 0 -5.5 1.14 -3.0 3.3
N34 0 -3.3 1.00 -3.7 0
N36 0 -2.8 1.34 -5.7 2.2
N38 0 -3.0 1.00 -4.4 0
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Table 6. Continued.
HxDMS
(mM)
20 30
U (kV) 11 10
Analyte m a b Rs m a b Rs
N02 -7.5 1.01 -3.0 <0.6 -10.4 1.01 -2.9 <0.6
N10 -5.6 1.07 -3.9 0.7 -7.8 1.09 -2.9 0.9
N12 -17.3 1.05 -1.3 3.7 -18.5 1.06 -1.2 4.2
N13 -8.1 1.00 -2.1 0 -10.3 1.00 -2.2 0
N15 -4.5 1.06 -4.7 0.8 -6.1 1.07 -3.6 1.0
N21 -9.1 1.02 -2.5 <0.6 -11.9 1.03 -2.4 <0.6
N24 -3.6 1.01 -6.2 <0.6 -4.7 1.01 -5.2 <0.6
N25 -14.9 1.03 -1.5 1.4 -18.9 1.04 -1.5 2.8
N26 -7.4 1.01 -2.1 <0.6 -9.2 1.01 -3.0 <0.6
N27 -6.1 1.00 -3.2 0 -7.6 1.00 -3.6 0
N28 -5.9 1.00 -3.2 0 -7.3 1.00 -3.8 0
N30 -10.4 1.09 -2.9 1.9 -15.5 1.06 -1.8 2.8
N34 -6.0 1.00 -3.4 0 -7.5 1.00 -3.3 0
N36 -5.0 1.30 -2.5 3.4 -6.4 1.26 -4.3 2.9
N38 -5.1 1.01 -4.4 <0.6 -6.8 1.02 -4.1 <0.6
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Table 6. Continued.
HxDMS
(mM)
40 50
U (kV) 8 6
Analyte m a b Rs m a b Rs
N02 -12.6 1.01 -2.1 <0.6 -13.3 1.01 -1.8 <0.6
N10 -9.3 1.11 -2.8 2.0 -9.8 1.06 -2.5 0.7
N12 -19.2 1.06 -1.4 10 -19.9 1.06 -1.3 5.6
N13 -11.7 1.00 -2.6 0 -12.0 1.00 -1.9 0
N15 -7.5 1.07 -3.4 0.7 -8.4 1.05 -1.7 2.2
N21 -13.5 1.03 -2.2 0.8 -14.7 1.04 -1.8 1.1
N24 -5.6 1.02 -5.3 <0.6 -6.6 1.03 -3.8 <0.6
N25 -21.9 1.05 -1.4 2.3 -22.7 1.04 -1.1 2.0
N26 -11.1 1.01 -2.7 <0.6 -12.1 1.01 -2.0 <0.6
N27 -8.8 1.00 -2.9 0 -8.9 1.00 -2.5 0
N28 -8.8 1.00 -2.7 0 -9.2 1.00 -2.4 0
N30 -20.5 1.04 -1.4 2.1 -21.8 1.02 -1.2 1.9
N34 -8.8 1.00 -2.4 0 -9.6 1.00 -2.5 0
N36 -7.8 1.24 -3.9 4.7 -8.2 1.22 -3.1 3.5
N38 -8.3 1.02 -3.5 <0.6 -9.5 1.01 -2.7 <0.6
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Table 6. Continued.
HxDMS (mM) 0 10
U (kV) 12
Analyte m m a b Rs
NSA- 0
A02 0 -10.9 1.03 -1.9 0.7
A22 0 -10.5 1.01 -2.1 <0.6
A23 0 -12.8 1.00 -1.4 0
A26 0 -15.4 1.00 -1.1 0
A27 0 -14.1 1.00 -1.6 0
A28 0 -5.3 1.02 -4.3 0.6
A30 0 -10.4
-10.9
-11.0
-11.0
1.05
1.05
1.00
-1.8 3.1
1.1
0
A31 0 -6.5 1.02 -3.5 <0.6
A36 0 -4.2 1.00 -5.2 0
    * Polarity (-) to (+), NSA- as secondary EOF marker
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Table 6. Continued.
HxDMS
(mM)
20 30
U (kV) 11 10
Analyte m a b Rs m a b Rs
NSA- -27.5 -26.9
A02 -17.4* 1.03 -0.2 0.8 -20.3* 1.02 -0.2 <0.6
A22 -16.0 1.03 -2.0 1.2 -20.4 1.02 -1.3 0.6
A23 -17.3* 1.00 -0.1 0 -20.6* 1.00 -0.7 0
A26 -20.4* 1.01 -0.03 <0.6 -24.2 1.00 -1.2 0
A27 -27.9* 1.00 -0.2 0 -25.3* 1.00 -0.9 0
A28 -8.2 1.03 -1.6 1.3 -10.7 1.02 -2.4 2.1
A30 -17.1*
-16.4*
-14.9*
-14.6*
1.04
1.10
1.02
-0.06 2.0
4.4
1.0
-18.2*
-17.6*
-14.1*
-12.6*
1.03
1.25
1.12
-0.2 1.9
3.5
<0.6
A31 -11.5 1.02 -1.4 1.3 N/A
A36 -8.7 1.00 -1.8 0 -11.0* 1.00 -0.8 0
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Table 6. Continued.
HxDMS
(mM)
40 50
U (kV) 8 6
Analyte m a b Rs m a b Rs
A02 -22.0 1.01 -1.4 1.0 -22.1 1.01 -1.2 1.4
A22 -23.5 1.01 -1.2 <0.6 -24.2 1.01 -1.2 <0.6
A23 -22.4 1.00 -1.3 0
A26 -27.5 1.00 -1.1 0
A27 -22.4 <1.01 -1.3 <0.6 -20.0 <1.01 -1.2 <0.6
A28 -11.8 1.02 -2.0 0.8 -12.6 1.01 -2.1 0.6
A30 -20.5
-20.6
-20.6
-20.6
1.01
1.00
1.00
-1.5 0.6
0
0
-18.0
-18.1
-18.1
-18.1
<1.01
1.00
1.00
-1.4 0.6
0
0
A31 N/A -10.5 1.02 -1.8 <0.6
A36 -13.1 1.00 -1.4 0 -14.6 <1.01 -1.3 <0.6
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Table 6. Continued.
HxDMS
(mM)
5 10
U (kV) 12 12
Analyte m a b Rs m a b Rs
B02 7.7 1.05 1.9 <0.6
B03 10.4 1.04 1.5 <0.6
B08 14.5 1.00 0.8 0
B09
B10 9.7 1.04 1.3 <0.6
B11 6.9 1.10 2.1 0.7
B13 5.8 1.12 2.6 0.9
B14 8.3 1.09 1.8 0.7
B18 -2.1 0.54 -14 2.4 -6.6 0.63 -2.2 8.0
B20 15.1 1.02 1.6 <0.6
B22 16.4 1.00 1.2 0
B23 -4.9 0.59 -5.8 3.0 -9.4 0.70 -1.5 5.2
B24 -0.7 1.00 -16 0
B25 5.9 1.04 2.1 0.6
B31 12.1 1.00 2.0 0
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Table 6. Continued.
HxDMS
(mM)
20 30
U (kV) 11 10
Analyte m a b Rs m a b Rs
B02 2.5 1.25 14  1.0 -0.9 0.81 -39 <0.6
B03 -2.3 0.90 -14 <0.6 -7.8 0.95 -4.1 1.0
B08 10.4 1.00 0.7 0 7.5 1.00 4.3 0
B09 6.0 1.00 1.1 0 3.0 1.00 5.4 0
B10 6.0 1.12 2.1 <0.6 3.2 1.34 11 0.9
B11 1.8 1.91 19  2.1 N/A
B13 -1.0 0.63 -30 0.7 -4.3 0.85 -7.2 1.7
B14 1.6 1.19 16 0.6 -2.3 0.93 -6.9 0.7
B18 -10.8 0.80 -2.7 6.4 -13.7 0.84 -2.5 7.3
B20 8.9 1.06 1.6 <0.6 6.2 1.11 2.2 0.6
B22 12.3 1.00 0.5 0 9.6 1.00 3.7 0
B23 -12.1 0.80 -2.2 11 -13.9 0.84 -2.2 7.6
B24 -3.5 1.00 -7.4 0 -5.8 1.00 -5.1 0
B25 1.1 1.34 20  0.8 -1.0 0.78 -30 19
B31 8.0 1.00 0.6 0 5.7 1.00 4.1 0
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Table 6. Continued.
HxDMS
(mM)
40 50
U (kV) 8 6
Analyte m a b Rs m a b Rs
B02 -2.5 0.90 -12 <0.6 -4.2 0.94 -6.3 0.6
B03 -8.9 0.96 -3.1 1.4 -10.1 0.96 -2.6 1.4
B08 4.4 1.00 5.8 0 2.9 1.00 8.1 0
B09 1.4 1.00 22 0 N/A
B10 0.7 1.59 43 0.7 -0.8 0.74 -32 0.6
B11 -2.9 0.67 -10 2.4 -4.8 0.81 -5.6 2.9
B13 -6.5 0.90 -4.5 1.8 -7.6 0.93 -3.4 1.9
B14 -5.4 0.95 -5.1 0.8 -3.9 0.93 -3.4 2.1
B18 -14.9 0.87 -2.0 8.6 -14.3 0.89 -1.8 8.2
B20 5.3 1.08 5.3 <0.6 4.4 1.07 19 <0.6
B22 7.8 1.00 3.6 0 6.3 1.00 3.9 0
B23 -14.8 0.88 -2.0 7.8 -14.0 0.91 -1.8 6.1
B24 -7.7 0.98 -3.9 <0.6 -8.9 0.98 -2.9 <0.6
B25 -2.8 0.83 -11 1.2 -4.2 0.89 -6.1 1.2
B31 3.7 1.00 6.8 0 2.2 1.00 11 0
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Table 6. Continued.
HxDMS
(mM)
5 10
U (kV) 12
Analyte m a b Rs m a b Rs
B34 16.1 1.01 0.9 <0.6
B35 1.2 1.09 24 1.0 -5.5 0.90 -2.3 1.9
B36 4.1 1.06 7.3 0.9 -0.8 0.86 -17 1.3
B37 6.5 1.00 1.9 0
B38 N/A
B39 15.0 1.02 0.8 <0.6
B41 6.6 1.00 2.1 0
B42 3.2 1.07 5.9 0.7
B45 10.6 1.00 1.2 0
B46 10.1 1.00 1.2 0
B51 8.1 1.00 1.8 0
B53 -2.9 0.83 -4.2 0.9
B54 -0.7 1.00 -19 0
B56 2.1 1.04 14 <0.6 -6.6 0.97 -2.7 0.7
Z04 2.1 1.33 6.3 0.7
Z06 2.1 1.27 6.9 <0.6
 * Polarity (-) to (+), NSA- as secondary EOF marker 
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Table 6. Continued.
HxDMS
(mM)
20 30
U (kV) 11 10
Analyte m a b Rs m a b Rs
B34 10.9 1.03 0.8 <0.6 8.1 1.04 22 <0.6
B35 -11.2* 0.91 -0.3 2.8 -14.7** 0.93 -1.5 7.1
B36 -5.7 0.95 -3.0 1.5 -9.8 0.96 -2.4 1.4
B37 3.8 1.00 2.1 0 1.2 1.13 9.9 <0.6
B38 3.6 1.11 4.3 <0.6 1.1 1.35 11 0.6
B39 4.7 1.03 2.9 <0.6 -1.3 0.92 -8.8 <0.6
B41 0.2 1.00 47 0 N/A
B42 -2.3 0.90 -4.8 1.5 -5.1 0.96 -4.8 0.6
B45 5.8 1.02 0.8 <0.6 2.6 1.31 8.5 <0.6
B46 6.4 1.00 0.7 0 4.6 1.07 2.8 <0.6
B51 3.1 1.08 3.4 <0.6 0.9 1.23 40 <0.6
B53 N/A -9.6 0.98 -2.2 <0.6
B54 -3.1 0.97 -4.2 <0.6 -4.3 1.00 -6.0 0
B56 -13.7 0.98 -2.1 0.7 -18.2** 0.99 -1.4 1.8
Z04 -8.1 0.90 -2.5 1.9 -13.7 0.94 -1.6 3.3
Z06 -9.5 0.82 -1.5 1.5 -18.3 0.87 -1.5 6.4
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Table 6. Continued.
HxDMS
(mM)
40 50
U (kV) 8 6
Analyte m a b Rs m a b Rs
B34 6.3 1.09 3.8 <0.6 5.3 1.08 4.9 <0.6
B35 -14.8 0.93 -1.8 5.1 -15.0 0.93 -1.6 18  
B36 -12.2 0.98 -2.3 1.3 -12.2 0.98 -2.0 0.6
B37 -0.6 1.00 -45 0 -2.1 1.00 -12 0
B38 -1.2 0.77 -32 0.7 -3.1 0.92 -8.2 0.8
B39 -5.7 0.94 -4.2 0.6 -8.9 0.95 -3.0 0.7
B41 -1.7 1.00 -16 0 -3.5 1.00 -7.0 0
B42 -6.7 0.98 -4.0 <0.6 -7.8 1.00 -3.3 0
B45 2.3 1.00 12 0 2.2 1.00 11  0
B46 4.7 1.00 6.1 0 4.7 1.00 5.2 0
B51 -1.0 0.90 -26 <0.6 -3.0 0.91 -8.6 0.8
B53 -11.0 1.00 -2.7 0 -11.4 1.00 -2.3 0
B54 -5.51 1.00 -4.4 0 -6.0 1.00 -4.1 0
B56 -16.6 0.99 -1.8 0.8 -14.8 0.99 -1.7 0.6
Z04 -16.6 0.96 -1.3 5.8 -19.0 0.95 -1.3 6.4
Z06 -22.4 0.91 -1.3 15 -18.0 0.96 -1.3 5.7
 ** U=11 kV
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Figure 71. Effective mobilities and separation selectivities for the separation of the
enantiomers of nonionic analytes in pH = 2.5 BGEs with HxDMS.
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bottom panels show the corresponding separation selectivities. The strength of complexation
between 1-phenylpentanol (N25) and 2-phenyl-2-pentanol (N26) and the three CD derivatives
decreased in the order of: HxDMS > HDMS > ODMS. Though the selectivities for both N25
and N26 with HDMS are larger than with HxDMS (Figure 72, bottom panel), the Rs values
obtained with HxDMS are much larger than with HDMS because stronger complexation with
HxDMS leads to more favorable b values (in most of the case, around -1) which, in turn,
compensate for the lower separation selectivities and helped peak resolution. Further along the
same lines, the enantiomers of methylmandelate (N15), styrene glycol (N24), 1-phenylpentanol
(N25), 2-phenyl-2-pentanol (N26), 1-indanol (N36) and 2-phenyl-2-butanol (N38), could not
be separated  with ODMS [110]; but most of them could be baseline-resolved with HxDMS.
The effects of structurally different substituents at the 2,3-positions (for the same CD) are well
demonstrated by the behavior of the two g-butyrolactone in our screening kit: g-(2-naphthyl)-g-
butyrolactone (N12) and g-(2-phenyl)-g-butyrolactone (N13). Under comparable conditions (i.
e., about 30 mM resolving agent concentration), the effective anionic mobilities of the naphthyl-
group containing N12 range (in 10-5 cm2/Vs units) from about -4, through -5 to -18 with HxS,
HxDAS and HxDMS, while the separation selectivities are 1.00, 1.04 and 1.06. On the other
hand, the effective anionic mobilities of the phenyl-group containing N13 cover a range of only
from about -3, through -7 to -11 (in 10-5 cm2/Vs units) with HxS, HxDAS and HxDMS, while
the separation selectivities decrease from about 1.15 through 1.03 to 1.00. Clearly, the
differences in the separation behavior are large.
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Figure 72. Effects of the cyclodextrin cavity size on the separation of the enantiomers of 1-
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5.2.2 Weakly Acidic Enantiomer Separations
Use of HxDMS as the chiral resolving agent in the pH = 2.5 BGEs for the separation
of a set of nine weak acid enantiomers yielded a total of seven separations with a > 1. The
mobilities of the weak acid analytes in the HxDMS - free BGEs were initially zero. The
effective mobility of the bands of the weak acid analytes become increasingly anionic with
increasing HxDMS concentration. Separation selectivities observed for the weak acid analytes
passed through a maximum at low HxDMS concentrations and are generally between 1.08 and
1.2. Figure 73 shows typical mobility (top panel) and separation selectivity (bottom panel)
plots for five of the weakly acidic enantiomers in the low pH HxDMS BGE. Baseline
separation was achieved for five of the seven analytes with a > 1, in part because the b values
were favorable (around -1).
HxDMS also complexed with all of the weak acid analytes tested quite strongly. While
the effective anionic mobilities were similar for A28 and A36 that have similar structural
features, they were much smaller than the anionic effective mobilities for A02 or A22. The
latter can be rationalized by the more extended hydrophobic backbone of both A02 and A22,
compared to A28 and A36 (analogously to the case of N12 vs. N13). While separation
selectivities for A02 and A22 that had similar mobilities (about -20x10-5 cm2/Vs) in the 30 mM
HxDMS BGE were similar (1.02), comparable effective mobilities for A28 and A36 (about
-11x10-5 cm2/Vs) were accompanied by quite different separation selectivities (1.02 vs. 1.00).
Just as with the nonionic analytes, the size of the cyclodextrin cavity has significant 
189
0 20 40
1.00
1.02
1.04
1.00
1.02
1.04
0 20 40
-25
-20
-15
-10
-5
0
-25
-20
-15
-10
-5
0
 
a
C 
H x D M S
 /  mM
 
m
ef
f  /
 1
0-
5  c
m
2
 V
-1
 s
-1
C 
H x D M S
 /  mM
 A 0 2
 A 2 2
 A 2 8
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effects on the enantiomer recognition process for weak acid analytes. Figure 74 shows the
effective mobility plots (top panel) and the corresponding separation selectivities (bottom
panel) for fenoprofen (A22) with HxDMS, HDMS and ODMS  as chiral resolving agents in the
pH 2.5 = BGE. Unlike the separation trends that were observed with HxS, HS, OS, and
HxDAS, HDAS, ODAS, fenoprofen (A22) interact with HxDMS much more strongly than with
HDMS and ODMS: the strength of interaction decrease in the order: HxDMS > HDMS @
ODMS.
Compared with the other 6-O-sulfo-a-CD, HxS and HxDMS interact with A02 and A28
similarly strongly, while HxDAS interact with them very weakly. On the other hand, separation
selectivity for A02 is similarly low with HxS and HxDMS (1.03 vs. 1.02), but it is high (1.4)
with the weakly complexing HxDAS. For other weak acids, such as A28, separation selectivity
is 1.02 with HxDMS, but 1.00 with HxS and HxDAS. These observations, which cannot be
rationalized by simple, intuitive structural arguments, further emphasize the need for (and the
value of) detailed NMR spectroscopic studies in deciphering the mysteries of enantiomer
interactions with sulfated CDs.
5.2.3 Separation of the Enantiomers of Weak Bases
The enantiomers of 24 of the 29 pharmaceutical weak bases were fully or partial
separated with HxDMS in the pH = 2.5 BGEs. Just as with the other single-isomer sulfated
CDs, the weak base enantiomers can also be classified as weakly binding bases (the effective
mobilities did not become anionic throughout the entire HxDMS concentration range studied,
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Figure 74. Effects of the cyclodextrin cavity size on the separation of the enantiomers of
fenoprofen in pH = 2.5 BGEs with HxDMS, HDMS, ODMS.
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0 to 50 mM, e. g., B22), moderately strongly binding bases (the effective mobilities did become
anionic but remained close to zero in the HxDMS concentration range studied, e. g., B10), and
strongly binding bases (the effective mobilities did become anionic at low HxDMS
concentration and passed a shallow local maximum as the HxDMS concentration was
increased, e. g. B56). 
The effective mobility and separation selectivity curves for two of the weakly binding
weak base enantiomers are shown in the top panels in Figure 75. The initial effective mobilities
(left top panel in Figure 75) are between 26 and 28 mobility units. As the HxDMS
concentration is increased, the mobilities approach zero but still remain cationic due to the
effects of both the increased mole fractions of the analyte - HxDMS complexes, and the
increased ionic strength and viscosity of the BGE. Separation selectivities (right top panel in
Figure 75) go through a maximum value. 
The effective mobilities of the moderately strongly and strongly binding weak bases are
cationic at low HxDMS concentrations and anionic at  high HxDMS concentrations. The middle
and bottom panels in Figure 75 show the mobility (left panel) and separation selectivity curves
(right panel) for four typical, moderately strongly and strongly binding weak bases,
respectively. As the mobility of the slower enantiomer approaches zero, there is a discontinuity
in separation selectivity.
The size of the like-substituted cyclodextrin has a significant effect on the separation
of the enantiomers of the weak bases as well. For example, while the enantiomers of
bupivacaine (B10), bupropion (B11), mepenzolate bromide (B25) and oxyphencyclimine 
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(B36) could not be separated with ODMS, despite the quite reasonable b value [110], they
could all be baseline separated with HxDMS.
The effects of the structure of the 2,3-substituents of sulfated a-CDs on the separation
of the enantiomers of the weak bases are typified by Figure 76. Figure 76 shows the effective
mobility plots (top panel) and the corresponding separation selectivities (bottom panel) for
fluoxetine (B18) with HxDMS, HxDAS and HxS as the chiral resolving agent. The strength of
the interactions between fluoxetine (B18) and HxDMS, HxDAS and HxS decrease in the
following order: HxDMS > HxDAS > HxS. Similarly, the strength of the interaction between
alprenolol (B02), aminogluthetimide (B03), oxybutynin (B35), pindolol (B41) and propranolol
(B42) and the sulfated a-CDs decrease in the order of HxDMS > HxDAS > HxS. On the other
hand, the effective mobilities in the 50 mM sulfated a-CD BGEs are about equal for atenolol
(B08). For norephedrine (B34), the interaction strength is strongest for HxS and weakest for
HxDAS, while for phenylglycinonitrile (B39), the interaction strength is strongest for HxDMS
and weakest for HxDAS. These observations further demonstrate that there are significant
differences between the interaction strengths of the differently2,3-substituted 6-O-sulfo-a-CD,
but that our current level of understanding, the differences cannot be explained from the
structure of the analyte. Detailed NMR studies are desperately needed to find an explanation
for the observed differences. 
Representative electropherograms obtained for some of the nonelectrolyte, weak acid,
and weak bases at low pH are included in Figures 77 and 78, respectively.
195
0 20 40 60
-1
0
1
-1
0
1
0 20 40 60
-20
-10
0
10
20
-20
-10
0
10
20
 
a
C 
C D
 / mM
B18
HxDMS
HxDAS
HxS
 
m
 e
ff
 /
 1
0-
5  c
m
2
 V
-1
 s
-1
C 
C D
 / mM
Figure 76. Effects of the type of the CD substituents on the separation of the enantiomers of
fluoxetine in pH = 2.5 BGEs with HxS, HxDAS, HxDMS.
196
4 5 6 7 8 4 6 8 10 12 14 16 10 15 20 25 30
4 6 8 10 12 14 16 4 6 8 10 12 14 16 18 4 6 8 10 12 14
4 5 6 5 . 0 5 . 5 35 40 45 3 4 5
5 10 15 20 3 4 5 6 4 8 12 16 20
D M S O
T i m e  /  m i n
N 1 0 ,  8  k V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
N 1 2 ,  8  k V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
N 1 5 ,  6  k V
5 0  m M  H x D M S
D M S O
T i m e  /  m i n
N 2 1 ,  6  k V
5 0  m M  H x D M S
D M S O
T i m e  /  m i n
N 2 5 ,  8  k V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
N 3 0 ,  8  K V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
N 3 6 ,  1 2  k V
1 0  m M  H x D M S
D M S O
T i m e  /  m i n
A 0 2 ,  6  k V
5 0  m M  H x D M S
D M S O
T i m e  /  m i n
A 2 2 ,  1 1  k V
2 0  m M  H x D M S
D M S O
T i m e  /  m i n
A 2 8 ,  1 1  k V
2 0  m M  H x D M S
N S A
-
T i m e  /  m i n
A 3 0 ,  1 1  k V
2 0  m M  H x D M S
D M S O
T i m e  /  m i n
A 3 1 ,  1 1  k V
2 0  m M  H x D M S
Figure 77. Typical electropherograms of separation of the enantiomers of the nonelectrolyte and
weak acid analytes in pH = 2.5 BGEs with HxDMS.
197
4 5 6 5 .0 5 .5 6 .0 6 .5 7 .0 2 .8 3 .0 3 .2 3 .4
6 7 8 9 2 3 4 5 3 4 5 6
3 .6 3 .8 4 .0 4 .2 4 6 8 1 0 4 5 6 7
2 4 6 8 1 0 1 2
D M S O
T i m e  /  m i n
B 0 3 ,  8  k V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 1 1 ,  6  k V
5 0  m M  H x D M S D M S O
T i m e  /  m i n
B 1 3 ,  1 0  k V
3 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 1 4 ,  6  k V
5 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 1 8 ,  1 0  k V
3 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 2 3 ,  1 1  k V
2 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 2 5 ,  8  k V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 3 5 ,  8  k V
4 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 3 6 ,  1 1  k V
2 0  m M  H x D M S
D M S O
T i m e  /  m i n
B 5 6 ,  1 1  k V
3 0  m M  H x D M S
Figure 78. Typical electropherograms of separation of the enantiomers of the weak base
analytes in pH = 2.5 BGEs with HxDMS.
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5.3 Enantiomer Separations in pH = 9.5 BGEs
The enantiomer of a series of neutral, weak acid and weak base analytes were also
 separated  with HxDMS in pH = 9.5 BGEs. Table 7 lists values of  m (the effective mobilities
of the less mobile enantiomer), a, b, Rs, and U in the pH = 9.5 BGEs. Again, N/A indicates that
the aforementioned values could not be calculated due to either overlap with non-comigrating
system peaks or comigration of an enantiomer peak with the neutral marker.
5.3.1 Separation of the Enantiomers of Nonionic Analytes
The enantiomers of eight of the thirteen nonionic analytes were separated by HxDMS
in the high pH BGEs. The anionic mobilities of the non-charged enantiomers increased
monototically with increasing HxDMS concentration (top panel in Figure 79). The selectivity
plots resembled those obtained at low pH (bottom panel in Figure 79). 
The anionic effective mobilities of the nonelectrolyte analytes were almost identical
in the pH=9.5 and pH=2.5 BGEs. This behavior is different from what was observed with HxS,
with which the effective mobilities in the high pH BGEs were lower than in the acidic BGEs
indicating that components of the ethanolamine - MSA buffer competed with the nonelectrolyte
analytes for HxS more strongly than components of the H3PO4 - LiOH buffer did. Not
surprisingly, separation selectivities were almost identical in the low pH and high pH HxDMS
BGEs, reinforcing the notion that for this set of analytes, there were no preferred
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Table 7. Separation data in pH=9.5 HxS BGEs.   (m, in 10-5 cm2 / Vs units)
HxDMS (mM) 0 10
U (kV) 11
Analyte m m a b Rs
N02 0 -3.2 1.00 -14 0.0
N12 0 -12.3 1.00 -2.8 0.0
N13 0 -4.5 1.00 -10 0.0
N21 0 -4.3 1.00 -11 0.0
N24 0 -1.4 1.00 -33 0.0
N25 0 -8.3 1.02 -4.1 <0.6
N26 0 -3.3 1.00 -14 0.0
N27 0 -2.6 1.00 -18 0.0
N28 0 -2.6 1.00 -18 0.0
N30 0 -5.2 1.20 -6.7 1.6
N34 0 -3.1 1.00 -15 0.0
N36 0 -2.3 1.35 -15 1.1
N38 0 -2.5 1.00 -19 0.0
A02 -23.0 -26.2 <1.01 -1.7 <0.6
A22 -21.1 -24.0 1.00 -1.5 0.0
A23 -22.7 -23.1 1.00 -1.6 0.0
A27 -19.6 -21.2 1.00 -1.6 0.0
A28 -29.1 -27.5 1.00 -1.7 0.0
A30 -24.0 -22.3 1.00 -1.9 0.0
A31 -20.9 -21.4 1.00 -1.8 0.0
A36 -23.9 -23.2 1.00 -2.0 0.0
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Table 7. Continued. 
HxDMS
(mM)
20 30
U (kV) 11 10
Analyte m a b Rs m a b Rs
N02 -6.50 1.00 -4.7 0 -9.4 1.00 -3.3 0
N12 -17.0 1.02 -2.3 0.8 -18.5 1.07 -1.7 5.7
N13 -7.98 1.00 -3.7 0 -10.1 1.00 -3.1 0
N21 -8.0 1.02 -5.0 <0.6 -10.9 1.03 -3.3 <0.6
N24 -3.05 1.00 -12 0 -4.6 1.00 -7.1 0
N25 -14.22 1.04 -2.7 0.7 -19.3 1.05 -1.8 1.6
N26 -7.0 1.01 -4.9 <0.6 -10.4 1.02 -3.0 <0.6
N27 -5.03 1.00 -5.2 0 -6.9 1.00 -4.5 0
N28 -4.88 1.00 -5.1 0 -6.8 1.00 -4.6 0
N30 -10.5 1.13 -3.6 2.4 -15.7 1.07 -2.2 1.7
N34 -5.33 1.00 -4.2 0 -6.9 1.00 -4.6 0
N36 -4.79 1.31 -7.6 2.8 -6.4 1.27 -5.5 3.6
N38 -5.02 1.00 -6.8 0 -6.4 1.00 -4.9 0
A02 -26.3 <1.01 -1.7 <0.6 -26.4 <1.01 -1.3 0.6
A22 -25.5 1.00 -1.7 0 -26.2 1.00 -1.5 0
A23 -23.6 1.00 -1.8 0 -24.0 1.00 -1.6 0
A28 -26.9 1.00 -1.6 0 -26.7 1.00 -1.3 0
A30 -22.0 <1.01 -2.0 <0.6 -21.9 <1.01 -1.5 0.7
A31 -21.9 1.00 -2.0 0 -22.6 1.00 -1.7 0
A36 -22.1 1.00 -2.0 0 -21.9 1.00 -1.5 0
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Table 7. Continued.
HxDMS
(mM)
40 50
U (kV) 8 6
Analyte m a b Rs m a b Rs
N02 -11.3 1.00 -2.5 0  -12.6 1.00 -2.2 0
N12 N/A N/A
N13 -11.0 1.01 -2.7 <0.6 -11.6 1.01 -2.3 <0.6
N21 -12.1 1.04 -2.7 <0.6 -12.6* 1.04 -1.9 1.2
N24 -5.4 1.02 -5.5 <0.6 -6.0 1.03 -3.3 <0.6
N25 -20.7 1.05 -1.6 1.8 -20.8 1.05 -1.2 3.2
N26 -12.6 1.03 -2.6 0.6 -13.2 1.02 -2.0 <0.6
N27 -7.96 1.00 -4.1 0 -8.7 1.00 -2.8 0
N28 -7.97 1.00 -4.1 0 -8.9 1.00 -2.6 0
N30 -18.3 1.05 -1.6 2.5 -19.4 1.03 -1.3 2.4
N34 -7.94 1.00 -4.1 0 -9.0 1.00 -2.8 0
N36 -7.18 1.25 -4.2 4.0 -7.7 1.23 -3.3 5.5
N38 -7.5 1.00 -4.3 0 -8.6 1.02 -2.8 <0.6
 *U=5 kV
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Table 7. Continued.
HxDMS
(mM)
0 10 20
U (kV) 18 11 11
Analyte m m a b Rs m a b Rs
B02 10.4 2.7 1.52 18 <0.6 -1.1 0.94 -47 <0.6
B03 8.6 -2.0 0.94 -20 <0.6 -5.9 0.95 -6.9 0.6
B08 10.9 8.0 1.02 4.4 <0.6 6.2 1.04 6.6 <0.6
B10 0.8 -2.4 0.80 -12 <0.6 -5.1 0.85 -8.2 <0.6
B11 1.5 -7.1 0.87 -4.2 1.2 -11.4 0.88 -3.7 2.3
B13 14.8 N/A -3.4 0.89 -8.4 0.7
B14 5.9 -2.1 0.90 -21 1.4 -5.5 0.95 -8.0 0.6
B18 10.3 -4.7 0.69 -6.6 2.1 -11.4 0.80 -3.7 3.2
B22 10.0 -2.3 0.85 -20 0.6 -6.6 0.86 -6.3 1.5
B23 9.0 -18.2 0.81 -2.4 4.0 -23.5 0.83 -1.8 10
B24 7.0 -5.2 1.00 -6.6 0 -9.9
-10.2
0.99
0.97
-4.0 <0.6
<0.6
B25 18.0 4.9 1.10 9.0 <0.6 1.6 1.33 27 <0.6
B31 10.6 6.2 1.01 7.3 <0.6 4.1 1.03 9.7 <0.6
B34 8.5 5.9 1.02 6.9 <0.6 4.2 1.03 7.5 <0.6
B35 8.5 -17.5 0.88 -2.5 1.2 -22.0 0.89 -1.7 2.8
B36 16.0 -2.2 0.88 -13 <0.6 -7.1 0.94 -5.9 0.7
B39 0.0 -2.7 1.07 -14 <0.6 -4.6 1.06 -9.0 <0.6
B42 10.1 -0.9 1.00 -50 0 -4.6 0.88 -8.8 <0.6
B51 8.0 -2.1 0.88 -20 <0.6 -7.2 0.95 -5.8 0.6
B54 0.0 -4.5 1.14 -7.8 <0.6 -7.2 1.13 -5.8 <0.6
B56 9.9 -9.8 0.98 -4.7 <0.6 -17.0 0.99 -2.5 <0.6
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Table 7. Continued.
HxDMS (mM) 30 40
U (kV) 10 8
Analyte m a b Rs m a b Rs
B02 -3.9 0.94 -9.0 <0.6 -6.2 0.96 -4.6 0.7
B03 -7.8 0.95 -5.0 0.6 -9.0 0.95 -3.7 1.1
B08 4.6 1.05 8.0 <0.6 3.9 1.05 8.7 <0.6
B10 -7.9 0.93 -4.1 <0.6 -9.6 0.97 -3.4 0.8
B11 -14.8 0.90 -2.7 3.7 -15.9 0.91 -2.1 5.5
B13 -7.6 0.91 -2.8 1.1 -10.8 0.93 -3.1 0.6
B14 -10.2 0.95 -2.7 0.8 -14.1 0.96 -2.4 0.9
B18 -15.1 0.85 -2.6 3.8 -16.2 0.88 -2.1 4.4
B22 -10.0 0.87 -3.7 3.2 -12.0 0.87 -2.8 3.3
B23 -24.5 0.86 -1.5 15 -24.3 0.89 -1.4 17
B24 -12.4
-12.7
0.99
0.97
-1.9 <0.6
0.8
-14.7
-15.1
0.99
0.97
-2.1 <0.6
0.7
B25 N/A -2.0 0.77 -16 0.9
B31 2.4 1.05 15 <0.6 1.6 1.07 20 <0.6
B34 2.7 1.05 9.8 <0.6 2.6 1.06 12 <0.6
B35 -22.6 0.90 -1.6 1.1 -22.6 0.91 -1.4 9.1
B36 -10.4 0.96 -2.0 0.8 -11.4 0.97 -2.9 0.9
B39 -6.3 1.05 -5.8 0.6 -7.3 1.05 -4.5 0.8
B42 -7.3 0.89 -2.9 <0.6 -8.8 0.91 -3.6 <0.6
B51 -10.8 0.96 -3.4 0.7 -13.9 0.96 -2.4 0.8
B54 -9.8 1.10 -3.7 <0.6 -12.6 1.07 -2.6 <0.6
B56 -19.9 0.99 -1.8 <0.6 -20.5 0.99 -1.6 0.6
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Table 7. Continued.
HxDMS (mM) 50
U (kV) 6
Analyte m a b Rs
B02 -8.6 0.97 -3.1 <0.6
B03 -9.7 0.95 -2.8 1.1
B08 4.1 1.05 6.2 0.8
B10 -11.1 0.96 -2.4 1.7
B11 -16.1 0.91 -1.7 6.2
B13 -12.0 0.92 -2.2 0.7
B14 -17.6 0.97 -1.6 2.8
B18 -17.1 0.90 -1.7 8.2
B22 -13.9 0.87 -2.0 6.8
B23 -23.2 0.88 -1.3 18
B24 -14.6
-14.9
0.99
0.98
-1.8 <0.6
0.8
B25 -3.6 0.87 -7.8 1.3
B31 1.9 1.06 14 <0.6
B34 2.9 1.05 27 <0.6
B35 -21.8 0.89 -1.2 22
B36 -11.9 0.98 -2.3 0.9
B39 -8.1 1.05 -3.4 1.1
B42 -10.2 1.00 -2.6 0.0
B51 -13.8 0.96 -1.9 1.7
B54 -15.0 1.06 -1.7 <0.6
B56 N/A
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Figure 79. Effective mobilities and separation selectivities for the separation of the
enantiomers of nonionic analytes in pH = 9.5 BGEs with HxDMS.
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BGE in terms of the pH of the BGE.
Again, just as in the low pH BGEs, the unfavorable b values in the high pH BGEs with
ODMS and  HDMS system led to unsuccessful enantiomer separations. However, neutral
analytes complexed strongly complexed with HxDMS, which led to favorable b values, and
good peak resolution values. Figure 80 shows the effective mobilities (top panel) and
separation selectivities (bottom panel) for 1-phenylpentanol (N25) in  pH = 9.5 BGEs with
HxDMS, HDMS and ODMS. The complexation strength between N25 and these three chiral
resolving agents follows the order: HxDMS >> HDMS @ ODMS. Though separation selectivity
for N25 with HDMS is bigger than with HxDMS, the Rs values with HDMS are smaller than
with HxDMS because the b value are unfavorable(-6 to -15 ) with HDMS. ODMS did not
resolve the enantiomers of N25.
HxDMS performed as a better chiral resolving agent than ODMS: the enantiomers of
1-phenylbutanol  (N21), styrene glycol (N24), 1-phenylpentanol (N25), 2-phenyl-2-pentanol
(N26), 1-indanol (N36) and 2-phenyl-2-butanol (N38), were separated by HxDMS; but not by
ODMS.
5.3.2 Separation of the Enantiomers of Weak Acids
With HxDMS, the anionic effective mobilities of the weak acid analytes typically
increased as the concentration of HxDMS was increased, and were higher (or considerably
higher) than what was observed with HxS, indicating stronger intermolecular interactions.
There were two weak acids that behaved atypically: the effective mobilities of A28 and A30
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decreased as the concentration of HxDMS was increased, a difference with respect to what
was observed with HxS as well. In general, separation selectivities were inferior compared
to what were seen in the low pH BGEs. Partial separation was observed for the enantiomers
of only two  of the weak acids compared to five (A02, A22, A26, A28 and A31) in the low pH
BGE’s. This behaviors reinforces the notion introduced in Ref. 119 that for weak electrolyte
analytes the CE enantiomer separations might be desionoselective or ionoselective, and call
for trying the separations in two BGE’s with pH values sufficiently far below and above the
pKa of the analytes. Again, NMR spectroscopic studies might be able to reveal why separation
selectivity became equal to one at high pH, despite the fact that the effective mobilities in the
low and high pH BGEs were virtually identical. Although the solubility of the weak acid
enantiomers was better in the high pH BGEs than in the low pH BGEs, peak resolution was
generally poor due to the unfavorable b values.
The pH of the BGEs play a big role in the chiral recognition process: in the low pH
BGEs, the enantiomers of fenoprofen (A22) could be separated, in the high pH BGEs, they
could not be separated, similarly to what was seen for HxS in Chapter IV.
5.3.3 Separation of the Enantiomers of Weak Bases
Almost all the weak base enantiomers that we tested showed some measure of
separation selectivity with HxDMS in high pH aqueous BGEs. Separations of the weak base
analytes with HxDMS in the high pH BGEs were fast because the EOF mobility is considerably
high (26-50 mobility unit) due to the increased charge density of the capillary wall. As the
HxDMS concentration is increased in the high pH BGEs, the enantiomer bands acquire anionic
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effective mobilities at considerably lower HxDMS concentrations than in the low pH BGE. The
weak base analytes can be classified into two categories: weakly binding and strongly binding.
The left panels in Figure 81 show the effective mobility (top panel) and separation selectivity
(bottom panel) curves of three typical, weakly binding weak base enantiomers, while the right
panels show the mobility (top panel) and separation selectivity curves (bottom panel) for seven
typical, strongly binding weak bases. 
Even though the number of enantiomers for which favorable separation selectivities
were found in the high pH BGEs is similar to that in the low pH BGEs, separation selectivities
with HxDMS were different. Desionoselective and ionoselective separations were observed
as well. For example, the enantiomers of four weak base analytes, such as, atenolol (B08),
ketamine (B22), metoprolol (B31) and verapamil (B54), could not be separated with HxDMS
in the low pH BGEs, but were successfully separated in high pH BGEs. 
In addition to the pH effects, differences in the strength of interactions were found for
the weak base analytes with the 6-O-sulfo CDs that were similarly substituted, but have
different size. Significant separation selectivity differences were also found. HxDMS  behave
as a better chiral resolving agent than ODMS for weak base analytes in high pH BGEs. The
enantiomers of following nine weak base analytes, such as, atenolol (B08), bupivacaine (B10),
bupropion (B11), ketamine (B22), mepenzolate bromide (B25), metoprolol (B31),
norephedrine (B34), oxyphencyclimine (B36) and 2-phenylglyicidonitrile (B39), could not be
separated by ODMS in the pH = 9.5 BGEs; however, the enantiomers of all these analytes 
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were resolved with HxDMS in the pH = 9.5 BGEs. The cavity size of the CDs also affected
the separation tendencies. Figure 82 shows the effective mobility plots (top panel) and the
corresponding separation selectivities (bottom panel) for ketamine (B22) with HxDMS, HDMS
and ODMS as the chiral resolving agents in the pH = 9.5 BGEs. Just as in the low pH BGEs,
the strength of interactions between ketamine (B22) and the CD derivatives decreases in the
order: HxDMS > HDMS @ ODMS. 
Just as in the low pH BGEs, The type of the 2,3- substituents of the single -isomer 6-O-
sulfo a-CDs also plays a role in their interactions with the enantiomers of the weak base
analytes in the high pH BGEs. Figure 83 shows the effective mobility plots (top panel) and the
corresponding separation selectivities (bottom panel) for tolperisone (B51) with HxDMS,
HxDAS and HxS as chiral resolving agents. Tolperisone (B51) interacts with HxDMS very
strongly, with HxDAS moderately strongly, with HxS, weakly. A few typical enantiomer
separations obtained with HxDMS are illustrated in Figure 84. The numbers under the
compound codes show the concentration of HxDAS (in mM) and the applied potential (in kV)
used.
5.4 Summary
The third novel, single-isomer, sulfated cyclodextrin, the sodium salt of hexakis(2,3-di-
O-methyl-6-O-sulfo)-a-cyclomaltohexaose (HxDMS), has been produced on the large scale
with greater than 98% isomeric purity. It has been successfully used as a chiral resolving agent
for the capillary electrophoretic separation of neutral, weakly acidic and weakly basic
enantiomers in the pH = 2.5 and the pH = 9.5 aqueous BGEs.
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CHAPTER VI
CONCLUSIONS
The low aqueous solubility of native a-cyclodextrin limits its application as the chiral
resolving agent in aqueous BGEs. Charged a-cyclodextrins provide at least two important
advantages over neutral a-CDs. First, both neutral chiral analytes and charged chiral analytes
can be enantioresolved with charged a-CDs. Second, introduction of ionic groups on the a-CD
enhances the solubility of charged a-CDs in aqueous media. Single-isomer charged a-CDs
could provide a very reproducible separation system. Since the type of the CD substituents
profoundly influences the chiral recognition process, three, pure, single-isomer, 6-O-sulfo a-
cyclodextrins, the sodium salts of hexakis (2,3-di-O-acetyl-6-O-sulfo)-a-CD (HxDAS),
hexakis (6-O-sulfo)-a-CD (HxS), and hexakis (2,3-di-O-methyl-6-O-sulfo)-a-CD (HxDMS)
have been synthesized, analytically characterized and used as chiral resolving agents in
capillary electrophoresis. HxDAS, HxS and HxDMS were synthesized on a large scale (500
grams) in greater than 98% purity, through a synthetic scheme which sequentially protects-
deprotects the 2,3- and 6-hydroxyl groups of native a-cyclodextrin by using regioselective
chemical processes. The purity of each synthetic intermediate and of the final products was
determined by either HPLC-ELSD or indirect UV-detection capillary electrophoresis (CE).
The chemical and structural identity of each single-isomer intermediate and final product was
verified by 1D 1H, 13C and 2D COSY, HETCOR NMR spectroscopy and by high resolution
MALDI-TOF MS and ESI-TOF MS. These characterization methods, when interpreted
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together, yielded convincing evidence that HxDAS, HxS and HxDMS are isomerically pure and
have the expected substitution patterns. 
A series of neutral, acidic, basic and ampholytic enantiomers were separated in both
aqueous and nonaqueous background electrolytes (BGEs) with HxDAS, HxS and HxDMS using
CE. Rapid separations with satisfactory separation selectivity and peak resolution values were
obtained for most of the analytes. 
Using HxS, HxDAS and HxDMS for the separation of weak base enantiomers in both
aqueous (pH 2.5 and pH 9.5) and nonaqueous BGEs (for HxDAS), it was found that most bases
exhibited one of two specific mobility trends. The first group was called the group of strongly
binding weak bases: their effective mobilities became anionic even at very low HxS, or
HxDAS or HxDMS concentrations. The other group was called the group of weakly binding
weak bases: their effective mobilities remained cationic over the entire CD concentration range
tested.
The anionic effective mobilities of the neutral analytes increase monotonously with
increasing concentration of the three CD derivatives. They interact with the sulfated a-CDs
weakly which leads to short analysis times. Since most of the weak acid analytes are neutral
in low pH BGEs, the separation behavior is similar to those of the neutral analytes.
The use of HxDAS for the separation of the enantiomers of  weak base analytes in
acidic methanolic BGEs was very successful. Since high potential could be applied, very fast
separations were obtained. The b values were favorable for enantiomer separations in
methanolic BGEs. This resulted in  baseline separations in under 5 minutes, with very low
HxDAS concentrations. Many enantiomers were separated both in acidic aqueous and acidic
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methanolic BGEs, and showed decreased binding strengths in the acidic methanolic BGEs.
Experimental results show that the separation selectivity depends on (i) the cavity size
of the CD; (ii) the polarity of the substituents of the CD; (iii) the structure of the analyte; (iv)
the structure of the background electrolyte coion and counter-ion; (v) the type of organic
solvent; and (vi) the pH of the BGEs.
(i) Different substituents on the 6-O-sulfo-a-CDs lead to significantly different
enantiomer separations . The hydrophilic hydroxyl groups, the moderately hydrophobic acetyl
groups, and the hydrophobic methyl groups provided different inter-molecular interactions with
the chiral analytes. Thus, HxDAS, HxS and HxDMS can provide different enantiorecognition
for a large number of chiral analytes and offer complimentary separation selectivities. For
example, the enantiomers of halostachin, atenolol, metanephrine, methoxyphenamine,
metoprolol, norephedrine, oxybutynin, oxyphencyclimine, piperoxan, pindolol, and propranolol
could be separated by using HxDAS as a chiral resolving agent in pH=9.5 BGEs; but, no
separation was achieved by HxS. Enantiomer separations were achieved for atropine,
chlophedianol, 2-phenylglyicidonitrile, propafenone, quinidine, salbutamol, and scopolamine
by HxS in pH=9.5 BGEs, but not by HxDAS. The complexation strength between the analytes
and the cyclodextrin derivatives decreased in the order of: HxDMS > HxDAS > HxS. 
(ii) The effects of the ring size of the CD on enantiorecognition are also very significant.
Pindolol, 2-phenyl-2-butanolol could be separated in pH=2.5 BGEs by using either HxDAS
or ODAS, but not with HDAS. The complexation strength of neutral, weak acid and weak base
analytes with a-CD derivatives (HxS, HxDAS and HxDMS) were found to be very different
from their corresponding b-CD analogues (HS, HDAS and HDMS), and g-CD analogues (OS,
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ODAS and ODMS). The complexation strength of these analytes with b-CD derivatives and
with g-CD derivatives however were similar to each other. For the hydrophilic derivatives and
moderately hydrophobic CD derivatives, the complexation strength generally increased in the
order of: HxS < HS @ OS, HXDAS < HDAS @ ODAS. However, for the hydrophobic CD
derivatives, binding strength decreased in the order of: HxDMS > HDMS @ ODMS.
(iii) The effects of analyte structure on enantiorecognition are also very important. For
example, the enantiomers of 2-phenyl-2-butanol and 2-phenyl-2-pentanol could be separated
by HxDAS in low pH BGEs; but not those of 2-phenyl butanol. Furthermore, enantiomer
separation was achieved for methylmandelate by HxDAS in low pH BGEs, but not for
ethylmandelate. Small changes in the analyte structure can also affect the separation trend: for
example, Dansyl-leucine binds weakly with HxDAS in pH 2.5 BGEs; but Dansyl-norleucine
binds strongly. 
(iv) Since different BGEs result in different electroosmotic flow mobilities while
affecting analyte properties, the type of the BGE (aqueous/nonaqueous, low pH / high pH) also
plays very important roles. For example, the four stereoisomers of labetalol (B24) can be
baseline separated in pH=9.5 aqueous BGEs, partially separated in acidic methanolic BGEs,
and not separated in pH=2.5 aqueous BGEs with HxDAS. It is not surprising to note that the
complexation strength between weak bases and HxDAS is much stronger in acidic aqueous
BGEs than in acidic methanol BGEs, because HxDAS is less dissociated in acidic methanol
BGEs than that in acidic aqueous BGEs, and because methanol is expected to reduce the extent
of inclusion of analyte into the cavity of the CD. 
(v) The structure of the background electrolyte co-ion and counter-ion also plays
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important roles in enantiomer separations. The anionic effective mobilities of neutral analytes
increase as the  concentration of HxS or HxDAS or HxDMS is increased in pH=9.5 BGEs
(ethanolamine / MSA), but the increase is smaller than in the corresponding pH=2.5 (H3PO4
/ LiOH) BGEs, indicating that components of the ethanolamine / MSA buffer compete with the
neutral analytes more strongly than components of the H3PO4  / LiOH buffer.
 In conclusion, three novel, single-isomer, sulfated cyclodextrins, the sodium salts of
hexakis(6-O-sulfo)-a-cyclodextrins (HxS), hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-
cyclodextrins (HxDAS), hexakis(2,3-di-O-methyl-6-O-sulfo)-a-cyclodextrins (HxDMS), have
been produced on the large scale with greater than 98% isomeric purity. They have been
successfully used as chiral resolving agents for capillary electrophoretic separation of the
enantiomers of neutral, weak acid, weak base and ampholytic analytes in aqueous and
methanolic BGEs. HxS, HxDAS and HxDMS have been shown to offer unique mobility and
separation selectivity trends as compared to other single-isomer, sulfated CDs.
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APPENDIX 
SYNTHESIS PROTOCOL FOR SINGLE-ISOMER SULFATED a-
CYCLODEXTRINS
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Hexakis (6-O-tert-Butyldimethylsilyl)-a-Cyclodextrin
1.  Dry native a-CD in a vacuum oven at 80 C to constant weight.
2.  With minimum exposure to air, add 6 L of anhydrous DMF, 444.4 g imidazole and 16.4 g
4-N’,N-dimethylamino pyridine (DMAP), to the 24 L three-neck flask. Stir until there is a
clear, light yellow solution. While swirling the funnel around, add 1000 g hot, dry a-CD, taken
directly from the vacuum oven, through the funnel into the flask.
3. Dropwise adding 1390 mL of anhydrous dichloromethane solution containing 463.5 g TBDS
chloride into the flask through the addition funnel. Another batch of 1854 mL anhydrous
dichloromethane containing 463.5 g TBDS chloride were dropwise adding at a rate of 1s/drop.
The total reaction time was 20 days.
4. Once 6 equivalents of TBDS chloride have been added, monitor progress of the reaction by
TLC which use 2.5x10 cm aluminum-backed Silica 60 plates) and 50 :10 :1 CHCl3 : MeOH :
H2O as run solvent. Once TLC indicates that the amount of the undersilylated, pentakis(TBDS)-
a CD is much less than that of the target compound (TBDS6 a-CD), continue monitoring the
reaction by isocratic HPLC.
5. Adding a 10mL sample of the reaction mixture, 2mL dichloromethane and 20mL methanol to
a glass vial to quench the reaction by letting it stand for 15 min, analyze the sample by isocratic
HPLC, at room temperature, using a 4.6 mm x 250 mm C18 column (5 mm Luna II C18 or
Zorbax or similar) and 20 : 80 ethylacetate : methanol eluent at 2mL/min. The total separation
time should be less than 20 min.
6.  Once the reaction is judged complete, quench it by adding 50mL methanol for each mole of
230
TBDS chloride introduced in excess of the 6 moles of TBDS chloride per mole of a-CD.
Continue stirring the reaction mixture for another hour. Add enough dry dichloromethane to the
reaction mixture to bring the ratio of dry dichloromethane to dry a CD to 6mL/g.
7.  Washing the reaction mixture with deionized water several times until the imidazole salts
were completely removed. Rotovap the dichloromethane solution to dryness.
8.  Purify the TBDS6 a CD collected in Step 7 by using methylethylketone as recrystallization
solvent (8mL MEKT/g of CD). Heat and reflux until obtain clear solution. Let cool down to
room temperature overnight. Filter collect crystal and analyze both the crystals (dissolve 20
mg in 5mL dichloromethane) and the methyl ethyl ketone mother liquor by isocratic HPLC as
in Step 5. Typical purity values for the crystal are as follows: undersilylated:< 0.1%, target
TBDS6 a CD: > 99.5%, oversilylated: <0.5%.
9. Dry the material in a vacuum oven at low temperature to constant weight. Store the dried
material under anhydrous conditions.
Hexakis (2,3-di-O-Acetyl-6-tert-Butyldimethylsilyl)-a-Cyclodextrin
1. Dry the pure, hexakis(6-O-tert-butyldimethylsilyl) cyclomaltohexaose, TBDS6-a CD in a
vacuum oven at 80oC to constant weight.
2.  Add 400mL anhydrous ethyl acetate, 155mL anhydrous pyridine, and 164mL acetic
anhydride to a three-neck flask.  While stirring, add, through a wide-bore plastic funnel, 200g
dry, TBDS6-a CD. And 11.7g 4-N,N-dimethylamino pyridine (DMAP) as catalyst. The
reaction mixture should become clear, and slightly yellow.  The temperature will increase to
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about 40 C, increase and maintain the temperature of the reaction mixture between 50-55oC, and
continue stirring for 10 to 12 hours.
3. Monitor the progress of the reaction. Add a 10mL aliquot of the original reaction mixture and
4mL of methanol to the vial. Analyze the sample by reversed-phase HPLC with a mixture of
20:80 ethyl acetate : methanol as eluent. The total analysis time should be about 15 min. The
target material elutes between 8 and 11 min.  
4. Quench the reaction by adding 19mL of ethanol once the reaction complete at room
temperature.  Keeping stir about 2-3 hours.
5. Wash the reaction mixture with deionized water (1:1 volume ratio of water and reaction
mixture) three times. And then wash the organic layers with acidic solution which prepared by
adding 15.4mL acetic acid to enough water, to obtain the same volume of reaction mixture.
Again, wash the acidic organic layer with deionized water several times to neutral. Rotovap
the organic solution with the water bath at 50oC to dryness.
6.  Using DMF as the recrystallization solvent to purify the crude product obtained in step 5
(1mL DMF/g CD). Heat and regulate the temperature of the solution between 55-60oC.  Once
a clear solution is obtained, let the solution cool to room temperature to obtain white
precipitate product. Filter and collect the solid. Check the purity of the product by HPLC as in
Step 3. The purity of the target product should be > 99.5%. 
Hexakis (2,3-di-O-Acetyl-6-Hydroxy)-a-Cyclodextrin
1. Place hexakis(2,3-diacetyl-6-O-tert-butyldimethylsilyl)cyclomaltohexaose, Ac12TBDS6-a
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CD, into a vacuum oven and dry it at 80oC to constant weight.
2. Add 800mL dichloromethane (reagent grade) to the one-neck round bottom flask. While
vigorously stirring in a well-ventilated hood, gradually add 200g Ac12TBDS6-a CD to the flask
and obtain a clear solution. Add 87.8mL BF3-etherate to the flask. Stir the reaction mixture for
28 hours.
3. Check progress of the reaction by TLC.  Use Silica 60 plates and 50 :10 :1 CHCl3 : MeOH
: H2O as run solvent yielding Rf = 0.33 for the target component.
4. As soon as the reaction is completed, transfer the reaction mixture into a 4L sep funnel. Add
1000mL of water to hydrolyze BF3. Carefully shake the funnel for about 5 seconds, then
immediately, but carefully relieve the built-up pressure (mostly ethyl ether and dichloromethane
vapors). Repeat the shaking and pressure release steps until there is no more pressure build-up.
5. Dissolve 8.74g NaHCO3 in 50mL water. Add the saved organic layer and the NaHCO3
solution to the 4 L sep funnel. Carbon dioxide will evolve as neutralization occurs. Carefully,
but thoroughly shake the sep funnel to neutralize the last traces of HF. Separate the phases, save
the organic phase and dispose the aqueous phase as waste. Wash the organic layer with 400mL
deionized water twice.
6. Concentrate the combined dichloromethane solution on a Rotovap to 1/4 of its original
volume. While vigorously stirring, pour the concentrated dichloromethane solution into the
beaker containing 700mL hexane to obtain a solid material. Analyze the solid  by isocratic
aqueous reversed-phase HPLC, at 40 C, using a 4.6mm x 250mm C18 column and a mixture of
52 : 48 methanol : water as eluent at 1.2mL/min. The total analysis time are in 20 min. The
overacetylated material elutes before the target, Ac12 -aCD.
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7. Add 200 mL acetone into a 1 L round bottom flask. Add the solid Ac12TBDS6-aCD
collected in Step 6 above to the flask. Place the flask onto a Rotovap and heat it until the
solution becomes clear. Distill off 50mL of the solvent, the remaining solution will become a
slurry. Allow the slurry to cool to room temperature and filter it to collect the crystals. Analyze
the crystals by HPLC as in Step 6. Repeat the crystallization process (step 7) until the purity
of the product is > 99.5%. 
12. Place the pure Ac12 -a-CD into a vacuum oven and keep it at room temperature over night
to dryness an store the material in a desiccator.
Hexakis (2,3-di-O-Acetyl-6-O-Sulfo) -a-Cyclodextrin (HxDAS)
1.  Place hexakis(2,3-diacetyl-6-hydroxy) cyclomaltohexaose,  Ac12 a CD, into a vacuum oven
and dry it at 60°C to constant weight.
2.  Add 800mL anhydrous DMF and 33 mL anhydrous pyridine to a 2L, one-neck, round-bottom
flask. While stirring, slowly add, through a wide-bore, plastic funnel, 400g recrystallized, dry
Ac12 a-CD. Keeping stir until the cyclodextrin is dissolved. Through a wide-bore plastic
funnel, add 310g SO3-Py complex and let it react for 6 hours at room temperature.
3.   Monitor progress of the reaction by indirect UV detection CE. Background electrolyte: 20
mM para-toluenesulfonic acid (pTSA) titrated to pH 3.5 with b- alanine, - to + polarity, 10 kV
applied potential, 19/26 cm effective/total length, 25mm I.D., naked fused silica capillary, at
20oC. 
4. Prepare a slurry with 344 g of sodium hydrogen carbonate in 440mL of hot water. Transfer
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the reaction mixture into a 3 L beaker with a 4" flat stir bar.  SLOWLY  add the bicarbonate
slurry to the stirred reaction mixture until there is no more bubble formation. Keep adding
sodium bicarbonate to get a basic solution.  Filter-off  solid sodium sulfate and excess sodium
bicarbonate.
5.  Transfer the solution into a 3L, one-neck, round-bottom flask and rotovap the solution to
dryness,  in a high-vacuum rotovap, at 50oC.
6. Dissolve the solid in a minimum amount of hot water. To as many as required 4 L beakers,
add 2.5 L of isopropanol (IPA). While stirring, add slowly 500mL of the reaction mixture to
remove any remaining DMF (5mL IPA per 1mL of reaction mixture).  Let the solid descend to
the bottom of the beaker (this can take several hours).  Filter and obtain the solid. 
7. Check for purity by CE as in step 4. Check the removal of the DMF by 1H NMR. If needed,
repeat Step 6.
8. Dissolve the solid with minimum amount of hot water and rotovap it to dryness in a high-
vacuum rotovap at 50oC. 
Hexakis (6-O-Sulfo) a-Cyclodextrin (HxS)
1. Add 117 g NaOH into a 1L beaker.  Place the beaker into an ice/water bath, on a stir plate.
While stirring, add 300mL of water.  Keep stirring until a clear solution is obtained. 
2.  Into a 4 L beaker, add 630mL of 50oC deionized water.  Place the beaker on a
heating/stirring plate.  While stirring, add 500g HxDAS.  Once the HxDAS is dissolved, slowly
add the solution prepared in step 1.  Let it stir for 1 to 2 h
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3.  Monitor reaction progress by CE (indirect UV detection). Background electrolyte: 13 mM
TEMED titrated with phthalic acid to pH 5.5, - to + polarity, 10 kV applied potential, 19/26
cm effective/total length, 25mm I.D., naked fused silica capillary, at 20oC. 
4.  To as many as required 4 L beakers, add  3 L methanol. While stirring, slowly pour 430mL
of the reaction mixture into methanol (6.7mL methanol per 1mL of reaction mixture).  A white
solid forms which is collected by filtration, after it settle to the bottom of the beaker. Filter and
obtain solid.
5.  Dissolve the solid obtained in step 4 in hot water (2mL of water per 1g solid).  Titrate the
solution to pH 7 using a calibrated pH meter, by slowly adding DOWEX cation exchange resin
in the H+ form. The solid resin is then filtered from the solution.
6.  Precipitate HxS by adding the solution into methanol (4mL of methanol per 1mL of solution).
  Analyze the solid by CE as in step 3. 
 7.  Dissolve the solid obtained in step 6 in hot water (1mL of water per gram of solid).
Precipitate HxS as in step 6, to remove last traces of sodium acetate.  Repeat the step if needed
it. 
8. Place the solid into crystallizing dishes and dry it in a vacuum oven at 60oC, until constant
weight is achieved.
 
Hexakis(2,3-di-O-Methyl-6-O-t-Butyldimethylsilyl) a-Cyclodextrin
1. Pure heakis(6-O-t-butyldimethylsilyl)cyclomaltohexaose, TBDS6-a-CD, is dried in a
vacuum oven at 90oC to a constant weight. 
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2. In a well ventilated hood, flame dry a 4-L, three neck, round bottom flask equipped with a
4" teflon- coated stir bar, a dry source of N2 gas at one neck and, at another neck, an oil bubbler
with 1" of paraffin oil. The oil bubbler is connected to the reaction flask through a valved
adapter with tubulation. The third neck is capped with a ground glass stopper of appropriate
size.
3. Weigh 10.43 g of NaH into the above dried 4-L three necks flask, and then cannulate750mL
of dried THF to this reaction flask. Lower the reaction flask into a dry paraffin oil bath before
proceeding further. In another oven dried, 3-L, round bottom flasks weigh 50-g of TBDS6-a-
CD. Canulate 2,000-mL from a septum capped, dried THF container to the 3-L round bottom
flask containing the TBDS6-a-CD. Canulate 33.8mL of iodomethane from a septum capped
container to the 3-L round bottom flask containing the TBDS6-a-CD and THF. Once the transfer
of the reaction solvent is complete, place an oven dried 500mL self- equilibrating funnel
equipped with a septum at its fill spout to one of the reaction flask neck. Next, in a smooth
motion, place the oil bubbler outlet onto a Liebig condenser and fit the condenser to the
reaction flask.
4. Canulate one- fihth of the TBMS6-a-CD/ CH3I/ THF solution into the self- equilibrating
funnel. Equip the Liebig condenser with a recirculating ice water bath. Make certain that the
oil bath has a volume large enough to exceed the height of the reaction solvent by a full two
inches.
5. While vigorously stirring the hydride/ THF slurry, add the solution from the addition funnel
at the rate of a thin but steady stream.  Hydrogen evolution will be observed at the oil bubbler
in less than 1-2 minutes. During the addition, monitor the rate of hydrogen evolution, the rate
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of reflux and the degree of foaming of the reaction mixture. Hydrogen evolution should be
stabilized at around 1-2 bubbles every second, reflux should not exceed 1-2 drops per second
and foaming should not be so great that the entire surface of the reaction mixture is thickly
covered. All of these measures are monitored to ensure that the iodomethane (b.p. 42oC) is not
allowed to escape the reaction apparatus. As each  funnel is emptied, canulate another portion
of the TBMS6-a-CD/CH3I/THF solution into the self-equilibrating funnel. The addition should
be completed in approximately 60 minutes. The reaction will be complete in another 360
minutes and should be monitored rigorously by using a 5mm Luna C18 RP-HPLC column with
a 65:35 MeOH : EtOAc isocratic mobile phase at 2mL/min.
6. Once the reaction is judged complete, quench it with the slow addition of 4.4mL of
anhydrous ethanol through the addition funnel over a period of 15- to 20 minutes. Allow the
quenched solution to continue stirring for another hour.
7. Filter the quenched reaction solution to remove the precipitated NaI. Rotovap the fitrate. The
water bath should be kept at approximately 50oC to prevent the formation of an amorphous
solid. Beware that the solution bumps violently as more NaI precipitates. Filter as necessary.
Once the crude product begins precipitating, continue to rotovap at the specified temperature
until no more solvent condenses into the collection vessel. At this point it is safe to increase
the temperature to rotovap all of the solvent away.
8. Add 2200 mL ethanol : H2O (1:10 v:v) mixture to to a 4-L one-neck round bottom flask. Add
the crude product (containing trace NaI salt and cyclodextrin impurities) 200 g to the flask
through a plastic funnel. Warm the slurry (keep 50oC) for 30 min. Turn off the Varic and let the
slurry cool down to room temperature. Filter off the Me12TBDS6 a-CD from the mother liquor
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Wash the filter cake while on the funnel with 10mL ice-cooled ethanol : H2O solvent. Analyze
both crystal and mother liquor  by isocratic RP-HPLC as step 5. 
9. Once the salt was completely removed, then add 475mL ethanol to a 2-L one-neck round
bottom flask. Add the Me12TBDS6 a-CD collected in step 8 (about (190 g) to the flask through
the funnel.  Heating the slurry to reflux for 2 hrs. Turn off the Varic and let the flask cool
overnight to form the final crystals. Filter off the Me12TBDS6 a-CD from the mother liquor
ethanol. Wash the filter cake while on the funnel with 10mL ice-cooled ethanol. Analyze both
crystal and mother liquor  by isocratic RP-HPLC as step 5. Typically purity value for the
crystal is: target Me12TBDS6 a-CD : >99.6%.
10. Dry the material in a vacuum at temperature 80oC until constant weight. Storied the dried
material.
Hexakis(2,3-di-O-Methyl)-a-Cyclodextrin 
1. In a 4-L polyethylene beaker containing 1.5-L of anhydrous ethanol while magnetically
stirring with a 4" teflon coated stir bar. After all Me12TBDS6-a-CD has dissolved (about 1
hour), slowly add, over a period of 20 minutes, 142.8mL of 48% aqueous HF solution. Cover
the beaker with aluminum foil and allow to stir 24 hrs. Check the completeness of the reaction
by TLC using 2.5x10 cm Silica 60 plates and 50 :10 :1 CHCl3 : MeOH : H2O as run solvent.
2. When the reaction is judged complete, take a 50mL aliquot and place it in a clean,
polyethylene beaker. Next, place the reaction flask in an ice bath and allow to cool for half
hour. Add a solution of 10mg of phenolpthalein in 1mL ethanol. Quench the reaction by slow
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addition of a 5M aqueous solution of NaOH in ethanol over the period of about 1 hour. The
quench solution is prepared by dissolving 144.54g of NaOH pellets in 128mL of deionized
water. This solution is cooled to room temperature before adding it  dropwise to 600mL of
anhydrous ethanol. Use the aliquot taken in step 2 to ensure that the reaction mixture is titrated
to the proper endpoint indicated by the faintest detectable pink color.
3. Once the solution is quenched, filter the NaF precipitate and wash the filter cake with 3 x
50mL of ice-cold, anhydrous ethanol. Rotovap the filtrate to dryness while filtering the NaF
precipitate as needed and properly washing the filter cake. Continue to rotovap in a boiling
water bath until dryness.
4. In a 5-L flask add the crude material 80 g to a 320mL of  DMF-water (1:1 v:v) mixture and
reflux while stirring for about an hour. Then turn off the Varic and add 20mL acetone to the
solution,  and let the solution cool overnight to get final product. Filter off the Me12 a-CD from
the mother liquor DMF-water-acetone. Wash the filter cake while on the funnel with 10mL ice-
cooled acetone. Continue recrystallization until no more t-butyldimethyl flouride peaks are
observed in the 1H- NMR and the product is of desired isomeric purity. Analyze both crystal
and mother liquor  by using a 5mm Luna C18 RP-HPLC column with a 75:25 MeOH: H2O
isocratic mobile phase at 1.2mL/min with temperature 50oC. Typically purity value for the
crystal is: target Me12 -a-CD : >99.6 %.
10.Dry the pure material in a 100oC in a vacuum oven to a constant weight. Storied the dried
material.
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Hexakis(2,3-di-O-Methyl-6-O-Sulfo)-a-Cyclodextrin
1.  Place 120g  recrystallized,   pure,   hexakis(2,3-O-methyl-6-hydroxy) cyclomaltohexaose,
Me12a-CD, into a vacuum oven and dry it at 60°C to constant weight.
2.  Add 500mL anhydrous DMF and 11mL anhydrous pyridine to a 2L, one-neck, round-bottom
flask.  While stirring, slowly add, through a wide-bore, plastic funnel; 100g recrystallized, dry
Me12a-CD.  Close the flask with a glass stopper and stir until the cyclodextrin is dissolved.
3. Through a wide-bore plastic funnel, add 100 g SO3-Py complex and let it react for 48 hours
at room temperature.
4.   Monitor progress of the reaction by indirect UV detection CE. Background electrolyte:  20
mM para-toluenesulfonic acid (pTSA) with 40mM tris(hydroxy)aminomethane (pH 8.3), + to -
polarity, 10 kV applied potential, 19/26 cm effective/total length, 25mm I.D., naked fused silica
capillary, at 20oC.
5. Prepare a slurry with 143 g of sodium bicarbonate in 175mL of hot water. Transfer the
reaction mixture into a 3 L beaker with a 4" flat stir bar.  SLOWLY  add the bicarbonate slurry
to the stirred reaction mixture until there is no more bubble formation.  When final solution is
basic, filter-off  solid sodium sulfate and excess sodium bicarbonate. Rotovap the solution to
dryness,  in a high-vacuum rotovap, at 50oC.
6. Add a volume of anhydrous ethanol equal to 6 times the amount of water required to dissolve
the material. The product will precipitate rapidly. Allow to cool and filter.  Repeat the
recrystallization with the same minimum volume of water and a 6 fold amount of anhydrous
ethanol until DMF is no longer detectable by 1H NMR. To remove Na2SO4, dissolve 100g of
241
recrystallized material in 25mL of deionized water and add 125mL ethanol and filter. Verify
the success of SO42- removal by indirect UV CE using the same BGE as the used for monitoring
the completion of the reaction.  This process will reduce the Na2SO4 contaminant to
approximately 1% by mass. A more complete removal is accomplished by filtration from a
50mM solution in methanol. Once the material is deemed free of all sulfate, DMF and
dimethylamine, transfer it to a 5L flask and add 500mL of deionized water. Rotovap the ethanol
as its water azeotrope until the product appears completely dry. Check that all ethanol has been
removed by 1H NMR.
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